WO2000053113A1 - Apparatus and method for treatment of tissue - Google Patents

Apparatus and method for treatment of tissue Download PDF

Info

Publication number
WO2000053113A1
WO2000053113A1 PCT/US2000/006496 US0006496W WO0053113A1 WO 2000053113 A1 WO2000053113 A1 WO 2000053113A1 US 0006496 W US0006496 W US 0006496W WO 0053113 A1 WO0053113 A1 WO 0053113A1
Authority
WO
WIPO (PCT)
Prior art keywords
electrode
coupled
energy delivery
tissue
delivery device
Prior art date
Application number
PCT/US2000/006496
Other languages
French (fr)
Other versions
WO2000053113A9 (en
Inventor
Roger Stern
Original Assignee
Thermage, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thermage, Inc. filed Critical Thermage, Inc.
Priority to DE60021063T priority Critical patent/DE60021063T2/en
Priority to AU37415/00A priority patent/AU779100B2/en
Priority to AT00916288T priority patent/ATE298536T1/en
Priority to CA2364098A priority patent/CA2364098C/en
Priority to EP00916288A priority patent/EP1158919B1/en
Priority to JP2000603604A priority patent/JP4102031B2/en
Publication of WO2000053113A1 publication Critical patent/WO2000053113A1/en
Publication of WO2000053113A9 publication Critical patent/WO2000053113A9/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/02Radiation therapy using microwaves
    • A61N5/04Radiators for near-field treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/40Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1402Probes for open surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • A61B2018/00023Cooling or heating of the probe or tissue immediately surrounding the probe with fluids closed, i.e. without wound contact by the fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452Skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452Skin
    • A61B2018/00458Deeper parts of the skin, e.g. treatment of vascular disorders or port wine stains
    • A61B2018/00464Subcutaneous fat, e.g. liposuction, lipolysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00696Controlled or regulated parameters
    • A61B2018/00702Power or energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00779Power or energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00875Resistance or impedance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1495Electrodes being detachable from a support structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/06Measuring instruments not otherwise provided for
    • A61B2090/064Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension

Definitions

  • This invention relates generally to a method and apparatus for treating tissue. More particularly, the invention relates to a method and apparatus for treating tissue using the controlled delivery of energy.
  • the human skin is composed of two elements: the epidermis and the underlying dermis.
  • the epidermis with the stratum corneum serves as a biological barrier to the environment.
  • pigment-forming cells called melanocytes are present in the basilar layer of the epidermis. They are the main determinants of skin color.
  • the underlying dermis provides the main structural support of the skin. It is composed mainly of an extracellular protein called collagen. Collagen is produced by fibroblasts and synthesized as a triple helix with three polypeptide chains that are connected with heat labile and heat stable chemical bonds. When collagen containing tissue is heated, alterations in the physical properties of this protein matrix occur at a characteristic temperature. The structural transition of collagen contraction occurs at a specific "shrinkage" temperature. The shrinkage and remodeling of the collagen matrix with heat is the basis for the technology.
  • Collagen crosslinks are either intramolecular (covalent or hydrogen bond) or intermolecular (covalent or ionic bonds).
  • the thermal cleavage of intramolecular hydrogen crosslinks is a scalar process that is created by the balance between cleavage events and relaxation events (reforming of hydrogen bonds). No external force is required for this process to occur.
  • intermolecular stress is created by the thermal cleavage of intramolecular hydrogen bonds.
  • the contraction of the tertiary structure of the molecule creates the initial intermolecular vector of contraction.
  • Collagen fibrils in a matrix exhibit a variety of spatial orientations.
  • the matrix is lengthened if the sum of all vectors acts to distract the fibril.
  • Contraction of the matrix is facilitated if the sum of all extrinsic vectors acts to shorten the fibril.
  • Thermal disruption of intramolecular hydrogen bonds and mechanical cleavage of intermolecular crosslinks is also affected by relaxation events that restore preexisting configurations.
  • a permanent change of molecular length will occur if crosslinks are reformed after lengthening or contraction of the collagen fibril.
  • the continuous application of an external mechanical force will increase the probability of crosslinks forming after lengthening or contraction of the fibril.
  • Hydrogen bond cleavage is a quantum mechanical event that requires a threshold of energy.
  • the amount of (intramolecular) hydrogen bond cleavage required corresponds to the combined ionic and covalent intermolecular bond strengths within the collagen fibril. Until this threshold is reached, little or no change in the quaternary structure of the collagen fibril will occur. When the intermolecular stress is adequate, cleavage of the ionic and covalent bonds will occur. Typically, the intermolecular cleavage of ionic and covalent bonds will occur with a ratcheting effect from the realignment of polar and nonpolar regions in the lengthened or contracted fibril.
  • Cleavage of collagen bonds also occurs at lower temperatures but at a lower rate.
  • Low level thermal cleavage is frequently associated with relaxation phenomena in which bonds are reformed without a net change in molecular length.
  • An external force that mechanically cleaves the fibril will reduce the probability of relaxation phenomena and provides a means to lengthen or contract the collagen matrix at lower temperatures while reducing the potential of surface ablation.
  • Soft tissue remodeling is a biophysical phenomenon that occurs at cellular and molecular levels. Molecular contraction or partial denaturization of collagen involves the application of an energy source, which destabilizes the longitudinal axis of the molecule by cleaving the heat labile bonds of the triple helix. As a result, stress is created to break the intermolecular bonds of the matrix.
  • the initial inflammatory response consists of the infiltration by white blood cells or leukocytes that dispose of cellular debris. Seventy-two hours later, proliferation of fibroblasts at the injured site occurs. These cells differentiate into contractile myofibroblasts, which are the source of cellular soft tissue contraction. Following cellular contraction, collagen is laid down as a static supporting matrix in the tightened soft tissue structure. The deposition and subsequent remodeling of this nascent scar matrix provides the means to alter the consistency and geometry of soft tissue for aesthetic purposes.
  • edge effect phenomena In general, when RF energy is being applied or delivered to tissue through an electrode which is in contact with that tissue, the current patterns concentrate around the edges of the electrode, sharp edges in particular. This effect is generally known as the edge effect. In the case of a circular disc electrode, the effect manifests as a higher current density around the perimeter of that circular disc and a relatively low current density in the center. For a square shaped electrode there is a high current density around the entire perimeter, and an even higher current density at the corners where there is a sharp edge.
  • Edge effects cause problems in treating the skin for several reasons. First they result in a nonuniform thermal effect over the electrode surface. In various treatments of the skin, it is important to have a uniform thermal effect over a relatively large surface area, particularly for dermatologic treatments. Large in this case being on the order of several square millimeters or even a square centimeter. In electrosurgical applications for cutting tissue, there typically is a point type applicator designed with the goal of getting a hot spot at that point for cutting or even coagulating tissue. However, this point design is undesirable for creating a reasonably gentle thermal effect over a large surface area. What is needed is an electrode design to deliver uniform thermal energy to skin and underlying tissue without hot spots.
  • a uniform thermal effect is particularly important when cooling is combined with heating in skin/tissue treatment procedure.
  • a non-uniform thermal pattern makes cooling of the skin difficult and hence the resulting treatment process as well.
  • the tissue at the electrode surface tends to be warmest with a decrease in temperature moving deeper into the tissue.
  • One approach to overcome this thermal gradient and create a thermal effect at a set distance away from the electrode is to cool the layers of skin that are in contact with the electrode.
  • cooling of the skin is made difficult if there is a non-uniform heating pattern.
  • One embodiment of an apparatus for treating the skin includes a template having a tissue interface surface and an energy delivery device coupled to the template.
  • the energy delivery device is configured to be coupled to a power source and has a variable resistance portion.
  • a sensor is coupled to one of the template, the energy delivery device, the tissue interface surface or a power source coupled to the energy delivery device.
  • variable resistance portion is configured to reduce an electrode edge effect.
  • Figure 1 is a lateral view of embodiments of the skin treatment apparatus illustrating components of the apparatus including the treatment template, energy delivery device and tissue interface surface.
  • Figure 2 is a lateral view of an embodiment illustrating the use of a handpiece coupled to the treatment template.
  • Figure 2b is a lateral view of an embodiment illustrating the delivery of cooling fluid to the electrode using lumens, nozzles control valves and a control system. The figure also illustrates a detachable electrode.
  • Figure 3 is a lateral view of an embodiment illustrating the use of a variable resistance coating on the surface of the electrode
  • Figures 4 and 5 are perspective and cross-sectional views illustrating an embodiment of an electrode with rings of resistance material interposed between conductive material to generate a radial resistance gradient on the electrode surface.
  • Figures 6A and 6B are perspective and cross-sectional views illustrating an embodiment of a cylindrical electrode with rings of resistance material interposed between conductive material, the resistance rings having increasing thickness moving in the outward radial direction.
  • Figure 7 is a cross-sectional/schematic view illustrating an embodiment of a ringed electrode coupled to a switching device, whereby duty cycle control of the conductive rings is used to achieve a more uniform current density across the surface of the electrode.
  • Figure 8 is a cross-sectional/schematic view illustrating an embodiment of an energy delivery device having a linear array of bipolar electrodes.
  • Figure 9 is a cross-sectional/lateral view illustrating an embodiment of an electrode having a contoured thickness profile configured to produce a resistance gradient across the surface of the electrode to achieve a uniform current density.
  • Figure 10a is a lateral view of an embodiment of an electrode illustrating the use of a dielectric coating on the surface of the electrode to achieve a uniform current density.
  • Figure 10b is a perspective view of an embodiment of an electrode illustrating the use of an attached and/or conformable dielectric layer to achieve a uniform current density.
  • Figure 11 is a schematic view illustrating the current path from the dielectric-coated electrode to the body and return electrode for monopolar electrode embodiments.
  • Figure 12 is a schematic view illustrating the current through tissue for dielectric -coated bipolar electrode embodiments.
  • Figure 13 is a lateral view of an embodiment of a dielectric-coated electrode where the dielectric coating comprises a copper coating on a polyamide substrate.
  • Figure 14 is a lateral view of an embodiment of a dielectric-coated electrode where the dielectric coating comprises an oxide coating grown on a conductive substrate.
  • Figure 15 is a cross-sectional view of the skin illustrating the target tissue zone and target tissue structures that can be treated by embodiments of the invention.
  • Figure 16 is a cross sectional/schematic view illustrating an embodiment using a circulating cooled fluid to cool the electrode.
  • Figure 17a is a cross-sectional/schematic view illustrating an embodiment using a coolant/refrigerant spray to cool an electrode within an electrode housing.
  • Figure 17b is a related embodiment to that shown in Figure 17a where the coolant spray is regulated by a solenoid valve coupled to an electronic control system and/or a physician-activated foot switch.
  • Figure 18 is a flow chart for the selection of treatment parameters such as cooling and heating sequences, durations etc.
  • Figure 19 illustrates various embodiments of duty cycles cooling and heating during different phases of treatment.
  • Figure 20 is a cross-sectional view illustrating a bipolar electrode embodiment comprising a dense array of multiple electrodes.
  • Figure 21 depicts a block diagram of the feedback control system that can be used with the pelvic treatment apparatus.
  • Figure 22 depicts a block diagram of an analog amplifier, analog multiplexer and microprocessor used with the feedback control system of Figure 21.
  • Figure 23 depicts a block diagram of the operations performed in the feedback control system depicted in Figure 22.
  • the apparatus can be used to deliver thermal energy to modify tissue including, collagen containing tissue, in the epidermal, dermal and subcutaneous tissue layers including adipose tissue.
  • the modification of the tissue includes modifying a physical feature of the tissue, a structure of the tissue or a physical property of the tissue.
  • the modification can be achieved by delivering sufficient energy to cause collagen shrinkage, and/or a wound healing response including the deposition of new or nascent collagen.
  • Various embodiments of the invention utilize novel electrode designs and cooling methods for providing a more uniform thermal effect in tissue at a selected depth while preventing or minimizing thermal damage to the skin surface and other non target tissue.
  • the result is an improved aesthetic result/clinical outcome with an elimination/reduction in adverse effects and healing time.
  • the invention can be utilized for performing a number of treatments of the skin and underlying tissue including: dermal remodeling and tightening, wrinkle reduction, elastosis reduction sebaceous gland removal/deactivation, hair follicle removal, adipose tissue remodeling/removal and spider vein removal and combinations thereof.
  • an apparatus 10 to treat the skin includes a treatment template 12.
  • template 12 can be coupled to a handpiece 14.
  • template 12 can include a receiving opening 15 adapted to receive and/or fit a body structure and make full or partial contact with the skin layer of that structure.
  • One or more energy delivery devices 16 can be coupled to template 12 including receiving opening 15, and can form an energy delivery surface 12' on template 12.
  • Energy delivery devices can have a tissue contacting layer 16' that delivers energy to the skin and/or underlying tissue.
  • energy can be delivered to the skin and/or underlying tissue, from energy delivery device 16, template energy delivery surface 12' or a combination of both.
  • Energy delivery device 16 is coupled to an energy source 18.
  • Suitable energy sources 18 and energy delivery devices 16 that can be employed in one or more embodiments of the invention include: (i) a radio-frequency (RF) source coupled to an RF electrode, (ii) a coherent source of light coupled to an optical fiber, (iii) an incoherent light source coupled to an optical fiber, (iv) a heated fluid coupled to a fluid delivery device, (v) a cooled fluid coupled to a fluid delivery device, (vi) a cryogenic fluid, (vii) a microwave source providing energy from 915 MHz to 2.45 GHz and coupled to a microwave antenna, or
  • RF radio-frequency
  • an ultrasound power source coupled to an ultrasound emitter, wherein the ultrasound power source produces energy in the range of 300 KHZ to 3 GHz.
  • the energy source utilized is an RF source and energy delivery device 16 is one or more RF electrodes 16.
  • all of the other herein mentioned energy sources and energy delivery devices are equally applicable to skin treatment apparatus 10.
  • a sensor 20 can be positioned at template energy delivery surface 12' or energy delivery device 16 to monitor temperature, impedance, pressure and the like. Suitable sensors 20 include impedance, pressure and thermal devices. Sensor 20 is used to control the delivery of energy and reduce the chance of cell necrosis at the surface of the skin as well as damage to underlying soft tissue structures. Sensor 20 is of conventional design, and includes but is not limited to thermistors, thermocouples, resistive wires, and the like.
  • a suitable thermal sensor 20 includes a T type thermocouple with copper constantan, J type, E type, K type, fiber optics, thermistors, resistive wires, thermocouple IR detectors, and the like.
  • handpiece 14 can be configured for multiple functions and can include one or more of the following: a fitting 14' for detachable electrodes, fluid and gas fittings 14", electrical fittings 14'" (e.g. Lemo connectors) for connection to power and control systems, a coolant valve 50 and a coolant spray nozzle 52.
  • a fitting 14' for detachable electrodes can include one or more of the following: a fitting 14' for detachable electrodes, fluid and gas fittings 14", electrical fittings 14'" (e.g. Lemo connectors) for connection to power and control systems, a coolant valve 50 and a coolant spray nozzle 52.
  • variable resistance material 22 that has an electrical resistance that varies with temperature.
  • variable resistance material 22 is applied as a coating 22' on around tissue contact surface 16'.
  • Variable resistance material 22 can be selected to have a positive temperature coefficient of resistance (which means that its resistance increases with temperature.). These materials known as positive temperature coefficient semiconductors, can include ceramic semiconductive materials and polymers with embedded conductive particles. These and related materials, are well known in the art and are used for thermostats and other solid state temperature control devices. Such materials are available from the Raychem Corporation
  • electrode 16 comprises a circular disc, with a number of concentric conductive rings 24 of conductive material 24'. Interposed between the conductive rings 24, are resistance rings 26 made of material with a higher electrical resistance, called resistance material 26.
  • the conductive and resistance rings 24 and 26 are configured such that there is a radial resistance gradient, with a higher electrical resistance at the outer edges of the electrode that decreases moving radially inwards. As a result, less current flow (and hence less heating) occurs through the edges and outer portions of the electrode compared to the more central electrode portions.
  • Electrode 16 is cylindrically shaped and is fabricated such that it is made out of alternating layers of resistance material 26' and conductive material 24'.
  • the bottom portion of the electrode is the tissue contacting surface 16' and has a pattern of annular rings correlating to the layers of resistance and conductive material.
  • cylindrical electrode 16 is constructed such that the resistance rings 26 near the electrode center 16" are thinner than those at the outer edges 16'" with a continuous increase in thickness moving in the outer radial direction.
  • electrons flowing through electrode outer electrode edges 16'" must flow through more of resistance material 26 (e.g. encounter more resistance) than those flowing through the more central electrode portions 16". Consequently, the net current flow on outer edges 16'" is less than in the more central electrode portion 16".
  • This ringed pattern can be made to a mathematical limit where the annular rings become thinner and thinner and closer and closer to one another such that there is almost a continuous tissue contacting surface of conducting material 24, but also with a continuous resistance element that causes the current flow to be less on the outer electrode edges 16'" than the inner portions 16".
  • a related, but different, embodiment for reducing edges effects also involves dividing a circular disc electrode into annular conductive rings.
  • the flow of current through the rings is temporally controlled using a time sharing or duty cycle approach to turn on current flow to the inner and outer rings for fixed time periods.
  • RF current flow to the outer rings is turned on for the shortest periods of time with progressively longer on- times time moving inward in the radial direction.
  • the outer rings are turned on, they briefly have a higher current flow and are transiently hotter, this is compensated for by having them on for only a short time period and/or shorter than more centrally located electrode rings.
  • Over time e.g.
  • Adjacent rings can be switched on and off sequentially or in any other predetermined order or pattern. Also two or more rings can be turned on at the same time.
  • the switching of rings can be controlled by a switching device /circuit 28, known in the art, electrically coupled to the rings. Also, the rings can be multiplexed to energy source 18 using a multiplexing circuit 30 known in the art.
  • the energy delivery device 16 can comprise a number of small rectangular shaped electrodes that are laid down (on a supporting surface, structure or substrate) and operated in a bi-polar fashion.
  • every pair of bars could be a bi-polar electrode pair 17 possibly with sequential switching between different pairs of bars to create a bi-polar effect.
  • electrode 16 can be fabricated such that it has a continuous variation in resistance moving in a radial or other direction. More specifically, the electrode can be configured to have a continuously decreasing resistance moving inwardly in the radial direction.
  • Figure 9 illustrates an electrode fabricated to have a tapered or otherwise contoured profile, thickest at the outer edges 16'" and thinner moving inward in the radial direction.
  • the thicker sections of the electrode have increased resistance compared to the thinner sections (e.g. resistance is proportional to thickness).
  • a radial or other directional gradient in resistance can be achieved by doping, impregnating or coating the surface of the electrode with materials (known in the art) to increase its electrical resistance.
  • Electrodes 16 can be coated with a dielectric material 32 to form a dielectric layer 32'.
  • electrode 16 is attached to a dielectric layer or film 32', which can be made of a conformable material that conforms to the surface of the skin.
  • the electrode 16 that is attached to dielectric layer 32' can be of any geometry, e.g. circular, oval, rectangular, etc.
  • electrode 16 can have between 1 to 100% the surface area of layer 32', with specific embodiments 25, 50, 75%, and 90%.
  • dielectric layer 32' with electrode 16
  • the most important of which is the ability to produce a more uniform current flow through the electrode and subsequently to the underlying skin and tissue. This is attributable in part to a capacitance effect created by the use of layer/coating 32'.
  • the use of layer 32' creates an electronic capacitor (e.g., two conductors separated by an insulator) where, one conductor is the electrode, the second conductor is the skin or the tissue being treated, and the insulator separating them is the dielectric layer on the electrode.
  • the capacitive effect of dielectric layer 32 can be controlled through the selection of the thickness, surface area and dielectric constant of layer 32, as well as by controlling the frequency of the RF signal.
  • the dielectric coating creates an increased impedance to the flow of electrical current through the electrode. Owing to this increased impedance, and to the fact that electrical current naturally seeks the path of least impedance, the current is biased/forced to take the shortest path length between the two conductors, which is the path straight down through the electrode to the tissue. By corollary, the electrical current is unlikely to take any paths that would result in a longer path length and hence increased impedance. Such a longer path length would be the case for any concentration of current flowing out of the edges of the electrode.
  • the use of the dielectric coating serves to force a more uniform distribution of electrical current paths across the electrode surface and down into the tissue.
  • dielectric coating 32' produces a more uniform impedance through the electrode and causes a more uniform current to flow through the electrode.
  • the resulting effect minimizes or even eliminates, edge effects around the edges 16'" of electrode 16 which includes the perimeter for a circular disk-shaped electrode, and the perimeter and corners for a rectangular electrode. It is desirable to have the electrical impedance of the dielectric layer
  • the impedance of layer 32' at the operating frequency can be in the range of 200 ⁇ per square centimeter or greater.
  • Suitable materials for a dielectric coating 32' include, but are not limited to, Teflon® and the like, silicon nitride, polysilanes, polysilazanes, polyimides, Kapton and other polymers, antenna dielectrics and other dielectric materials well known in the art.
  • Another advantage of using a dielectric layer 32' is that there is little or no increase in current density resulting from only partial contact of electrode 16 with the tissue surface. Normally, such partial contact would increase current density in the electrode portions remaining in contact with tissue increasing the size and severity of hot spots and the likelihood of spark discharge and burns to the tissue.
  • the impedance of the electrode goes up (due to a decrease in the capacitance) as the surface area of the electrode tissue contact zone is reduced. This causes the current density flowing through the electrode to remain relatively constant. This effect is achieved by configuring the dielectric layer/electrode to have an impedance higher than the contacting tissue.
  • the dielectric coating on the electrode presents an important safety advantage over the use of just a conductive electrode in contact with the tissue, since there is little or no increase in current density and resulting hot spots from only partial tissue contact of the electrode.
  • Such partial contact with a conventional electrode not only cause the edge effects and hot spots, but as the amount of tissue contact decreases, the current density can increase to the point where the electrode begins to act like a electrosurgical knife (e.g. a bovie) with a spark discharge causing serious burns to the patient and also possibly to the medical practitioner.
  • a electrosurgical knife e.g. a bovie
  • partial tissue contact at a point would result in almost no current flowing because the impedance would be very high.
  • embodiments using the dielectric- coated electrode have safety advantages in the clinical setting where partial tissue contact often occurs.
  • a dielectric coating Another advantage of the use of a dielectric coating is the minimization of the need to use a conductive fluid (e.g. saline solution) to conduct RF energy to the skin surface and/or assure electrical contact of the electrode with the skin surface.
  • a conductive fluid e.g. saline solution
  • the use of conductive fluids minimizes tissue contact problems when the electrode is a conductive electrode.
  • the conductive fluid is less important because the dielectric coating causes capacitively coupling of the energy into the tissue.
  • First is from an ease of use standpoint, since fluids and/or conductive gels can be difficult to work with.
  • the second advantage is one of safety and control, since the physician can not always control where the fluid goes, possibly heating and burning tissue not intended to be treated, as well as presenting a possible shock hazard to the patient and medical personnel.
  • the third advantage is reproducibility, since conductive fluids having different electrolyte concentrations will have different conductivities and hence, cause more or less current to be conducted to the tissue causing varying amounts of heating.
  • a dielectric-coated electrode can be bi-polar or mono-polar.
  • electrode 16 can comprise a single electrode covered with a dielectric coating 32' that capacitively couples energy into the skin or other tissue used in conjunction with a return electrode 34.
  • a capacitively coupled electrode can comprise multiple electrodes delivering energy to the skin.
  • electrical current uniformly flows out from a first electrode 17' of a bi-polar pair 17 through its dielectric coating into the tissue then through the dielectric coating of the second electrode 17" of the bi-polar pair 17 into the second electrode and then back to the RF energy source 18.
  • the area of substantial current flow and hence the treatment zone 44 is substantially confined to an area of tissue between each bipolar pair
  • a dielectric coated/capacitively coupled electrode can comprise a copper coating 36 adhered to a polyimide substrate 38 that is about 0.001 " in thickness.
  • a copper coating 36 adhered to a polyimide substrate 38 that is about 0.001 " in thickness.
  • Such an electrode is similar to a standard flex circuit board material commercially available in the electronics industry; however in this case the flex circuit substrate (e.g. the polyamide layer) is much thinner than that found in a standard electric circuit board.
  • the copper-polyimide laminate material can be an off-the-shelf commercially available material and the deposition of copper down on polyimide is a well-known process in the circuit board industry. However, the present invention uses this material in a fashion contrary to its standard or known usage or configuration.
  • the polyimide is touching the skin and the copper is separated from the skin with the 0.001" ( 1 mil) polyimide layer.
  • the 1 mil layer of polyimide is too thick and does not perform well as a capacitor from an electrical standpoint.
  • One way of improving the performance of a 1 mil polyimide copper electrode is to increase the frequency of the RF current going to the copper-polyimide electrode. In various embodiments using 1 mill polyimide-copper electrodes, the RF current supplied to the electrode can be operated at approximately six MHz.
  • the frequency of the RF current can be reduced to the standard range recited above.
  • One method for decreasing the thickness of the polyimide layer would be to grow the copper layer on the polyimide using sputtering, electrodeposition, chemical vapor deposition, plasma deposition and other deposition techniques known in the art. These methods could be equally applicable to other thin polymer dielectric films known in the art. Alternatively these same processes could be used to deposit a dielectric layer such as paralyne, onto a conductive layer. Also, the copper layer could be adhered to a thinner 0.0003" polyimide film.
  • yet another embodiment of a dielectric- coated electrode involves growing an oxide layer (usually a metal oxide layer) 40, on a conductive material 42 such as a metal conductor.
  • oxide layer 40 presents a number of possible technical advantages. The first of which is a reduced thermal resistance and hence improved heat transfer through electrode 16 and ultimately through the skin verses metal-polymer film and other electrodes. Specifically the thermal conductivity of a deposited oxide film (such as an aluminum oxide on an aluminum conductive layer) is significantly improved over that of a polyimide layer.
  • an aluminum oxide layer grown on an aluminum conductor has a thermal conductivity approximately 20 to 100 times better than a polyimide layer.
  • Aluminum oxide layers can be readily grown on an aluminum using the commercially available process of anodization. The result is an electrode that has a dielectric layer 32', the aluminum oxide, which is also a very good thermoconductor. Oxide layers can also be grown on titanium, platinum, stainless steel, silver, gold and other conductors using similar anodization or other commercially available processes known in the art.
  • the use of dielectric-coated electrodes or otherwise capacitively coupled electrodes has one or more of the following advantages: i) improved the ability to uniformly treat tissue (e.g. more uniform thermal effect), ii) improved safety features such as partial tissue contact not resulting in burns, and minimizes the requirement for an electrically conducting fluid or electrolytic fluid to couple the electrode into the tissue; and iii) improved cooling ability for oxide coated electrodes such as an aluminum oxide coated aluminum electrode.
  • the target tissue zone 44 for therapy can include, but is not limited to, tissue at a depth from approximately 100 ⁇ m beneath the surface of the skin down to as deep as a couple of millimeters, depending upon the type of treatment (e.g.
  • the invention can be used to treat different structures 44' of the skin lying at different depths.
  • Such structures can include the hair follicles and sebaceous glands and related structures.
  • the invention can even be used to treat deeper structures or tissue such as the subcutaneous fat layer. Treatment in this case meaning the delivery of thermal or other energy to that tissue to produce a therapeutic effect.
  • cooling may be important in each of these applications.
  • all the devices disclosed in this application can incorporate some form of a cooling device 46, system 46' and/or method (see Figures 16 and 17).
  • Cooling device 46 or system 46' can be configured to precool the surface layers of the target tissue such that when the electrode structure is in contact with the tissue and/or prior to turning on the RF energy source the superficial layers of the target tissue are already cooled.
  • RF energy source is turned on or delivery of RF to the tissue otherwise begins, resulting in heating of the tissues, the tissue that's been cooled is protected from thermal effects including thermal damage. The tissue that has not been cooled will warm up to therapeutic temperatures resulting in the desired therapeutic effect.
  • the treatment process can include one or more of the following steps: i) precooling (before the delivery of energy to the tissue has started), ii) an on phase or energy delivery phase in conjunction with cooling, and iii) post cooling after the delivery of energy to tissue has stopped.
  • Pre-cooling gives time for the thermal effects of cooling to propagate down into the tissue. More specifically, precooling allows the achievement of a desired tissue depth thermal profile, with a minimum desired temperature being achieved at a selectable depth. This can be facilitated with the use of thermal sensors positioned within or on the skin.
  • the amount or duration of precooling can be used to select the depth of the protected zone of untreated tissue. Longer durations of precooling produce a deeper protected zone and hence a deeper level in tissue for the start of the treatment zone. The opposite is true for shorter periods of precooling, all other factors (e.g. RF power level) being relatively equal.
  • Post cooling can be important because it prevents and/or reduces heat delivered to the deeper layers from propagating upward (via conduction ) and warming up the more superficial layers possibly to therapeutic temperature range even though external energy delivery to the tissue has ceased. In order to prevent this and related thermal phenomena, it is desirable to maintain cooling of the treatment surface for some period of time after application of the RF energy has ceased. In various embodiments varying amounts of post cooling can be combined with "real time cooling" and/or precooling.
  • cooling involves the circulation of a coolant or cold fluid 48, inside a hollow dielectric-coated electrode or other electrode structure such that this cooling fluid is an intimate contact with the electrode.
  • this cooling fluid also cools the skin via thermal conduction and/or radiation of heat from the skin to the electrode and then the transfer of heat from the electrode to the cooling solution by convection and conduction.
  • heat transfer through the electrode can be facilitated by the selection of materials (e.g. materials with high thermal conductivity such as metals), dimensions (e.g. thickness, etc.) and shape. Accordingly, heat transfer through the copper- polyamide electrode and related electrode embodiments can be optimized by minimizing the thickness of the polyamide layer. This will allow these types of electrodes to have good thermal coupling to the tissue.
  • metal oxide- metal electrodes such as the aluminum-aluminum oxide electrode
  • metal oxide dielectric layer 40 has a much higher thermoconductivity than the polyamide dialectic, allowing a thicker dielectric layer and a thicker electrode. These factors allow for stronger electrode structure and potentially a higher degree of electrode capacitance and capacitive coupling.
  • FIG. 17a other embodiments of the invention utilizing cooling can incorporate a spray valve 50 (or valve 50) coupled to a nozzle 52 positioned inside in the 54' interior of a hollow electrode structure/housing 54 of electrode 16.
  • Nozzle 52 is used to spray a coolant or refrigerant 48 onto the inner surface 54" of the electrode structure 54, where it evaporates and cools the electrode.
  • Refrigerant 48 cools the electrode 16 by combination of one or more of evaporative cooling, convection and conduction. The electrode in turn, cools the tissue that is beneath it through conduction.
  • Possible refrigerants 48 include, but are not limited to, halogenated hydrocarbons, carbon dioxide and others known in the art.
  • the refrigerant is R134A which is available from Refron, Inc. (38- 18 33rd St. Long Island City, New York 11101) and commonly used to cool electronic components.
  • evaporative cooling allows more precise temporal control of the cooling process. This is because cooling only occurs when the refrigerant is sprayed and it is evaporating (the latter being a very fast short lived event) Thus cooling ceases rapidly after the spray of refrigerant is stopped. The overall effect is to confer very precise time on-off control of the spray. Improved temporal control can also be obtained through the use of thin electrodes having negligible thermal mass, alone or in conjunction with a refrigerant spray. The negligible thermal mass of such electrodes results in an almost instantaneous cooling of the electrode and underlying skin.
  • spray valve 50 can be a solenoid valve 50, which can be fluidically coupled to a cryogen reservoir 48'.
  • Solenoid valve 50 can be electronically coupled to and controlled by an electronic/computer control system 56 or manually controlled by the physician by means of a foot switch 53 or similar device. Such valves have response times on the order of five to ten milliseconds.
  • Suitable solenoid valves include, but are not limited to a solenoid pinch valve manufactured by the N-Research
  • the electrode can have a variety of hollow structures which are simultaneously configured for spray cooling of the electrode and conductive cooling of the skin in contact with the electrode. This can be accomplished by a combination of one or more of the following i) maximizing the internal hollow surface area of the electrode, minimizing the wall thickness of the electrode in contact with the skin, and iii) designing the hollow area of the electrode to maximize the internal surface area that can be reached by the spray jet of a nozzle. It is also desirable to have an opening in the electrode, or chamber containing the electrode, to allow the evaporated refrigerant to escape. This escape can include a pressure relief valve to control pressure in the chamber.
  • cryogen 48 can be dispersed or sprayed through a porous or open cell structure (which can include the electrode) that can be configured to have cryogen 48 make direct contact with the skin if necessary.
  • the refrigerant is sprayed on the inside of a hollow electrode tubular structure, with the electrode external surface in contact with the skin. It is beneficial in this design to make the electrode surface strong enough (e.g. able to withstand compressive forces greater than 0J to 1 lbs) so that the electrode can support itself when pressed against the skin in order to improve heat transfer between the skin and the electrode. This can be accomplished through the selection of higher strength electrode materials, electrode thickness and shape.
  • a structurally strong electrode involves the use of a metal oxide electrode such as titanium oxide electrode.
  • portions of electrode 16 can be configured to be sufficiently flexible to conform to the skin, but still have sufficient strength and/or structure to provide good thermal coupling when pressed against the skin surface.
  • a polyamide (or other polymer) copper film electrode that needs to be kept thin to optimize thermal conductivity.
  • the electrode may comprise or be integral to a hollow tissue probe that has a tissue contacting electrode external surface and an internal electrode surface that is integral to or otherwise exposed within an internal chamber of the probe where evaporation of the refrigerant takes place.
  • the internal chamber of the hollow electrode 54 or probe is sealed, but can include a venting means 58.
  • venting means 58 can be a pressure relief valve 58 vented to the atmosphere or a vent line.
  • the refrigerant spray comes into contact with the electrode and evaporates, the resulting gas pressurizes the inside of this sealed chamber/cylinder causing the thin flexible tissue contacting electrode surface to partially inflate and bow out from the surface of the supporting structure of the tissue probe.
  • This inflated/pressurized configuration provides the thinner polyamide-copper film electrodes with a tissue contacting surface/structure with sufficient strength to provide good thermal coupling when pressed against the skin, while when in a deflated state or if there is no pressure in the chamber, the electrode remains flexible.
  • the refrigerant spray serves two purposes.
  • the inflated electrode configuration can be configured to enhance thermal contact with the skin and also result in some degree of conformance of the electrode surface with the skin.
  • relief valve 58 can be configured to open at pressures including but not limited to 0J psi to 30 psi, with a preferred narrower range of 0.5 to 5 psi and specific embodiments of and 0.5, 1, 2, 4, 8, 14.7, 20 and 25 psi.
  • the probe chamber can be fabricated from stainless steel and other machinable metals known in the art.
  • Suitable pressure relief valves 58 include, but are not limited to, mechanical valves including spring actuated valves, polymer valves, and electronically controlled valves.
  • pressure relief valve 58 can be of a mechanical type manufactured by the McMaster-Carr Corporation.
  • the spring- actuated valves are controlled by an internal spring opens the valve, when the pressure reaches a certain level.
  • Embodiments using the electrically operated valves can include a pressure sensor/transducer 20 positioned inside the chamber and an electronic controller 56 which is electronically coupled to both the electronic valve and the pressure sensor. The controller sends a signal to open the valve when a programmed pressure has been reached.
  • cryogen spray 48 is used as cooling source through evaporative cooling and contact with the electrode that's touching the skin, and also to inflate a probe/electrode chamber to provide pressure which will inflate and/or bow out the thin flexible electrode to provide improved contact (e.g. thermal and mechanical) with the skin and also some degree of conformance with the skin.
  • a probe/electrode chamber to provide pressure which will inflate and/or bow out the thin flexible electrode to provide improved contact (e.g. thermal and mechanical) with the skin and also some degree of conformance with the skin.
  • the flexible thin polyamide electrode tissue contacting structure can become very rigid, and can have similar properties (e.g. stiffness, rigidity etc.) to Mylar®. Then, decreasing the pressure several psi (e.g.
  • the rigidity and/or conformity of the electrode can be selectable with chamber pressure and adjusted for the mechanical properties and shape of the skin surface being treated in order to obtain the desired level of thermal coupling to the skin.
  • Chamber pressures between five to ten psi have been found to perform well for many applications. More rigid structures can be obtained at higher chamber pressures, and contrarily very flexible conformable structures can be obtained at lower pressures.
  • the use of a sealed evaporation chamber and "bowable" electrode could also be employed with electrodes having a dielectric oxide layer, such as the aluminum-aluminum oxide.
  • electrode thickness, surface length and support structure are configured to allow the electrode surface to bow outward with pressure in the 1 to 10 psi or other range disclosed herein.
  • the flexibility of a metal electrode can be increased using one or more of the following approaches: by making the electrode thinner, increasing the unsupported length of the electrode surface and using materials/processing methods with reduced stiffness (e.g. Young's Modulus).
  • an aluminum-aluminum oxide electrode could be in the form of a foil type electrode and may have a comparable thicknesses to commercially available aluminum foil.
  • Circulating water cooling systems have the limitation of not being able to have fast enough thermal response times due to a number of factors (e.g. thermodynamic properties of water, heat and mass transfer limitations, etc.).
  • the use of the spray cryogens in combination with a thin film electrode e.g. polyamide-copper ) overcomes these limitations and provides the capability to perform a number of different types of algorithms for skin treatment that could not be performed with a circulating cold water cooling system.
  • the refrigerant spray could be turned on the order of milliseconds before the start of RF energy delivery to the desired tissue and subsequently cycled off and on in millisecond durations.
  • a cryogen supply e.g. a compressed gas canister
  • these valves could be coupled to a computer control system or could be manually controlled by the physician by means of a foot switch or similar device.
  • the cryogen nozzle and solenoid valve can be coupled to or otherwise configured to be used with a chopper wheel (not shown). The chopper wheel is adapted for intermittently allowing the spray of the cryogen onto the tissue or electrode.
  • the cryogen spray is directed at an approximate perpendicular angle into the face of a chopper wheel that rotates at selectable angular velocity.
  • the chopper wheel has an approximately circular geometry and has an open section, which can be a sector, radially oriented rectangle, or other geometric shape positioned at a selectable position on the face of the wheel. When the open section is aligned with refrigerant spray stream coming out of the solenoid valve then the spray goes down and hits the tissue.
  • the chopper wheel can rotate at angular velocities between 1 and 10,000 rpm.
  • the wheel, wheel mechanism and timing system can be similar to those used on optical chopper wheels well known in the art. Alternatively, various high speed small motor mechanisms (such as a brushless dc motor) can also be used.
  • An important advantage of embodiments of the invention employing a solenoid valve alone, or in combination with a chopper wheel is the ability to deliver the cryogen in very short bursts (via spray or other means).
  • This short burst capability allows the physician to titrate and/or selectively control the amount of heat removed by the cryogen from the tissue. This is because from a thermodynamic standpoint, the amount of heat removed by a given volume of a given cryogen as it evaporates is predictable (e.g. known latent heat of vaporization, known cryogen temperature, etc.) So for a milliliter volume of cryogen spray, the number of calories of heat loss from the tissue can be predicted with a reasonable degree of accuracy (e.g.. approx +/- 5% or better).
  • This information can be used to design a treatment algorithm that's very quantitative, e.g. the amount of cooling delivered is correlated to the RF power level or other metric of energy delivery.
  • the algorithm can be configured to control the amount of thermal energy (e.g. heating) delivered to the tissue in an accurate manner in order to obtain a desired tissue temperature and/or effect at selectable depth and similarly can control the amount of cryogen delivered to the tissue to produce a selectable amount of cooling sufficient to protect non target tissue from thermal injury.
  • Such ratios of cooling delivered to energy delivered can be preprogrammed into the algorithm and can be configured for depth of tissue to be treated, type of tissue (e.g. skin vs.
  • adipose tissue thermal conductivity of treated skin or tissue, desired target tissue temperature and desired maximum non target tissue temperature.
  • desired target tissue temperature desired maximum non target tissue temperature.
  • the volume of cryogen delivered would have to be able to cool/ remove 5 joules of energy from the tissue. If each ml of cryogen spray removed one joule of energy by evaporation, then 5ml of cryogen would have to be delivered to the tissue. This could be delivered in the same 0.1 seconds as the energy delivery or could be delivered in series often 0.010 second burst over 0.2 seconds with 0.2 ml of cryogen per spray burst.
  • cryogen spray is the availability to implement rapid on and off control, with the 0.005 second response times for solenoid valves, or even faster with embodiments using some type of electronically controlled aperture or shutter known in the art.
  • a varied number of pulse on-off type cooling sequences and algorithms may be employed.
  • the treatment algorithm comprises precooling the tissue by starting a cryogen spray, followed by a short pulse of RF energy into the tissue, with the cryogen spray continuing during the duration of the energy delivery and then stopping shortly thereafter (e.g. on the order of milliseconds). This or another treatment sequence could be repeated again.
  • the treatment sequence can comprise a pulsed sequence of cooling on, heat, cooling off, cooling on, heat, cool off, and with cooling and heating durations on orders of tens of milliseconds.
  • every time the surface of the tissue of the skin is cooled heat is removed from the skin surface.
  • this cooling effect is not appreciable for the deeper tissue away from the surface area where the cryogen spray is directed and having its effect.
  • the cryogen burst duration and interval between burst can be in the tens of milliseconds ranges which allows surface cooling, while still delivering the desire thermal effect into the deeper target tissue.
  • the burst duration and interval can be adjusted for the heat transfer rate/thermoconductivity between deeper target tissue and the skin such that the cooling rate of the skin equal or exceeds the rate of heat transfer from the RF heated deeper target tissue to the skin.
  • the rapid response time and precise temporal control of embodiments of the invention employing burst cryogen spray cooling allows the performance of a number of noninvasive tissue treatment methods that could not be performed by apparatus/methods employing water and other slower, less controllable cooling methods due to a risk of thermal injury of nontarget tissue and other thermal related complications.
  • noninvasive treatment methods include skin resurfacing, collagen shrinkage, treatment of sebaceous glands, hair follicle removal, treatment removal of subcutaneous fat and other skin treatments known in the art of dermatology or plastic surgery.
  • the depth of the thermally effected zone can be controlled by the amount of precooling.
  • the longer periods of precooling result in a deeper penetration in the tissue before the thermal effect starts.
  • little or no precooling results in the thermal effect starting at or near the skin surface.
  • the thickness of the thermal effect zone in the tissue can be controlled by the duration of the RF energy delivery. The longer the period of RF energy delivery, the deeper the thermal effect.
  • the starting depth and thickness of the thermal effect zone can be selected through control of both the duration/amount of precooling and the duration of RF energy delivery.
  • control presents a distinct advantage in that it allows the selected treatment of a discrete anatomical layer or tissue structure located at various depths within or beneath the skin without injury to surrounding tissue. This and other benefits can be derived from the combination of cryogen spray with pulsed cooling and/or heating.
  • Figure 18 is a flow chart for the selection of treatment parameters including, duration of precooling, RF on time, RF power levels, and postcool durations for treatment algorithms for different tissue depths discussed herein, including superficial, thin effect and deep tissue treatments.
  • FIG 19 shows various duty cycles (e.g. on times) of cooling and heating during the different phases of treatment.
  • the figure illustrates the specific duty cycles (e.g. on-times and interval between on-times) of cooling and heating during the stages of pre-cooling, energy delivery (heating) and post cooling.
  • the cooling and heating duty cycles can be controlled and dynamically varied by an electronic control system known in the art.
  • the control system can be used to control the electronic solenoid valve (described herein) for controlling the flow of coolant and the RF generator supplying RF energy.
  • the invention can include sensors to measure parameters such as the skin surface temperature, the interior or exterior temperature of the electrode structure, the dielectric layer temperature, or the tissue temperature at a selectable depth.
  • sensors 20 can be positioned in the interior or exterior of the electrode structure and adjacent dielectric layer 32'.
  • One or more sensors 20 can be coupled to electronic control system 56 and can be used to control the delivery of one or both energy and cooling to the skin and target tissue.
  • Suitable temperature sensors and sensor technologies include thermocouples, thermistors, infrared sensors/technology and ultrasound sensors/technology. The latter two being well suited for measuring temperature at tissue sites located down inside the tissue as opposed to near or on the surface. Such sensors enable the measurement and generation of temperature depth or thermoprofile of the tissue.
  • thermoprofile could be used for process control purposes to assure that the proper amounts of heating and cooling were being delivered to achieve a desired elevated deep tissue temperature while maintaining skin tissue layers below a threshold temperature for thermal injury.
  • the physician would use the measured temperature profile to assure that they were staying within the bound of an ideal/average profile for a given type of treatment (e.g. sebaceous gland treatment).
  • the invention can be configured for skin rejuvenation.
  • the delivery of thermal energy to the target tissue is controlled/reduce to only cause a wound healing response and not necessarily collagen contraction. This would healing response results by delivering thermal energy to the tissue to induce a condition called fibroplasia. This is a condition in which there is a proliferation or otherwise infiltration into the dermis of a large number of fibroblast cells. These fibroblast cells in turn, lay down or deposit collagen into or adjacent the thermal affect zone causing the skin rejuvenation process. However by delivering a selected amount of energy, a proportion of the fibroblasts in the dermis can be killed off.
  • a wound healing response occurs, in which there is large infiltration of fibroblasts into the dermis, with a large number of fibroblasts present than before treatment. These new fibroblasts lay down new collagen as part of a wound healing response and this rejuvenates the skin.
  • the resulting tissue affect can be titrated to produce skin rejuvenation for lower levels of delivered energy, or collagen contraction configured to tighten the skin for higher levels of delivered energy. If the collagen contraction/skin tightening is positioned very superficially, it can help to minimize the appearance of wrinkles. If the area of collagen contraction is located deeper in the dermis, it can tighten up areas of loose skin.
  • One bi-polar embodiment shown in Figure 20 can comprise very dense arrays of small electrodes 16 where every other electrode in the array is an opposite pole of a bi-polar electrode pair.
  • the electrode array in this embodiment will produce a very superficial delivery of thermal energy into the tissue extending from one bi-polar pair to another.
  • a mono-polar electrode will produce a much deeper tissue affect than will the bi-polar electrodes. This depth difference in thermal affect between the two types of electrodes results from the difference in current paths for mono-polar versus bi-polar electrodes.
  • the current flows from the positive electrode to a return electrode located far away on the patient's body.
  • all the current paths are localized between electrode pairs located on the electrode array (e.g the energy delivery device).
  • different electrode configurations can be employed for different targeted tissue layers or sites or for different forms of treatment to the same site.
  • a mono-polar electrode configuration could be selected for its ability to delivery energy to the deeper tissue sites.
  • a bi-polar electrode configuration would be preferable.
  • the depth of the thermal tissue affect is limited to the more superficial tissue layers with little or no deep tissue effect, even for longer periods of energy delivery.
  • various bi-polar embodiments can be readily configured for use with continuous cooling system/apparatus either in the form of a continuous spray or a circulating fluid.
  • continuous cooling presents several advantages in that i) more conventional and potentially less expensive cooling systems (e.g. water cooling, air cooling and the like) can be employed, ii) the complexity of the system or apparatus is reduced in that reduced hardware and soft resources are required to control the delivery of coolant; and iii) improved ease of use for the medical practitioner.
  • Many current dermatological procedures involving the delivery of heat to tissue are done with lasers.
  • the use of lasers for dermatologic procedures has several technical drawbacks which limit the access and depth of tissue treatment, reduce efficacy and cause undesirable patient complications.
  • laser light propagating in tissue exhibits a phenomena known as scattering in which the incident light is scattered by incident cells and tissue from its original optical path.
  • This scattering results in the incident light beam no longer traveling in a straight, and hence, predictable path within the target tissue.
  • the scattering has the further detrimental effect of causing nonuniform intensity within the beam surface and hence a nonuniform thermal effect in the tissue contacted by the beam.
  • the outer areas of the laser beam undergo more scattering than the interior or more central portions of the beam. This causes the central portions of the beam to become more focused as the beam propagates deeper into the tissue or in other words, the central portion becomes more intense while the outer areas and beam edges less intense.
  • This nonuniform beam intensity can in turn lead to non-uniform heating and tissue effects as the beam moves deeper into the tissue and becomes increasingly focused on a smaller and smaller area.
  • This non-uniform intensity can readily cause a nonuniform cosmetic effect. More importantly it may be significant enough to cause severe thermal injury with related medical complications (e.g. burning, damage or destruction of nerves, blood vessels, etc.).
  • Various mono-polar electrode embodiments of the present invention provide improvements and features for overcoming these and other limitations. They also provide the medical practitioner with an apparatus generally better suited for treating the skin and underlying tissue including the deeper dermal and subdermal tissue. These improvements/advantages include a more uniform delivery of energy in the target tissue beneath the surface of the electrode and dispersement of delivered energy outside the target tissue site.
  • the bi-polar electrodes can comprise an array of electrodes, including a highly dense array of electrodes. As shown in Figure 20, such an array can include a multiple bar pattern of electrodes, where every other electrode of a sequence of thin rectangular bars is an electrode of a bi-polar pair. In embodiments where the electrodes are located very close to each other tissue, thermal effects (e.g. treatment) tends to occur in the tissue underlying gap between the electrodes. In various embodiments the gap between electrodes of a bi-polar pair can include but is not limited to a range from 0.0001 to 1 inch, with specific embodiments of 0.001, 0.010, 0.025, 0.050, 0J, 0.25 and 0.5 inches.
  • the electrodes begin to behave like mono-polar electrodes. That is they are not influenced by the presence of another electrode that may be in the same or other tissue treatment area.
  • the electrode spacing or electrode gap can be varied or modulated along one or more axis of an electrode a ⁇ ay.
  • the electrode gap can be controllably varied in the longitudinal direction in order to tailor the resulting pattern of thermal/tissue affect in the targeted tissue. Portions of the linear array can have a very small electrode gap producing a near continuous affect, while other portions can have a wider gap producing discrete zones of thermal affect with adjacent substantially untreated zones.
  • an intermediate electrode gap could be chosen to achieve both a bi-polar and mono-polar effect in terms of depth and pattern of the thermal effect.
  • dielectric coating and capacitive coupling could be used on bi-polar pairs as well as mono-polar pairs.
  • Another drawback of the use of lasers in dermatologic procedures such as skin resurfacing is the fact that the procedure has to be done in patchwork fashion. Specifically a small area of the face is treated, approximately one square centimeter area, either with a laser that has a beam that's that size, or a beam that has a smaller beam diameter and some kind of a scanning mirror system that would result in the beam moving over a one square centimeter area.
  • the nature of this procedure is a discrete or patchwork delivery of energy/treatment to one small area at a. So one square centimeter is treated and the laser is moved to next area. Consequently, it is a very time consuming and arduous process. Also it can result in the necessity of coming back for treatment sessions in separate visits to the physician with the patient having to undergo the undesirable side affect (e.g. redness, blistering, etc.) each time.
  • the apparatus may be used to treat one square centimeter skin, using the spray cryogen to achieve a pre, inter or post cooling affect as needed. After treating the fist area of skin the electrode/device would be lifted off the surface the skin and moved to the next area (e.g. square centimeter) of skin to be treated with this procedure being repeated until the entire desired target skin/tissue site was treated. In alternative embodiments the procedure could be done in a quasi- continuous or even a continuous fashion.
  • One embodiment of treatment method would involve a quasi-continuous pulsed method where a short spray of precooling is done, then a short application of RF energy, followed by a short spray of post-cooling and then a period of waiting where the physician observes the physical appearance of the skin as well as monitoring the skin and/or tissue temperature using sensor described herein. The procedure is then repeated as needed until the entire desired target site is treated.
  • the procedure could be done in an even more continuous fashion with a painting or sliding motion of the energy delivery device/electrode across the surface of the skin.
  • both cooling and heating application sequences would be done in a more continuous fashion and the pulsing method (e.g of cooling and heating) is one approach that lends itself to that.
  • cycles of cooling, heating and cooling could be done between five and ten times a second, or even faster.
  • the depth of the tissue effect could be increased with a longer RF heating phase (which could be pulse or continuous) and if necessary a longer period of precooling.
  • bi-polar electrode configurations would be particularly well suited for continuous treatment embodiments using continuous cooling and heating, since the depth of current flow, and hence energy delivery, for bi-polar configurations is limited.
  • the ability to treat tissue in more continuous fashions where the device/electrode is slid across the surface of the skin is a distinct advantage over the use of laser treatment used to treat discrete areas of skin in a patchwork approach.
  • the continuous skin treatment methods afforded by embodiments of the present invention would be particularly advantageous/desirable to surgeons and other physicians who typically use their hands during medical procedures would rather have a instrument where they can have some control over movement of the instrument.
  • the apparatus of the present invention presents the further advantage of allowing physicians to utilize their surgical skills and manual dexterity to achieve a finer and precise level of control over the delivery of the treatment and hence the quality of the clinical outcome versus laser devices that can only be used to treat skin in a noncontinuous patchwork fashion.
  • the use of more continuous treatment with embodiments of the present invention could also significantly shorten procedure times. Also if the physician wanted to deliver more treatment in anyone spot he/she leaves the electrode/device there a little bit longer. This allows the physician to titrate the treatment effect in different areas of the target tissue.
  • Another advantage of various embodiments of energy delivery devices e.g., dielectric-coated cryogen cooled electrodes
  • energy delivery devices e.g., dielectric-coated cryogen cooled electrodes
  • a laser could not get easily get access or would otherwise be obstructed.
  • Such areas include parts of the body with pronounced curvature, acute angles or otherwise rough and uneven surfaces.
  • collagen-containing tissue is treated by controllably delivering thermal and/or mechanical energy through the epidermis to the collagen containing tissue so as to change a physical feature or property of the epidermis through the thermal modification of the collagen containing tissue.
  • the physical feature can be one or more of the following, a reduction in size of a wrinkle in the epidermis, a reduction in an elastosis of the epidermis, an improvement of an epidermis contour irregularity, a tightening of the epidermis, remodeling of the underlying collagen containing tissue site, remodeling of the epidermis, changes in three- dimensional contouring, and combinations thereof.
  • the collagen containing tissue can be in a dermal layer, a deep dermal layer, a subcutaneous layer underlying a dermal layer, in fat tissue, and the like. Intracellular modification of the epidermis and skin appendages can also be achieved.
  • a reverse thermal gradient wherein the temperature of the epidermis is less than a temperature of the collagen containing tissue, can be used to create the composition of matter. With the reverse thermal gradient, the surface temperature of the skin can be at, above or below body temperature.
  • the collagen As used in the application "in vivo" refers to the thermal, mechanical and/or magnetic modification of tissue within a living composition of matter.
  • An aesthetic composition of modified living matter is a composite three dimensional phenotype that is comprised of a remodeled preexisting cutaneous container of preexisting soft tissue contents.
  • the aesthetic composition of matter can include combined remodeling of the soft tissue contents and its container. Matrix interactions of collagen with energy involve native or preexisting collagen and or the de novo production of nascent collagen by the induction of the wound healing sequence. These interactions are produced by the molecular and cellular remodeling of the collagen matrix. Molecular remodeling of the extracellular matrix occurs from the contraction and distraction of preexisting collagen fibrils. Cellular remodeling of the matrix is a delayed phenomenon and involves the activation of a wound healing sequence with fibroblast contraction and nascent collagen production as a static supporting structure of the remodeled matrix.
  • Electromagnetic and mechanical modalities are used to remodel the matrix and to alter intracellular metabolism. These modalities may be applied separately or in a coupled device geometry. Coupled mechanical force reduces the energy requirement to create a specific morphological result and is typically applied externally.
  • An alternating electrical cu ⁇ ent may be used to remodel the extracellular collagen matrix of the dermis and subcutaneous tissue.
  • weaker magnetic fields can also be employed to delicately modify the intracellular metabolism of these structures including the epidermis and skin appendages. More rapid phenotypic changes can occur from electrical remodeling of the extracellular matrix than magnetic modification of intracellular processes of the epidermis and skin appendages. Rather than producing observable changes, magnetic modification may also be used for maintenance or homeostasis of the aesthetic phenotype.
  • the visual perception of animate matter is due to a composite electromagnetic field of component atoms in various soft tissue structures.
  • the human perception of animated matter is also determined and restricted by the limited span of the visual spectrum in comparison to the entire electromagnetic spectrum.
  • Changes in this broader EM spectrum may be detected before they become visually apparent.
  • the pattern of change in the EMF may be used as a diagnostic modality before phenotypic changes of aging occur in tissue. These previously non- visualized changes in the EMF of individuals may provide an early warning signal before these changes become morphologically apparent.
  • manipulation of the EMF pattern to a more youthful EMF profile may provide the means to limit or reverse the morphological expression of this aging process.
  • Ablative methods include non invasive and minimally invasive removal of subcutaneous fat in addition to resurfacing of the skin.
  • Non-ablative methodologies remodel skin and soft tissue with a minimum of cellular and extracellular necrosis. Both ablative and non-ablative methodologies are used to create an aesthetic composition of matter (ACM).
  • ACM aesthetic composition of matter
  • a treatment modality matrix is created to determine the most effective combination of electromagnetic energy, mechanical force, method of application (ablative or non ablative) and tissue interaction (molecular vs. cellular remodeling).
  • an energy source including but not limited to electromagnetic energy
  • Complimentary application of mechanical force can be used to lower electromagnetic energy requirements and potential side effects of treatment.
  • the pattern of thermal energy delivery is no longer a random Brownian process. Instead, energy delivery becomes a directed process that produces a specific morphological effect without collateral tissue damage.
  • the epidermis is the cutaneous barrier to the outside world and is provided by the keratin bilipid layer of the stratum corneum which is produced by the continuing upward maturation of keratinocytes within the epidermis. Thermal and biological components of the skin barrier are created from this maturation process.
  • the solar or ultraviolet component of the barrier is provided by melanocytes that reside in basilar layer of the epidermis. Melanin granules are produced in these cells which are then distributed to upwardly migrating keratinocytes by dendritic extensions of the cell membrane. An additional population of melanocytes and keratinocytes is also present in the skin appendages.
  • the dermis is the main structural support of the skin and is immediately subjacent to the epidermis.
  • This supporting layer is mainly comprised of collagen fibrils that are subdivided into papillary and reticular component. The more superficial papillary dermis is immediately subjacent to the epidermis and is less dense than the deeper reticular dermis.
  • Burns are the morphological result of thermal energy interactions with skin and are classified into first, second and third degrees on the basis of dermal depth.
  • a first-degree burn is a thermal injury that extends superficially into the epidermis and does not involve blistering or ablation of the skin.
  • a temporary erythema of the skin occurs that resolves within twenty-four hours.
  • a healing or reepithelialization process is not required.
  • a second degree burn is a deeper thermal injury that extends into the dermis for a variable depth and is characterized by blistering and crusting. Ablation of the epidermis occurs with destruction of the dermis at either a superficial or deeper level.
  • Superficial second-degree burns extend into the papillary dermis and are readily heal by reepithelialization because the skin appendages are not destroyed. For deeper second degree burns, a greater portion of the dermis is ablated which may complicate healing and reepithelialization. With a deep second degree burn, many of the skin appendages are destroyed in addition to the loss of normal dermal architecture. Thinning and disruption of normal dermal anatomy can permanently alter the texture and elasticity of the skin. For many of these bum patients, a plastic or translucent appearance of their face is apparent. Obviously, a thinner margin of safety is present in deep second degree burns. For this reason, deeper second-degree bums are more frequently converted to bum scar deformities than more superficial bums.
  • a third degree burn is characterized by the full thickness destruction or ablation of all skin layers including the skin appendages.
  • Healing by reepithelialization does not occur normally but is achieved by the lengthy healing process of secondary intention.
  • the bum wound can form granulation tissue that slowly contracts to close the open rent in the biological barrier. Excessive sca ⁇ ing and deformity is likely.
  • a thin scar epithelium is typically formed over the bum scar. This fragile biological ba ⁇ ier is easily disrupted with minor trauma. Repeated ulceration of the bum scar may even require subsequent revisional surgery.
  • Aging of the skin can also be classified in a manner similar to thermal bums. Wrinkling is mainly caused by depletion of collagen matrix in the papillary dermis. This intradermal or second-degree deficit is a more superficial contour deformity than glabellar or nasolabial creases which are full thickness dermal defects that extend through the entire papillary and reticular dermis.
  • Resurfacing of the skin can also be classified in a manner similar to thermal bums.
  • skin appendages play a central role in the reepithelialization process.
  • Skin appendages are present in different densities depending upon the specific area of the body. The highest density is present in the fascial skin where current laser modalities of resurfacing are practiced. Skin appendage density in other areas such as the neck, trunk and extremities is inadequate to provide a consistent pattern of reepithelialization.
  • a four to eight month period of bum wound maturation ensues that is characterized by hyperemia and transparency in which the skin appears shinny and pink. Thinning of the remodeled dermis produces a porcelain texture of the skin that is similar to the faces of many bum patients. Although wrinkling is diminished, this alteration of normal skin texture remains a permanent feature of a patient's face.
  • the use of a conformance-energy delivery device offers benefits of enhanced clinical outcomes and a reduction of treatment side effects. Enhanced clinical outcomes include a greater effectiveness to correct superficial and deep wrinkling of facial skin. Duration and pain during the healing period are significantly reduced as the level of resurfacing is more superficial. A conformance-energy delivery device can be safely applied to areas outside the face because the depth of dermal ablation has been minimized without loss of clinical effectiveness. Skin tightening of treatment areas is also provided while simultaneously correcting surface irregularities.
  • Use of the conformance-energy delivery device reduces side effects by lowering the amount of thermal energy needed to resurface a treatment area. With this device, superficial resurfacing is capable of achieving deeper thermal effects. Healing from a superficial second degree resurfacing reduces the depigmentation and texture changes that are more common with deep second degree resurfacing. A prolonged period of erythema is avoided. Instead of an operating room, patients can be treated in an office setting without the occupational risks of a laser. With the composition of modified living matter of the present invention, a matrix of different operational modes can be used to create different tissue effects.
  • a "pressing" or stationary mode of application with convection cooling can conform the skin surface with minimal ablation. In this instance, wrinkles and creases are treated by selectively heating and conforming the dermis. Skin tightening without ablation is also performed in this particular mode of application.
  • a different mode of application is used to treat sun damaged skin or residual wrinkling that is not co ⁇ ected by non-ablative applications. The device is applied in a mobile fashion similar to "ironing" a shirt. Mobile compression without convection cooling creates the present composition of matter resulting in a resurfacing of the skin and application of shearing vectors of force that additionally smooth the matrix.
  • a matrix of different modes of application can be created depending upon the clinical circumstances.
  • a cold iron convection cooling with shearing and compression
  • This mode of application provides the greatest benefit in the hip and thigh areas where contour i ⁇ egularities of cellulite are severe but solar damage is minimal. Patients with severe wrinkling of the face without solar damage may also benefit from this particular permutation.
  • the creation of the composition of modified living matter of the present invention can employ the creation of a reverse thermal gradient and involve other strategies to avoid the blistering of skin. Hydration facilitates the passage of an electrical cu ⁇ ent through the epidermis by reducing surface impedance. Another significant effect is the increase in thermal conductance of the stratum corneum. Tissue components such as the keratin/lipid bilayer of the stratum corneum are poor thermal conductors and function as thermal insulators to preserve the overall heat content of the patient. Hydrated stratum comeum is a better thermal conductor which promotes heat transfer to underlying collagen containing tissues. The collagen containing dermis that has not been hydrated can behave as a thermal insulator as well as an electrical resistor.
  • the thermal content of the target collagen containing tissue is increased selectively.
  • Energy delivered to the soft tissue system defined by the collagen containing tissue site, remodels the collagen matrix by disrupting the intermolecular crosslinks within the fibril.
  • temperature is a measure of heat content, an accurate measure of energy delivery to the tissue is required.
  • Measure of dose rate and overall dose to the tissue is required to determine the most effective control parameters. Dose rate is important due to the time dependence of thermal conduction, thermal convection and relaxation processes. Total dose is also important as there are a known number of molecules to be contracted with a required amount of energy per molecule.
  • Another factor that affects the heat content of tissue is the thermal dissipation that occurs through thermal conduction away from the target tissue and the thermal convection from vascular and surface structures.
  • the collagen shrinkage temperature (Ts) is an indication of molecular stability and is determined by the amount of cross linkage. Reagents such as hyaluronidase (Wydase) that enzymatically decrease fiber stability can reduce the shrinkage temperature (Ts). Typically, a reduction of 10 C in the Ts is obtained by the injection of this reagent. As a result, power requirements to target collagen containing tissues are reduced.
  • the solution can be combined with a dilute local anesthetic and injected into target tissues with the "tumescent" technique.
  • Thermal shrinkage, or tightening of the underlying collagen containing tissue can be provided without the destruction of the overlying epidermis.
  • This process of molecular contraction has an immediate biophysical effect upon the matrix and is based upon the cleavage cascade of intramolecular and intermolecular bonds within the collagen fibril.
  • Skin tightening with thermal contraction and remodeling of collagen can correct areas such as the thighs, knees, arms, back and hips without unsightly sca ⁇ ing of standard techniques. Areas previously co ⁇ ected by surgical procedures, such as face and neck lifts, could also be co ⁇ ected without requiring surgery or the typical incisions around the ear. Elastosis, or stretching of the abdominal skin from pregnancy, can be co ⁇ ected without the long scar commonly associated with an abdominoplasty. Thermal remodeling of underlying collagen containing tissues is effective, non- invasive alternative for the aesthetic treatment of these areas.
  • Another component of electromagnetic remodeling is cellular remodeling of collagen containing tissues with a thermal-conformance device.
  • the use of low level thermal treatments over several days provides an additional way to contract skin without blistering.
  • the cellular contraction process is initiated and involves the inflammatory/wound healing sequence that is perpetuated over several days with sequential and lengthy low level thermal treatments.
  • This cellular contraction process is a biological threshold event that is initiated by the degranulation of the mast cell that releases histamine which initiates the inflammatory wound healing sequence. Histamine alters endothelial permeability and allows the creation of inflammatory edema.
  • contraction of skin is achieved through fibroblastic multiplication and contraction with the deposition of a static supporting matrix of nascent scar collagen.
  • the nascent matrix is simultaneously remodeled with a conformance template that is incorporated in the thermal energy delivery device.
  • molecular and cellular effects occur in tandem with each other.
  • Aesthetic conformers with a thermal energy source can also be used to remodel the subcutaneous fat of hips and thighs in addition to the tightening of the skin envelope.
  • Digital capture of a preexisting aged contour is used to digitally form an aesthetic three dimensional contour that subsequently provides the means to fabricate a conformance template. Additional aesthetic applications include congenital prominence of the ear in which the convolutions (antehelical fold) are altered by remodeling the collagen within the cartilage.
  • the nasal tip can be conformed to a more aesthetically pleasing contour without surgery.
  • a conforming aesthetic template can be used with any process that remodels underlying collagen containing tissue.
  • chemical modalities that invoke the wound healing sequence can be combined with a conforming esthetic template.
  • Glycolic acid can induce a low level inflammatory reaction of the skin.
  • Scar collagen and fibroblastic (cellular contraction) are directed by converging and diverging vectors created from a conformer that smooths and tightens the skin envelope into a more desirable contour. Additionally, a softer and more compliant skin texture in achieved.
  • skin treatment apparatus 10 can be coupled to an open or closed loop feedback system/resources 60.
  • feedback system 60 couples sensor 346 to power source 392.
  • energy delivery device 314 is one or more RF electrodes 314 and power source 392 is an RF generator, however all other energy delivery devices and power sources discussed herein are equally applicable.
  • the temperature of the tissue, or of RF electrode 314 is monitored, and the output power of energy source 392 adjusted accordingly.
  • the physician can, if desired, ove ⁇ ide the closed or open loop system.
  • a controller 394 or microprocessor 394 can be included and incorporated in the closed or open loop system 60 to switch power on and off, as well as modulate the power.
  • the closed loop system utilizes microprocessor 394 to serve as a controller to monitor the temperature, adjust the RF power, analyze the result, refeed the result, and then modulate the power. More specifically, controller 394 governs the power levels, cycles, and duration that the radio frequency energy is distributed to the individual electrodes 314 to achieve and maintain power levels appropriate to achieve the desired treatment objectives and clinical endpoints.
  • Controller 394 can also in tandem, govern the delivery of cooling fluid. Controller 394 can be integral to or otherwise coupled to power source 392 and can also be coupled to a fluid delivery apparatus. In one embodiment controller 394 is an Intel® Pentium® microprocessor, however it will be appreciated that any suitable microprocessor or general purpose digital or analog computer can be used to perform one or more of the functions of controller 394 stated herein. With the use of sensor 346 and feedback control system 60 skin or other tissue adjacent to RF electrode 314 can be maintained at a desired temperature for a selected period of time without causing a shut down of the power circuit to electrode 314 due to the development of excessive electrical impedance at electrode 314 or adjacent tissue. Each RF electrode 314 is connected to resources which generate an independent output.
  • the output maintains a selected energy at RF electrode 314 for a selected length of time.
  • Cu ⁇ ent delivered through RF electrode 314 is measured by cu ⁇ ent sensor 396.
  • Voltage is measured by voltage sensor 398.
  • Impedance and power are then calculated at power and impedance calculation device 400. These values can then be displayed at user interface and display 402.
  • Signals representative of power and impedance values are received by a controller 404.
  • a control signal is generated by controller 404 that is proportional to the difference between an actual measured value, and a desired value.
  • the control signal is used by power circuits 406 to adjust the power output in an appropriate amount in order to maintain the desired power delivered at respective RF electrodes 314.
  • temperatures detected at sensor 346 provide feedback for maintaining a selected power.
  • Temperature at sensor 346 is used as a safety means to interrupt the delivery of energy when maximum pre-set temperatures are exceeded.
  • the actual temperatures are measured at temperature measurement device 408, and the temperatures are displayed at user interface and display 402.
  • a control signal is generated by controller 404 that is proportional to the difference between an actual measured temperature and a desired temperature.
  • the control signal is used by power circuits 406 to adjust the power output in an appropriate amount in order to maintain the desired temperature delivered at the sensor 346.
  • a multiplexer can be included to measure cu ⁇ ent, voltage and temperature at sensor 346. Energy can be delivered to RF electrode 314 in monopolar or bipolar fashion.
  • Controller 404 can be an analog or digital controller, or a computer with driven by control software.
  • controller 404 When controller 404 is a computer it can include a CPU coupled through a system bus. On the system can be a keyboard, disk drive, or other non- volatile memory systems, a display, and other peripherals, as are well known in the art. Also coupled to the bus are a program memory and a data memory. Also, controller 404 can be coupled to imaging systems including, but not limited to, ultrasound, thermal and impedance monitors. The output of cu ⁇ ent sensor 396 and voltage sensor 398 are used by controller 404 to maintain a selected power level at RF electrode 314. The amount of RF energy delivered controls the amount of power. A profile of the power delivered to electrode 314 can be incorporated in controller 404 and a preset amount of energy to be delivered may also be profiled.
  • Circuitry, software and feedback to controller 404 result in process control, the maintenance of the selected power setting which is independent of changes in voltage or cu ⁇ ent, and is used to change the following process variables: (i) the selected power setting, (ii) the duty cycle (e.g., on-off time), (iii) bipolar or monopolar energy delivery; and, (iv) fluid delivery, including flow rate and pressure.
  • process variables are controlled and varied, while maintaining the desired delivery of power independent of changes in voltage or cu ⁇ ent, based on temperatures monitored at sensor 346.
  • Analog amplifier 410 can be a conventional differential amplifier circuit for use with sensor 346.
  • the output of analog amplifier 410 is sequentially connected by an analog multiplexer 412 to the input of AID converter 414.
  • the output of analog amplifier 410 is a voltage which represents the respective sensed temperatures.
  • Digitized amplifier output voltages are supplied by A/D converter 414 to microprocessor 394.
  • Microprocessor 394 sequentially receives and stores digital representations of impedance and temperature. Each digital value received by microprocessor 394 co ⁇ esponds to different temperatures and impedances. Calculated power and impedance values can be indicated on user interface and display 402.
  • calculated impedance and power values can be compared by microprocessor 394 to power and impedance limits. When the values exceed predetermined power or impedance values, a warning can be given on user interface and display 402, and additionally, the delivery of RF energy can be reduced, modified or intermpted.
  • a control signal from microprocessor 394 can modify the power level supplied by energy source 392.
  • Figure 23 illustrates a block diagram of a temperature and impedance feedback system that can be used to control the delivery of energy to tissue site
  • a monitor 420 ascertains tissue impedance, based on the energy delivered to tissue, and compares the measured impedance value to a set value. If the measured impedance exceeds the set value, a disabling signal 422 is transmitted to energy source 392, ceasing further delivery of energy to RF electrode 314. If the measured impedance is within acceptable limits, energy continues to be applied to the tissue.
  • the control of the flow of cooling solution 48 to electrode 314 and or tissue site 416 is done in the following manner.
  • temperature measurement device 408 measures the temperature of tissue site 416 and/or RF electrode 314.
  • a comparator 424 receives a signal representative of the measured temperature and compares this value to a pre-set signal representative of the desired temperature. If the tissue temperature is too high, comparator 424 sends a signal to a flow regulator 418 (which can be intergral to a pump 418) representing a need for an increased cooling solution flow rate. If the measured temperature has not exceeded the desired temperature, comparator 424 sends a signal to flow regulator 418 to maintain the cooling solution flow rate at its existing level.

Abstract

An apparatus to treat the skin includes a template having a tissue interface surface and an energy delivery device coupled to the template. The energy delivery device is configured to be coupled to a power source and has a variable resistance portion. A sensor is coupled to one of the template, the energy delivery device, the tissue interface surface or a power source coupled to the energy delivery device. In another embodiment the variable resistance portion is configured to reduce an electrode edge effect.

Description

APPARATUS AND METHOD FOR TREATMENT OF TISSUE
Cross-Reference to Related Application This application claims priority to U.S. Application No. 60/123,440, filed March 9, 1999, which is fully incorporated herein by reference.
Field of the Invention
This invention relates generally to a method and apparatus for treating tissue. More particularly, the invention relates to a method and apparatus for treating tissue using the controlled delivery of energy.
Description of Related Art
The human skin is composed of two elements: the epidermis and the underlying dermis. The epidermis with the stratum corneum serves as a biological barrier to the environment. In the basilar layer of the epidermis, pigment-forming cells called melanocytes are present. They are the main determinants of skin color.
The underlying dermis provides the main structural support of the skin. It is composed mainly of an extracellular protein called collagen. Collagen is produced by fibroblasts and synthesized as a triple helix with three polypeptide chains that are connected with heat labile and heat stable chemical bonds. When collagen containing tissue is heated, alterations in the physical properties of this protein matrix occur at a characteristic temperature. The structural transition of collagen contraction occurs at a specific "shrinkage" temperature. The shrinkage and remodeling of the collagen matrix with heat is the basis for the technology.
Collagen crosslinks are either intramolecular (covalent or hydrogen bond) or intermolecular (covalent or ionic bonds). The thermal cleavage of intramolecular hydrogen crosslinks is a scalar process that is created by the balance between cleavage events and relaxation events (reforming of hydrogen bonds). No external force is required for this process to occur. As a result, intermolecular stress is created by the thermal cleavage of intramolecular hydrogen bonds. Essentially, the contraction of the tertiary structure of the molecule creates the initial intermolecular vector of contraction.
Collagen fibrils in a matrix exhibit a variety of spatial orientations. The matrix is lengthened if the sum of all vectors acts to distract the fibril.
Contraction of the matrix is facilitated if the sum of all extrinsic vectors acts to shorten the fibril. Thermal disruption of intramolecular hydrogen bonds and mechanical cleavage of intermolecular crosslinks is also affected by relaxation events that restore preexisting configurations. However, a permanent change of molecular length will occur if crosslinks are reformed after lengthening or contraction of the collagen fibril. The continuous application of an external mechanical force will increase the probability of crosslinks forming after lengthening or contraction of the fibril.
Hydrogen bond cleavage is a quantum mechanical event that requires a threshold of energy. The amount of (intramolecular) hydrogen bond cleavage required corresponds to the combined ionic and covalent intermolecular bond strengths within the collagen fibril. Until this threshold is reached, little or no change in the quaternary structure of the collagen fibril will occur. When the intermolecular stress is adequate, cleavage of the ionic and covalent bonds will occur. Typically, the intermolecular cleavage of ionic and covalent bonds will occur with a ratcheting effect from the realignment of polar and nonpolar regions in the lengthened or contracted fibril.
Cleavage of collagen bonds also occurs at lower temperatures but at a lower rate. Low level thermal cleavage is frequently associated with relaxation phenomena in which bonds are reformed without a net change in molecular length. An external force that mechanically cleaves the fibril will reduce the probability of relaxation phenomena and provides a means to lengthen or contract the collagen matrix at lower temperatures while reducing the potential of surface ablation. Soft tissue remodeling is a biophysical phenomenon that occurs at cellular and molecular levels. Molecular contraction or partial denaturization of collagen involves the application of an energy source, which destabilizes the longitudinal axis of the molecule by cleaving the heat labile bonds of the triple helix. As a result, stress is created to break the intermolecular bonds of the matrix. This is essentially an immediate extracellular process, whereas cellular contraction requires a lag period for the migration and multiplication of fibroblasts into the wound as provided by the wound healing sequence. In higher developed animal species, the wound healing response to injury involves an initial inflammatory process that subsequently leads to the deposition of scar tissue.
The initial inflammatory response consists of the infiltration by white blood cells or leukocytes that dispose of cellular debris. Seventy-two hours later, proliferation of fibroblasts at the injured site occurs. These cells differentiate into contractile myofibroblasts, which are the source of cellular soft tissue contraction. Following cellular contraction, collagen is laid down as a static supporting matrix in the tightened soft tissue structure. The deposition and subsequent remodeling of this nascent scar matrix provides the means to alter the consistency and geometry of soft tissue for aesthetic purposes.
In light of the preceding discussion, there are a number of dermatological procedures that lend themselves to treatments which deliver thermal energy to the skin and underlying tissue to cause a contraction of collagen, and/or initiate a would healing response. Such procedures include skin remodeling/resurfacing, wrinkle removal, and treatment of the sebaceous glands, hair follicles adipose tissue and spider veins. Currently available technologies that deliver thermal energy to the skin and underlying tissue include Radio Frequency (RF), optical (laser) and other forms of electromagnetic energy. However, these technologies have a number of technical limitations and clinical issues which limit the effectiveness of the treatment and/or preclude treatment altogether. These issues include the following: i) achieving a uniform thermal effect across a large area of tissue, ii) controlling the depth of the thermal effect to target selected tissue and prevent unwanted thermal damage to both target and nontarget tissue, iii) reducing adverse tissue effects such as burns, redness blistering, iv) replacing the practice of delivery energy/treatment in a patchwork fashion with a more continuous delivery of treatment (e.g. by a sliding or painting motion), v) improving access to difficult to reach areas of the skin surface and vi) reducing procedure time and number of patient visits required to complete treatment. As will be discussed herein the current invention provides an apparatus for solving these and other limitations.
One of the key shortcomings of currently available RF technology for treating the skin is the edge effect phenomena. In general, when RF energy is being applied or delivered to tissue through an electrode which is in contact with that tissue, the current patterns concentrate around the edges of the electrode, sharp edges in particular. This effect is generally known as the edge effect. In the case of a circular disc electrode, the effect manifests as a higher current density around the perimeter of that circular disc and a relatively low current density in the center. For a square shaped electrode there is a high current density around the entire perimeter, and an even higher current density at the corners where there is a sharp edge.
Edge effects cause problems in treating the skin for several reasons. First they result in a nonuniform thermal effect over the electrode surface. In various treatments of the skin, it is important to have a uniform thermal effect over a relatively large surface area, particularly for dermatologic treatments. Large in this case being on the order of several square millimeters or even a square centimeter. In electrosurgical applications for cutting tissue, there typically is a point type applicator designed with the goal of getting a hot spot at that point for cutting or even coagulating tissue. However, this point design is undesirable for creating a reasonably gentle thermal effect over a large surface area. What is needed is an electrode design to deliver uniform thermal energy to skin and underlying tissue without hot spots.
A uniform thermal effect is particularly important when cooling is combined with heating in skin/tissue treatment procedure. As is discussed below, a non-uniform thermal pattern makes cooling of the skin difficult and hence the resulting treatment process as well. When heating the skin with RF energy, the tissue at the electrode surface tends to be warmest with a decrease in temperature moving deeper into the tissue. One approach to overcome this thermal gradient and create a thermal effect at a set distance away from the electrode is to cool the layers of skin that are in contact with the electrode. However, cooling of the skin is made difficult if there is a non-uniform heating pattern. If the skin is sufficiently cooled such that there are no burns at the corners of a square or rectangular electrode, or at the perimeter of a circular disc electrode, then there will probably be overcooling in the center and there won't be any significant thermal effect (i.e. tissue heating) under the center of the electrode. Contrarily, if the cooling effect is decreased to the point where there is a good thermal effect in the center of the electrode, then there probably will not be sufficient cooling to protect tissue in contact with the edges of the electrode. As a result of these limitations, in the typical application of a standard electrode there is usually an area of non-uniform treatment and/or burns on the skin surface. So uniformity of the heating pattern is very important. It is particularly important in applications treating skin where collagen containing layers are heated to produce a collagen contraction response for tightening of the skin. For this and related applications, if the collagen contraction and resulting skin tightening effect are non-uniform then a medically undesirable result may occur.
SUMMARY OF THE INVENTION
One embodiment of an apparatus for treating the skin includes a template having a tissue interface surface and an energy delivery device coupled to the template. The energy delivery device is configured to be coupled to a power source and has a variable resistance portion. A sensor is coupled to one of the template, the energy delivery device, the tissue interface surface or a power source coupled to the energy delivery device.
In another embodiment the variable resistance portion is configured to reduce an electrode edge effect.
BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a lateral view of embodiments of the skin treatment apparatus illustrating components of the apparatus including the treatment template, energy delivery device and tissue interface surface.
Figure 2 is a lateral view of an embodiment illustrating the use of a handpiece coupled to the treatment template.
Figure 2b is a lateral view of an embodiment illustrating the delivery of cooling fluid to the electrode using lumens, nozzles control valves and a control system. The figure also illustrates a detachable electrode.
Figure 3 is a lateral view of an embodiment illustrating the use of a variable resistance coating on the surface of the electrode
Figures 4 and 5 are perspective and cross-sectional views illustrating an embodiment of an electrode with rings of resistance material interposed between conductive material to generate a radial resistance gradient on the electrode surface. Figures 6A and 6B are perspective and cross-sectional views illustrating an embodiment of a cylindrical electrode with rings of resistance material interposed between conductive material, the resistance rings having increasing thickness moving in the outward radial direction.
Figure 7 is a cross-sectional/schematic view illustrating an embodiment of a ringed electrode coupled to a switching device, whereby duty cycle control of the conductive rings is used to achieve a more uniform current density across the surface of the electrode.
Figure 8 is a cross-sectional/schematic view illustrating an embodiment of an energy delivery device having a linear array of bipolar electrodes. Figure 9 is a cross-sectional/lateral view illustrating an embodiment of an electrode having a contoured thickness profile configured to produce a resistance gradient across the surface of the electrode to achieve a uniform current density. Figure 10a is a lateral view of an embodiment of an electrode illustrating the use of a dielectric coating on the surface of the electrode to achieve a uniform current density. Figure 10b is a perspective view of an embodiment of an electrode illustrating the use of an attached and/or conformable dielectric layer to achieve a uniform current density.
Figure 11 is a schematic view illustrating the current path from the dielectric-coated electrode to the body and return electrode for monopolar electrode embodiments.
Figure 12 is a schematic view illustrating the current through tissue for dielectric -coated bipolar electrode embodiments.
Figure 13 is a lateral view of an embodiment of a dielectric-coated electrode where the dielectric coating comprises a copper coating on a polyamide substrate.
Figure 14 is a lateral view of an embodiment of a dielectric-coated electrode where the dielectric coating comprises an oxide coating grown on a conductive substrate. Figure 15 is a cross-sectional view of the skin illustrating the target tissue zone and target tissue structures that can be treated by embodiments of the invention.
Figure 16 is a cross sectional/schematic view illustrating an embodiment using a circulating cooled fluid to cool the electrode. Figure 17a is a cross-sectional/schematic view illustrating an embodiment using a coolant/refrigerant spray to cool an electrode within an electrode housing. Figure 17b is a related embodiment to that shown in Figure 17a where the coolant spray is regulated by a solenoid valve coupled to an electronic control system and/or a physician-activated foot switch. Figure 18 is a flow chart for the selection of treatment parameters such as cooling and heating sequences, durations etc.
Figure 19 illustrates various embodiments of duty cycles cooling and heating during different phases of treatment.
Figure 20 is a cross-sectional view illustrating a bipolar electrode embodiment comprising a dense array of multiple electrodes.
Figure 21 depicts a block diagram of the feedback control system that can be used with the pelvic treatment apparatus. Figure 22 depicts a block diagram of an analog amplifier, analog multiplexer and microprocessor used with the feedback control system of Figure 21.
Figure 23 depicts a block diagram of the operations performed in the feedback control system depicted in Figure 22.
DETAILED DESCRIPTION
The present invention provides an apparatus and methods for overcoming the problems, limitations and clinical issues with existing technology for treating the skin with radio frequency (RF), optical (laser) and other forms of electromagnetic energy. In various embodiments, the apparatus can be used to deliver thermal energy to modify tissue including, collagen containing tissue, in the epidermal, dermal and subcutaneous tissue layers including adipose tissue. The modification of the tissue includes modifying a physical feature of the tissue, a structure of the tissue or a physical property of the tissue. The modification can be achieved by delivering sufficient energy to cause collagen shrinkage, and/or a wound healing response including the deposition of new or nascent collagen. Various embodiments of the invention utilize novel electrode designs and cooling methods for providing a more uniform thermal effect in tissue at a selected depth while preventing or minimizing thermal damage to the skin surface and other non target tissue. The result is an improved aesthetic result/clinical outcome with an elimination/reduction in adverse effects and healing time.
In various embodiments the invention can be utilized for performing a number of treatments of the skin and underlying tissue including: dermal remodeling and tightening, wrinkle reduction, elastosis reduction sebaceous gland removal/deactivation, hair follicle removal, adipose tissue remodeling/removal and spider vein removal and combinations thereof.
Referring now to Figures 1 and 2a, one embodiment of an apparatus 10 to treat the skin includes a treatment template 12. In various embodiments, template 12 can be coupled to a handpiece 14. Also template 12 can include a receiving opening 15 adapted to receive and/or fit a body structure and make full or partial contact with the skin layer of that structure. One or more energy delivery devices 16 can be coupled to template 12 including receiving opening 15, and can form an energy delivery surface 12' on template 12. Energy delivery devices can have a tissue contacting layer 16' that delivers energy to the skin and/or underlying tissue. In various embodiments, energy can be delivered to the skin and/or underlying tissue, from energy delivery device 16, template energy delivery surface 12' or a combination of both.
Energy delivery device 16 is coupled to an energy source 18. Suitable energy sources 18 and energy delivery devices 16 that can be employed in one or more embodiments of the invention include: (i) a radio-frequency (RF) source coupled to an RF electrode, (ii) a coherent source of light coupled to an optical fiber, (iii) an incoherent light source coupled to an optical fiber, (iv) a heated fluid coupled to a fluid delivery device, (v) a cooled fluid coupled to a fluid delivery device, (vi) a cryogenic fluid, (vii) a microwave source providing energy from 915 MHz to 2.45 GHz and coupled to a microwave antenna, or
(viii) an ultrasound power source coupled to an ultrasound emitter, wherein the ultrasound power source produces energy in the range of 300 KHZ to 3 GHz. For ease of discussion for the remainder of this specification, the energy source utilized is an RF source and energy delivery device 16 is one or more RF electrodes 16. However, all of the other herein mentioned energy sources and energy delivery devices are equally applicable to skin treatment apparatus 10.
A sensor 20 can be positioned at template energy delivery surface 12' or energy delivery device 16 to monitor temperature, impedance, pressure and the like. Suitable sensors 20 include impedance, pressure and thermal devices. Sensor 20 is used to control the delivery of energy and reduce the chance of cell necrosis at the surface of the skin as well as damage to underlying soft tissue structures. Sensor 20 is of conventional design, and includes but is not limited to thermistors, thermocouples, resistive wires, and the like. A suitable thermal sensor 20 includes a T type thermocouple with copper constantan, J type, E type, K type, fiber optics, thermistors, resistive wires, thermocouple IR detectors, and the like. Referring now to Figure 2b, in various embodiments handpiece 14 can be configured for multiple functions and can include one or more of the following: a fitting 14' for detachable electrodes, fluid and gas fittings 14", electrical fittings 14'" (e.g. Lemo connectors) for connection to power and control systems, a coolant valve 50 and a coolant spray nozzle 52. Handpiece
14 could be configured to be reusable, resterilized and compatible/interfacable with standard medical and electronic connectors and fittings known in the art.
Referring now to Figure 3, one embodiment for achieving uniform energy delivery from electrode 16 and minimizing edge effects involves coating all or a portion of the electrode with a variable resistance material 22 that has an electrical resistance that varies with temperature. In one embodiment, variable resistance material 22 is applied as a coating 22' on around tissue contact surface 16'.
Variable resistance material 22 can be selected to have a positive temperature coefficient of resistance (which means that its resistance increases with temperature.). These materials known as positive temperature coefficient semiconductors, can include ceramic semiconductive materials and polymers with embedded conductive particles. These and related materials, are well known in the art and are used for thermostats and other solid state temperature control devices. Such materials are available from the Raychem Corporation
(Menlo Park, California), an established supplier of positive temperature coefficient semiconductors. The use of such a positive temperature coefficient coating 22' prevents and/or reduces the formation of hot spots in the following manner. When hot spots begin to form on the edges of a coated electrode due to current concentration, the resistance of the coating 22' at the electrode edges goes up, resulting in a reduction in current flowing to and through these hot edges with an ultimate decrease in temperature of the edges and tissue in contact or near the edges.
Another embodiment for obtaining a more uniform energy delivery and thermal effect in tissue is shown in Figures 4 and 5. In this embodiment electrode 16, comprises a circular disc, with a number of concentric conductive rings 24 of conductive material 24'. Interposed between the conductive rings 24, are resistance rings 26 made of material with a higher electrical resistance, called resistance material 26. The conductive and resistance rings 24 and 26 are configured such that there is a radial resistance gradient, with a higher electrical resistance at the outer edges of the electrode that decreases moving radially inwards. As a result, less current flow (and hence less heating) occurs through the edges and outer portions of the electrode compared to the more central electrode portions. Another embodiment for achieving a radial resistance gradient and minimizing hot spots, involves having thicker rings of resistant material in the outer electrode portions and progressively thinner resistance rings going toward the center of the electrode. Varying the resistance of the energy delivery surface 16' of the electrode, through the use of interposing rings of conductive and resistance material serves to increase the uniformity of current density across the electrode energy delivery surface 16', resulting in a more uniform delivery of energy to underlying tissue. In related embodiments shown in Figures 6 A and 6B, electrode 16 is cylindrically shaped and is fabricated such that it is made out of alternating layers of resistance material 26' and conductive material 24'. The bottom portion of the electrode is the tissue contacting surface 16' and has a pattern of annular rings correlating to the layers of resistance and conductive material. Specifically, cylindrical electrode 16 is constructed such that the resistance rings 26 near the electrode center 16" are thinner than those at the outer edges 16'" with a continuous increase in thickness moving in the outer radial direction. As result of this configuration, electrons flowing through electrode outer electrode edges 16'" must flow through more of resistance material 26 (e.g. encounter more resistance) than those flowing through the more central electrode portions 16". Consequently, the net current flow on outer edges 16'" is less than in the more central electrode portion 16". This ringed pattern can be made to a mathematical limit where the annular rings become thinner and thinner and closer and closer to one another such that there is almost a continuous tissue contacting surface of conducting material 24, but also with a continuous resistance element that causes the current flow to be less on the outer electrode edges 16'" than the inner portions 16". Referring now to Figure 7, a related, but different, embodiment for reducing edges effects also involves dividing a circular disc electrode into annular conductive rings. However in this case, the flow of current through the rings is temporally controlled using a time sharing or duty cycle approach to turn on current flow to the inner and outer rings for fixed time periods. During a given duty cycle, RF current flow to the outer rings is turned on for the shortest periods of time with progressively longer on- times time moving inward in the radial direction. Although when the outer rings are turned on, they briefly have a higher current flow and are transiently hotter, this is compensated for by having them on for only a short time period and/or shorter than more centrally located electrode rings. Over time (e.g. on a time average basis) the result is a more uniform energy delivery to the tissue and hence thermal effect over the surface of the electrode. Adjacent rings can be switched on and off sequentially or in any other predetermined order or pattern. Also two or more rings can be turned on at the same time. The switching of rings can be controlled by a switching device /circuit 28, known in the art, electrically coupled to the rings. Also, the rings can be multiplexed to energy source 18 using a multiplexing circuit 30 known in the art.
In another embodiment shown in Figure 8, the energy delivery device 16 can comprise a number of small rectangular shaped electrodes that are laid down (on a supporting surface, structure or substrate) and operated in a bi-polar fashion. In this embodiment, every pair of bars could be a bi-polar electrode pair 17 possibly with sequential switching between different pairs of bars to create a bi-polar effect. In still other alternative embodiments for controlling electrode resistance and providing uniform energy delivery, electrode 16 can be fabricated such that it has a continuous variation in resistance moving in a radial or other direction. More specifically, the electrode can be configured to have a continuously decreasing resistance moving inwardly in the radial direction. One embodiment for achieving this result is shown in Figure 9, which illustrates an electrode fabricated to have a tapered or otherwise contoured profile, thickest at the outer edges 16'" and thinner moving inward in the radial direction. By definition, the thicker sections of the electrode have increased resistance compared to the thinner sections (e.g. resistance is proportional to thickness). In a related, but distinct embodiment, a radial or other directional gradient in resistance can be achieved by doping, impregnating or coating the surface of the electrode with materials (known in the art) to increase its electrical resistance.
Referring to Figures 10a and 10b, other embodiments of the invention for achieving a more uniform thermal effect, involve the use of a layer of dielectric material coupled to the electrode and positioned between the conductive portions of the electrode and the skin. In one embodiment shown in Figure 10a, all or a portion of electrode 16 can be coated with a dielectric material 32 to form a dielectric layer 32'. In a related embodiment shown in Figure 10b, electrode 16 is attached to a dielectric layer or film 32', which can be made of a conformable material that conforms to the surface of the skin. In various embodiments, the electrode 16 that is attached to dielectric layer 32' can be of any geometry, e.g. circular, oval, rectangular, etc. It is desirable to have the surface of the dielectric layer 32' extend beyond the edges of electrode 16 such that substantially all current must flow through the dielectric layer. This can be achieved by configuring electrode 16 to have a smaller surface area than layer 32' and having electrode 16 substantially centered on the surface of layer 32'. Accordingly, electrode 16 can have between 1 to 100% the surface area of layer 32', with specific embodiments 25, 50, 75%, and 90%.
There are several key benefits to the use of dielectric layer 32' with electrode 16, the most important of which is the ability to produce a more uniform current flow through the electrode and subsequently to the underlying skin and tissue. This is attributable in part to a capacitance effect created by the use of layer/coating 32'. Specifically, the use of layer 32' creates an electronic capacitor (e.g., two conductors separated by an insulator) where, one conductor is the electrode, the second conductor is the skin or the tissue being treated, and the insulator separating them is the dielectric layer on the electrode. In various embodiments, the capacitive effect of dielectric layer 32 can be controlled through the selection of the thickness, surface area and dielectric constant of layer 32, as well as by controlling the frequency of the RF signal. As a result of the above configuration, the dielectric coating creates an increased impedance to the flow of electrical current through the electrode. Owing to this increased impedance, and to the fact that electrical current naturally seeks the path of least impedance, the current is biased/forced to take the shortest path length between the two conductors, which is the path straight down through the electrode to the tissue. By corollary, the electrical current is unlikely to take any paths that would result in a longer path length and hence increased impedance. Such a longer path length would be the case for any concentration of current flowing out of the edges of the electrode. The use of the dielectric coating serves to force a more uniform distribution of electrical current paths across the electrode surface and down into the tissue. This occurs because the capacitance resulting from the dielectric coating presents impedance to the flow of electrical energy particularly at the edges of the electrode, where current concentrations are likely to occur. More specifically, the use of dielectric coating 32' produces a more uniform impedance through the electrode and causes a more uniform current to flow through the electrode. The resulting effect minimizes or even eliminates, edge effects around the edges 16'" of electrode 16 which includes the perimeter for a circular disk-shaped electrode, and the perimeter and corners for a rectangular electrode. It is desirable to have the electrical impedance of the dielectric layer
32' to be higher than that of the tissue. In various embodiments, the impedance of layer 32' at the operating frequency, can be in the range of 200 Ω per square centimeter or greater. Suitable materials for a dielectric coating 32' include, but are not limited to, Teflon® and the like, silicon nitride, polysilanes, polysilazanes, polyimides, Kapton and other polymers, antenna dielectrics and other dielectric materials well known in the art.
Another advantage of using a dielectric layer 32' is that there is little or no increase in current density resulting from only partial contact of electrode 16 with the tissue surface. Normally, such partial contact would increase current density in the electrode portions remaining in contact with tissue increasing the size and severity of hot spots and the likelihood of spark discharge and burns to the tissue. However, because of the capacitance effect of the dielectric layer, the impedance of the electrode goes up (due to a decrease in the capacitance) as the surface area of the electrode tissue contact zone is reduced. This causes the current density flowing through the electrode to remain relatively constant. This effect is achieved by configuring the dielectric layer/electrode to have an impedance higher than the contacting tissue.
Hence, use of the dielectric coating on the electrode presents an important safety advantage over the use of just a conductive electrode in contact with the tissue, since there is little or no increase in current density and resulting hot spots from only partial tissue contact of the electrode. Such partial contact with a conventional electrode, not only cause the edge effects and hot spots, but as the amount of tissue contact decreases, the current density can increase to the point where the electrode begins to act like a electrosurgical knife (e.g. a bovie) with a spark discharge causing serious burns to the patient and also possibly to the medical practitioner. In contrast for the dielectric- coated electrode, partial tissue contact at a point would result in almost no current flowing because the impedance would be very high. Thus, embodiments using the dielectric- coated electrode have safety advantages in the clinical setting where partial tissue contact often occurs.
Another advantage of the use of a dielectric coating is the minimization of the need to use a conductive fluid (e.g. saline solution) to conduct RF energy to the skin surface and/or assure electrical contact of the electrode with the skin surface. The use of conductive fluids minimizes tissue contact problems when the electrode is a conductive electrode. However for embodiments using a dielectric coating electrode, the conductive fluid is less important because the dielectric coating causes capacitively coupling of the energy into the tissue.
This is a distinct advantage from several standpoints. First is from an ease of use standpoint, since fluids and/or conductive gels can be difficult to work with. The second advantage is one of safety and control, since the physician can not always control where the fluid goes, possibly heating and burning tissue not intended to be treated, as well as presenting a possible shock hazard to the patient and medical personnel. The third advantage is reproducibility, since conductive fluids having different electrolyte concentrations will have different conductivities and hence, cause more or less current to be conducted to the tissue causing varying amounts of heating.
In various embodiments, a dielectric-coated electrode can be bi-polar or mono-polar. For a mono-polar configuration (shown in figure 11), electrode 16 can comprise a single electrode covered with a dielectric coating 32' that capacitively couples energy into the skin or other tissue used in conjunction with a return electrode 34. While for bi-polar embodiments, a capacitively coupled electrode can comprise multiple electrodes delivering energy to the skin. Referring now to Figure 12, in one bi-polar embodiment (with the dielectric coating on the tissue contacting side), electrical current uniformly flows out from a first electrode 17' of a bi-polar pair 17 through its dielectric coating into the tissue then through the dielectric coating of the second electrode 17" of the bi-polar pair 17 into the second electrode and then back to the RF energy source 18. The area of substantial current flow and hence the treatment zone 44 is substantially confined to an area of tissue between each bipolar pair
17 of electrodes. Because of the benefits of dielectric coating described herein, the current flowing through this area is very uniform resulting in a uniform thermal effect as well.
Referring now to Figure 13, another embodiment of a dielectric coated/capacitively coupled electrode can comprise a copper coating 36 adhered to a polyimide substrate 38 that is about 0.001 " in thickness. Such an electrode is similar to a standard flex circuit board material commercially available in the electronics industry; however in this case the flex circuit substrate (e.g. the polyamide layer) is much thinner than that found in a standard electric circuit board. The copper-polyimide laminate material can be an off-the-shelf commercially available material and the deposition of copper down on polyimide is a well-known process in the circuit board industry. However, the present invention uses this material in a fashion contrary to its standard or known usage or configuration. Specifically rather than having the copper in contact with the intended electrical device/circuit (e.g. the skin) as a conductive electrode, the polyimide is touching the skin and the copper is separated from the skin with the 0.001" ( 1 mil) polyimide layer. At standard electrosurgical operating electrical frequencies (e.g. several hundred KHz to perhaps a MHz), the 1 mil layer of polyimide is too thick and does not perform well as a capacitor from an electrical standpoint. One way of improving the performance of a 1 mil polyimide copper electrode is to increase the frequency of the RF current going to the copper-polyimide electrode. In various embodiments using 1 mill polyimide-copper electrodes, the RF current supplied to the electrode can be operated at approximately six MHz. In embodiments with a thinner polyimide layer (e.g. less than 0.001), the frequency of the RF current can be reduced to the standard range recited above. One method for decreasing the thickness of the polyimide layer would be to grow the copper layer on the polyimide using sputtering, electrodeposition, chemical vapor deposition, plasma deposition and other deposition techniques known in the art. These methods could be equally applicable to other thin polymer dielectric films known in the art. Alternatively these same processes could be used to deposit a dielectric layer such as paralyne, onto a conductive layer. Also, the copper layer could be adhered to a thinner 0.0003" polyimide film.
Referring now to Figure 14, yet another embodiment of a dielectric- coated electrode involves growing an oxide layer (usually a metal oxide layer) 40, on a conductive material 42 such as a metal conductor. The use of oxide layer 40 presents a number of possible technical advantages. The first of which is a reduced thermal resistance and hence improved heat transfer through electrode 16 and ultimately through the skin verses metal-polymer film and other electrodes. Specifically the thermal conductivity of a deposited oxide film (such as an aluminum oxide on an aluminum conductive layer) is significantly improved over that of a polyimide layer. This improves thermal conductivity, in turn improving the ability to cool and protect the skin by improving the transfer of heat from skin through the electrode, enabling the electrode to better dissipate heat from the skin (by convection and conduction) both with and without cooling of the electrode conduction. The net effect is to improve the cooling efficiency of the skin. For example, an aluminum oxide layer grown on an aluminum conductor has a thermal conductivity approximately 20 to 100 times better than a polyimide layer. Aluminum oxide layers can be readily grown on an aluminum using the commercially available process of anodization. The result is an electrode that has a dielectric layer 32', the aluminum oxide, which is also a very good thermoconductor. Oxide layers can also be grown on titanium, platinum, stainless steel, silver, gold and other conductors using similar anodization or other commercially available processes known in the art.
Thus, the use of dielectric-coated electrodes or otherwise capacitively coupled electrodes has one or more of the following advantages: i) improved the ability to uniformly treat tissue (e.g. more uniform thermal effect), ii) improved safety features such as partial tissue contact not resulting in burns, and minimizes the requirement for an electrically conducting fluid or electrolytic fluid to couple the electrode into the tissue; and iii) improved cooling ability for oxide coated electrodes such as an aluminum oxide coated aluminum electrode. Referring now to Figure 15, the target tissue zone 44 for therapy (also called therapeutic zone 44, or thermal effect zone 44), can include, but is not limited to, tissue at a depth from approximately 100 μm beneath the surface of the skin down to as deep as a couple of millimeters, depending upon the type of treatment (e.g. collagen contraction, hair removal, etc.). For treatments involving collagen contraction, it is desirable to cool both the epidermis and the superficial layers of the dermis of the skin which lies beneath the epidermis, to a cooled depth range between 100 m to several hundred m.
In various embodiments, the invention can be used to treat different structures 44' of the skin lying at different depths. Such structures can include the hair follicles and sebaceous glands and related structures. The invention can even be used to treat deeper structures or tissue such as the subcutaneous fat layer. Treatment in this case meaning the delivery of thermal or other energy to that tissue to produce a therapeutic effect. As such cooling may be important in each of these applications. Turning now to a discussion of optimal control of the cooling process, all the devices disclosed in this application can incorporate some form of a cooling device 46, system 46' and/or method (see Figures 16 and 17). Cooling device 46 or system 46' can be configured to precool the surface layers of the target tissue such that when the electrode structure is in contact with the tissue and/or prior to turning on the RF energy source the superficial layers of the target tissue are already cooled. When RF energy source is turned on or delivery of RF to the tissue otherwise begins, resulting in heating of the tissues, the tissue that's been cooled is protected from thermal effects including thermal damage. The tissue that has not been cooled will warm up to therapeutic temperatures resulting in the desired therapeutic effect.
In various embodiments, the treatment process can include one or more of the following steps: i) precooling (before the delivery of energy to the tissue has started), ii) an on phase or energy delivery phase in conjunction with cooling, and iii) post cooling after the delivery of energy to tissue has stopped. Pre-cooling gives time for the thermal effects of cooling to propagate down into the tissue. More specifically, precooling allows the achievement of a desired tissue depth thermal profile, with a minimum desired temperature being achieved at a selectable depth. This can be facilitated with the use of thermal sensors positioned within or on the skin. The amount or duration of precooling can be used to select the depth of the protected zone of untreated tissue. Longer durations of precooling produce a deeper protected zone and hence a deeper level in tissue for the start of the treatment zone. The opposite is true for shorter periods of precooling, all other factors (e.g. RF power level) being relatively equal.
Post cooling can be important because it prevents and/or reduces heat delivered to the deeper layers from propagating upward (via conduction ) and warming up the more superficial layers possibly to therapeutic temperature range even though external energy delivery to the tissue has ceased. In order to prevent this and related thermal phenomena, it is desirable to maintain cooling of the treatment surface for some period of time after application of the RF energy has ceased. In various embodiments varying amounts of post cooling can be combined with "real time cooling" and/or precooling.
Various embodiments of the invention may employ different cooling methods and those cooling methods can be configured for the specific treatment method or structure being treated (e.g. treatment of the sebaceous glands). Referring now to Figure 16, one embodiment of cooling involves the circulation of a coolant or cold fluid 48, inside a hollow dielectric-coated electrode or other electrode structure such that this cooling fluid is an intimate contact with the electrode. As a result, when the electrode is in contact or close proximity to the skin, this cooling fluid also cools the skin via thermal conduction and/or radiation of heat from the skin to the electrode and then the transfer of heat from the electrode to the cooling solution by convection and conduction. In these and related embodiments it is beneficial to have good heat transfer through the cooling fluid, the electrode and the tissue to be cooled. Optimization of heat transfer through the electrode can be facilitated by the selection of materials (e.g. materials with high thermal conductivity such as metals), dimensions (e.g. thickness, etc.) and shape. Accordingly, heat transfer through the copper- polyamide electrode and related electrode embodiments can be optimized by minimizing the thickness of the polyamide layer. This will allow these types of electrodes to have good thermal coupling to the tissue. For the case of the metal oxide- metal electrodes (such as the aluminum-aluminum oxide electrode), metal oxide dielectric layer 40 has a much higher thermoconductivity than the polyamide dialectic, allowing a thicker dielectric layer and a thicker electrode. These factors allow for stronger electrode structure and potentially a higher degree of electrode capacitance and capacitive coupling.
Referring now to Figure 17a, other embodiments of the invention utilizing cooling can incorporate a spray valve 50 (or valve 50) coupled to a nozzle 52 positioned inside in the 54' interior of a hollow electrode structure/housing 54 of electrode 16. Nozzle 52 is used to spray a coolant or refrigerant 48 onto the inner surface 54" of the electrode structure 54, where it evaporates and cools the electrode. Refrigerant 48 cools the electrode 16 by combination of one or more of evaporative cooling, convection and conduction. The electrode in turn, cools the tissue that is beneath it through conduction. Possible refrigerants 48 include, but are not limited to, halogenated hydrocarbons, carbon dioxide and others known in the art. In a specific embodiment, the refrigerant is R134A which is available from Refron, Inc. (38- 18 33rd St. Long Island City, New York 11101) and commonly used to cool electronic components.
There are several advantages to cooling using an evaporating refrigerant (also known as a cryogen). First, this type of cooling known as evaporative cooling allows more precise temporal control of the cooling process. This is because cooling only occurs when the refrigerant is sprayed and it is evaporating (the latter being a very fast short lived event) Thus cooling ceases rapidly after the spray of refrigerant is stopped. The overall effect is to confer very precise time on-off control of the spray. Improved temporal control can also be obtained through the use of thin electrodes having negligible thermal mass, alone or in conjunction with a refrigerant spray. The negligible thermal mass of such electrodes results in an almost instantaneous cooling of the electrode and underlying skin.
In another embodiment shown in Figure 17b, spray valve 50 can be a solenoid valve 50, which can be fluidically coupled to a cryogen reservoir 48'.
Solenoid valve 50 can be electronically coupled to and controlled by an electronic/computer control system 56 or manually controlled by the physician by means of a foot switch 53 or similar device. Such valves have response times on the order of five to ten milliseconds. Suitable solenoid valves include, but are not limited to a solenoid pinch valve manufactured by the N-Research
Corporation (West Caldwell, NJ).
In various embodiments, the electrode can have a variety of hollow structures which are simultaneously configured for spray cooling of the electrode and conductive cooling of the skin in contact with the electrode. This can be accomplished by a combination of one or more of the following i) maximizing the internal hollow surface area of the electrode, minimizing the wall thickness of the electrode in contact with the skin, and iii) designing the hollow area of the electrode to maximize the internal surface area that can be reached by the spray jet of a nozzle. It is also desirable to have an opening in the electrode, or chamber containing the electrode, to allow the evaporated refrigerant to escape. This escape can include a pressure relief valve to control pressure in the chamber. In other embodiments involving use of refrigerants, cryogen 48 can be dispersed or sprayed through a porous or open cell structure (which can include the electrode) that can be configured to have cryogen 48 make direct contact with the skin if necessary. In another embodiment, the refrigerant is sprayed on the inside of a hollow electrode tubular structure, with the electrode external surface in contact with the skin. It is beneficial in this design to make the electrode surface strong enough (e.g. able to withstand compressive forces greater than 0J to 1 lbs) so that the electrode can support itself when pressed against the skin in order to improve heat transfer between the skin and the electrode. This can be accomplished through the selection of higher strength electrode materials, electrode thickness and shape. One embodiment of a structurally strong electrode involves the use of a metal oxide electrode such as titanium oxide electrode.
In alternative embodiments, portions of electrode 16 can be configured to be sufficiently flexible to conform to the skin, but still have sufficient strength and/or structure to provide good thermal coupling when pressed against the skin surface. Such a configuration can be utilized with a polyamide (or other polymer) copper film electrode that needs to be kept thin to optimize thermal conductivity. In these and related embodiments, the electrode may comprise or be integral to a hollow tissue probe that has a tissue contacting electrode external surface and an internal electrode surface that is integral to or otherwise exposed within an internal chamber of the probe where evaporation of the refrigerant takes place. The internal chamber of the hollow electrode 54 or probe is sealed, but can include a venting means 58. In one embodiment shown in Figure 17b, venting means 58 can be a pressure relief valve 58 vented to the atmosphere or a vent line. When the refrigerant spray comes into contact with the electrode and evaporates, the resulting gas pressurizes the inside of this sealed chamber/cylinder causing the thin flexible tissue contacting electrode surface to partially inflate and bow out from the surface of the supporting structure of the tissue probe. This inflated/pressurized configuration provides the thinner polyamide-copper film electrodes with a tissue contacting surface/structure with sufficient strength to provide good thermal coupling when pressed against the skin, while when in a deflated state or if there is no pressure in the chamber, the electrode remains flexible. In these and related embodiments, the refrigerant spray serves two purposes. First, to cool the electrode and the tissue adjacent the electrode, and second, to inflate/expand at least portions of the electrode and/or chamber carrying the electrode in order to provide an electrode/chamber structure configured for good thermal coupling to the skin. In various embodiments, the inflated electrode configuration can be configured to enhance thermal contact with the skin and also result in some degree of conformance of the electrode surface with the skin.
In various embodiments, relief valve 58 can be configured to open at pressures including but not limited to 0J psi to 30 psi, with a preferred narrower range of 0.5 to 5 psi and specific embodiments of and 0.5, 1, 2, 4, 8, 14.7, 20 and 25 psi. Also in various embodiments, the probe chamber can be fabricated from stainless steel and other machinable metals known in the art.
Suitable pressure relief valves 58 include, but are not limited to, mechanical valves including spring actuated valves, polymer valves, and electronically controlled valves. In one embodiment pressure relief valve 58 can be of a mechanical type manufactured by the McMaster-Carr Corporation. The spring- actuated valves are controlled by an internal spring opens the valve, when the pressure reaches a certain level. Embodiments using the electrically operated valves, can include a pressure sensor/transducer 20 positioned inside the chamber and an electronic controller 56 which is electronically coupled to both the electronic valve and the pressure sensor. The controller sends a signal to open the valve when a programmed pressure has been reached.
In various embodiments, cryogen spray 48 is used as cooling source through evaporative cooling and contact with the electrode that's touching the skin, and also to inflate a probe/electrode chamber to provide pressure which will inflate and/or bow out the thin flexible electrode to provide improved contact (e.g. thermal and mechanical) with the skin and also some degree of conformance with the skin. In embodiments employing higher chamber pressures, approximately 10 to 20 psi, the flexible thin polyamide electrode tissue contacting structure can become very rigid, and can have similar properties (e.g. stiffness, rigidity etc.) to Mylar®. Then, decreasing the pressure several psi (e.g. 1 to 4 psi) the rigidity decreases and the tissue contacting surface of the electrode begins to become conformable. Thus, the rigidity and/or conformity of the electrode can be selectable with chamber pressure and adjusted for the mechanical properties and shape of the skin surface being treated in order to obtain the desired level of thermal coupling to the skin. Chamber pressures between five to ten psi have been found to perform well for many applications. More rigid structures can be obtained at higher chamber pressures, and contrarily very flexible conformable structures can be obtained at lower pressures. In alternative embodiments, the use of a sealed evaporation chamber and "bowable" electrode could also be employed with electrodes having a dielectric oxide layer, such as the aluminum-aluminum oxide. In such embodiments, electrode thickness, surface length and support structure are configured to allow the electrode surface to bow outward with pressure in the 1 to 10 psi or other range disclosed herein. The flexibility of a metal electrode can be increased using one or more of the following approaches: by making the electrode thinner, increasing the unsupported length of the electrode surface and using materials/processing methods with reduced stiffness (e.g. Young's Modulus). In one embodiment an aluminum-aluminum oxide electrode could be in the form of a foil type electrode and may have a comparable thicknesses to commercially available aluminum foil.
Improved thermal response time is another advantage of embodiments using sprayed cryogen 48 for cooling purposes. Circulating water cooling systems have the limitation of not being able to have fast enough thermal response times due to a number of factors (e.g. thermodynamic properties of water, heat and mass transfer limitations, etc.). The use of the spray cryogens in combination with a thin film electrode (e.g. polyamide-copper ) overcomes these limitations and provides the capability to perform a number of different types of algorithms for skin treatment that could not be performed with a circulating cold water cooling system. For example, the refrigerant spray could be turned on the order of milliseconds before the start of RF energy delivery to the desired tissue and subsequently cycled off and on in millisecond durations. In various embodiments this could be accomplished using commercially available solenoid valves coupled to a cryogen supply (e.g. a compressed gas canister) or the cryogen delivery loop. Such valves have response times on the order of five to ten milliseconds. In various embodiments, these valves could be coupled to a computer control system or could be manually controlled by the physician by means of a foot switch or similar device. One of the key advantages of this and related systems is the ability to rapidly respond and cool overheated tissue before the occurrence of thermal injury. In alternative embodiments the cryogen nozzle and solenoid valve can be coupled to or otherwise configured to be used with a chopper wheel (not shown). The chopper wheel is adapted for intermittently allowing the spray of the cryogen onto the tissue or electrode. This configuration provides the ability to shorten both the response time and the duration of cooling. In these and related embodiments, the cryogen spray is directed at an approximate perpendicular angle into the face of a chopper wheel that rotates at selectable angular velocity. The chopper wheel has an approximately circular geometry and has an open section, which can be a sector, radially oriented rectangle, or other geometric shape positioned at a selectable position on the face of the wheel. When the open section is aligned with refrigerant spray stream coming out of the solenoid valve then the spray goes down and hits the tissue. In various embodiments, the chopper wheel can rotate at angular velocities between 1 and 10,000 rpm. The wheel, wheel mechanism and timing system can be similar to those used on optical chopper wheels well known in the art. Alternatively, various high speed small motor mechanisms (such as a brushless dc motor) can also be used.
An important advantage of embodiments of the invention employing a solenoid valve alone, or in combination with a chopper wheel is the ability to deliver the cryogen in very short bursts (via spray or other means). This short burst capability allows the physician to titrate and/or selectively control the amount of heat removed by the cryogen from the tissue. This is because from a thermodynamic standpoint, the amount of heat removed by a given volume of a given cryogen as it evaporates is predictable (e.g. known latent heat of vaporization, known cryogen temperature, etc.) So for a milliliter volume of cryogen spray, the number of calories of heat loss from the tissue can be predicted with a reasonable degree of accuracy (e.g.. approx +/- 5% or better). This information can be used to design a treatment algorithm that's very quantitative, e.g. the amount of cooling delivered is correlated to the RF power level or other metric of energy delivery. Moreover, the algorithm can be configured to control the amount of thermal energy (e.g. heating) delivered to the tissue in an accurate manner in order to obtain a desired tissue temperature and/or effect at selectable depth and similarly can control the amount of cryogen delivered to the tissue to produce a selectable amount of cooling sufficient to protect non target tissue from thermal injury. Such ratios of cooling delivered to energy delivered can be preprogrammed into the algorithm and can be configured for depth of tissue to be treated, type of tissue (e.g. skin vs. adipose tissue), thermal conductivity of treated skin or tissue, desired target tissue temperature and desired maximum non target tissue temperature. For example, when delivering RF power at a 100 watt level for 0J second (assuming that 50%) of this heat propagates upward to a non target skin/tissue site), the volume of cryogen delivered would have to be able to cool/ remove 5 joules of energy from the tissue. If each ml of cryogen spray removed one joule of energy by evaporation, then 5ml of cryogen would have to be delivered to the tissue. This could be delivered in the same 0.1 seconds as the energy delivery or could be delivered in series often 0.010 second burst over 0.2 seconds with 0.2 ml of cryogen per spray burst. A key advantage of the cryogen spray is the availability to implement rapid on and off control, with the 0.005 second response times for solenoid valves, or even faster with embodiments using some type of electronically controlled aperture or shutter known in the art. In various embodiments, a varied number of pulse on-off type cooling sequences and algorithms may be employed. In one embodiment, the treatment algorithm comprises precooling the tissue by starting a cryogen spray, followed by a short pulse of RF energy into the tissue, with the cryogen spray continuing during the duration of the energy delivery and then stopping shortly thereafter (e.g. on the order of milliseconds). This or another treatment sequence could be repeated again. Thus in various embodiments, the treatment sequence can comprise a pulsed sequence of cooling on, heat, cooling off, cooling on, heat, cool off, and with cooling and heating durations on orders of tens of milliseconds. In these embodiments, every time the surface of the tissue of the skin is cooled, heat is removed from the skin surface. However this cooling effect is not appreciable for the deeper tissue away from the surface area where the cryogen spray is directed and having its effect. In various embodiments, the cryogen burst duration and interval between burst can be in the tens of milliseconds ranges which allows surface cooling, while still delivering the desire thermal effect into the deeper target tissue.
In various embodiments, the burst duration and interval can be adjusted for the heat transfer rate/thermoconductivity between deeper target tissue and the skin such that the cooling rate of the skin equal or exceeds the rate of heat transfer from the RF heated deeper target tissue to the skin. The rapid response time and precise temporal control of embodiments of the invention employing burst cryogen spray cooling allows the performance of a number of noninvasive tissue treatment methods that could not be performed by apparatus/methods employing water and other slower, less controllable cooling methods due to a risk of thermal injury of nontarget tissue and other thermal related complications. Such noninvasive treatment methods include skin resurfacing, collagen shrinkage, treatment of sebaceous glands, hair follicle removal, treatment removal of subcutaneous fat and other skin treatments known in the art of dermatology or plastic surgery.
In various embodiments, the depth of the thermally effected zone (also called the thermal effect zone) can be controlled by the amount of precooling. Specifically, the longer periods of precooling (for a given rate of energy delivery, or total amount of energy delivered), result in a deeper penetration in the tissue before the thermal effect starts. In contrast, little or no precooling results in the thermal effect starting at or near the skin surface. In related embodiments, the thickness of the thermal effect zone in the tissue can be controlled by the duration of the RF energy delivery. The longer the period of RF energy delivery, the deeper the thermal effect.
In still other related embodiments, the starting depth and thickness of the thermal effect zone can be selected through control of both the duration/amount of precooling and the duration of RF energy delivery. Such control presents a distinct advantage in that it allows the selected treatment of a discrete anatomical layer or tissue structure located at various depths within or beneath the skin without injury to surrounding tissue. This and other benefits can be derived from the combination of cryogen spray with pulsed cooling and/or heating.
Different treatment algorithms can incorporate different amounts of precooling, heating and post cooling phases in order to produce a desired tissue effect at a desired depth. Figure 18 is a flow chart for the selection of treatment parameters including, duration of precooling, RF on time, RF power levels, and postcool durations for treatment algorithms for different tissue depths discussed herein, including superficial, thin effect and deep tissue treatments.
Figure 19 shows various duty cycles (e.g. on times) of cooling and heating during the different phases of treatment. The figure illustrates the specific duty cycles (e.g. on-times and interval between on-times) of cooling and heating during the stages of pre-cooling, energy delivery (heating) and post cooling. The cooling and heating duty cycles can be controlled and dynamically varied by an electronic control system known in the art. Specifically the control system can be used to control the electronic solenoid valve (described herein) for controlling the flow of coolant and the RF generator supplying RF energy.
In various embodiments, the invention can include sensors to measure parameters such as the skin surface temperature, the interior or exterior temperature of the electrode structure, the dielectric layer temperature, or the tissue temperature at a selectable depth. Accordingly, sensors 20 can be positioned in the interior or exterior of the electrode structure and adjacent dielectric layer 32'. One or more sensors 20 can be coupled to electronic control system 56 and can be used to control the delivery of one or both energy and cooling to the skin and target tissue. Suitable temperature sensors and sensor technologies include thermocouples, thermistors, infrared sensors/technology and ultrasound sensors/technology. The latter two being well suited for measuring temperature at tissue sites located down inside the tissue as opposed to near or on the surface. Such sensors enable the measurement and generation of temperature depth or thermoprofile of the tissue. Such a thermoprofile could be used for process control purposes to assure that the proper amounts of heating and cooling were being delivered to achieve a desired elevated deep tissue temperature while maintaining skin tissue layers below a threshold temperature for thermal injury. The physician would use the measured temperature profile to assure that they were staying within the bound of an ideal/average profile for a given type of treatment (e.g. sebaceous gland treatment).
In addition to the treatment methods discussed herein, in other embodiments the invention can be configured for skin rejuvenation. In these embodiments, the delivery of thermal energy to the target tissue is controlled/reduce to only cause a wound healing response and not necessarily collagen contraction. This would healing response results by delivering thermal energy to the tissue to induce a condition called fibroplasia. This is a condition in which there is a proliferation or otherwise infiltration into the dermis of a large number of fibroblast cells. These fibroblast cells in turn, lay down or deposit collagen into or adjacent the thermal affect zone causing the skin rejuvenation process. However by delivering a selected amount of energy, a proportion of the fibroblasts in the dermis can be killed off. As a result, a wound healing response occurs, in which there is large infiltration of fibroblasts into the dermis, with a large number of fibroblasts present than before treatment. These new fibroblasts lay down new collagen as part of a wound healing response and this rejuvenates the skin. Thus by controlling the amount of thermal energy delivery to the target tissue (and/or temperature of), the resulting tissue affect can be titrated to produce skin rejuvenation for lower levels of delivered energy, or collagen contraction configured to tighten the skin for higher levels of delivered energy. If the collagen contraction/skin tightening is positioned very superficially, it can help to minimize the appearance of wrinkles. If the area of collagen contraction is located deeper in the dermis, it can tighten up areas of loose skin.
As discussed herein, various embodiments of the invention can employ either mono-polar or bi-polar electrode implementations. One bi-polar embodiment shown in Figure 20 can comprise very dense arrays of small electrodes 16 where every other electrode in the array is an opposite pole of a bi-polar electrode pair. The electrode array in this embodiment will produce a very superficial delivery of thermal energy into the tissue extending from one bi-polar pair to another. In contrast, a mono-polar electrode will produce a much deeper tissue affect than will the bi-polar electrodes. This depth difference in thermal affect between the two types of electrodes results from the difference in current paths for mono-polar versus bi-polar electrodes. For mono-polar electrode configurations, the current flows from the positive electrode to a return electrode located far away on the patient's body. In contrast for a bi-polar electrode pair, all the current paths are localized between electrode pairs located on the electrode array (e.g the energy delivery device).
In various embodiments, different electrode configurations can be employed for different targeted tissue layers or sites or for different forms of treatment to the same site. For example, when treating deeper target tissue layers (e.g. > 100 μm tissue depth) such as the subcutaneous fat or the deep dermis, a mono-polar electrode configuration could be selected for its ability to delivery energy to the deeper tissue sites. In other embodiments treating more superficial tissue layers (e.g. 100 μm tissue depth), for example wrinkle removal, a bi-polar electrode configuration would be preferable. In various bipolar electrode embodiments, the depth of the thermal tissue affect is limited to the more superficial tissue layers with little or no deep tissue effect, even for longer periods of energy delivery. Accordingly, various bi-polar embodiments can be readily configured for use with continuous cooling system/apparatus either in the form of a continuous spray or a circulating fluid. The use of continuous cooling presents several advantages in that i) more conventional and potentially less expensive cooling systems (e.g. water cooling, air cooling and the like) can be employed, ii) the complexity of the system or apparatus is reduced in that reduced hardware and soft resources are required to control the delivery of coolant; and iii) improved ease of use for the medical practitioner. Many current dermatological procedures involving the delivery of heat to tissue are done with lasers. However, the use of lasers for dermatologic procedures has several technical drawbacks which limit the access and depth of tissue treatment, reduce efficacy and cause undesirable patient complications. First, laser light propagating in tissue exhibits a phenomena known as scattering in which the incident light is scattered by incident cells and tissue from its original optical path. This scattering results in the incident light beam no longer traveling in a straight, and hence, predictable path within the target tissue. The scattering has the further detrimental effect of causing nonuniform intensity within the beam surface and hence a nonuniform thermal effect in the tissue contacted by the beam. Specifically, the outer areas of the laser beam undergo more scattering than the interior or more central portions of the beam. This causes the central portions of the beam to become more focused as the beam propagates deeper into the tissue or in other words, the central portion becomes more intense while the outer areas and beam edges less intense. This nonuniform beam intensity can in turn lead to non-uniform heating and tissue effects as the beam moves deeper into the tissue and becomes increasingly focused on a smaller and smaller area. This non-uniform intensity can readily cause a nonuniform cosmetic effect. More importantly it may be significant enough to cause severe thermal injury with related medical complications (e.g. burning, damage or destruction of nerves, blood vessels, etc.). Various mono-polar electrode embodiments of the present invention provide improvements and features for overcoming these and other limitations. They also provide the medical practitioner with an apparatus generally better suited for treating the skin and underlying tissue including the deeper dermal and subdermal tissue. These improvements/advantages include a more uniform delivery of energy in the target tissue beneath the surface of the electrode and dispersement of delivered energy outside the target tissue site. This is attributed to i) the more uniform cuπent density of dielectric coated mono-polar electrodes and ii) the tendency of current density (and hence energy density) in mono-polar electrodes to diffuse (as opposed to becoming concentrated) as it spreads out and travels through the body to the return electrode, becoming negligible outside the tissue treatment site. This actually has some advantages over other methods of heating the tissue.
In various embodiments the bi-polar electrodes can comprise an array of electrodes, including a highly dense array of electrodes. As shown in Figure 20, such an array can include a multiple bar pattern of electrodes, where every other electrode of a sequence of thin rectangular bars is an electrode of a bi-polar pair. In embodiments where the electrodes are located very close to each other tissue, thermal effects (e.g. treatment) tends to occur in the tissue underlying gap between the electrodes. In various embodiments the gap between electrodes of a bi-polar pair can include but is not limited to a range from 0.0001 to 1 inch, with specific embodiments of 0.001, 0.010, 0.025, 0.050, 0J, 0.25 and 0.5 inches. As the distance between electrodes comprising a pair increases, the electrodes begin to behave like mono-polar electrodes. That is they are not influenced by the presence of another electrode that may be in the same or other tissue treatment area. In various embodiments, the electrode spacing or electrode gap can be varied or modulated along one or more axis of an electrode aπay. In one embodiment with a linear array of rectangular electrodes, the electrode gap can be controllably varied in the longitudinal direction in order to tailor the resulting pattern of thermal/tissue affect in the targeted tissue. Portions of the linear array can have a very small electrode gap producing a near continuous affect, while other portions can have a wider gap producing discrete zones of thermal affect with adjacent substantially untreated zones. In various embodiments an intermediate electrode gap could be chosen to achieve both a bi-polar and mono-polar effect in terms of depth and pattern of the thermal effect. To avert any potential edge effects with bi-polar electrodes, dielectric coating and capacitive coupling could be used on bi-polar pairs as well as mono-polar pairs.
Another drawback of the use of lasers in dermatologic procedures such as skin resurfacing is the fact that the procedure has to be done in patchwork fashion. Specifically a small area of the face is treated, approximately one square centimeter area, either with a laser that has a beam that's that size, or a beam that has a smaller beam diameter and some kind of a scanning mirror system that would result in the beam moving over a one square centimeter area. The nature of this procedure is a discrete or patchwork delivery of energy/treatment to one small area at a. So one square centimeter is treated and the laser is moved to next area. Consequently, it is a very time consuming and arduous process. Also it can result in the necessity of coming back for treatment sessions in separate visits to the physician with the patient having to undergo the undesirable side affect (e.g.. redness, blistering, etc.) each time.
Using various embodiments of the invention discussed herein, a similar discrete treatment method could employed. However the use of cooling would prevent/reduce the occurrence of blistering and burning. Specifically the apparatus may be used to treat one square centimeter skin, using the spray cryogen to achieve a pre, inter or post cooling affect as needed. After treating the fist area of skin the electrode/device would be lifted off the surface the skin and moved to the next area (e.g. square centimeter) of skin to be treated with this procedure being repeated until the entire desired target skin/tissue site was treated. In alternative embodiments the procedure could be done in a quasi- continuous or even a continuous fashion. One embodiment of treatment method would involve a quasi-continuous pulsed method where a short spray of precooling is done, then a short application of RF energy, followed by a short spray of post-cooling and then a period of waiting where the physician observes the physical appearance of the skin as well as monitoring the skin and/or tissue temperature using sensor described herein. The procedure is then repeated as needed until the entire desired target site is treated.
In a related embodiment, the procedure could be done in an even more continuous fashion with a painting or sliding motion of the energy delivery device/electrode across the surface of the skin. In these embodiments both cooling and heating application sequences would be done in a more continuous fashion and the pulsing method (e.g of cooling and heating) is one approach that lends itself to that. In these embodiments, cycles of cooling, heating and cooling could be done between five and ten times a second, or even faster. The depth of the tissue effect could be increased with a longer RF heating phase (which could be pulse or continuous) and if necessary a longer period of precooling. The use of bi-polar electrode configurations would be particularly well suited for continuous treatment embodiments using continuous cooling and heating, since the depth of current flow, and hence energy delivery, for bi-polar configurations is limited. The ability to treat tissue in more continuous fashions where the device/electrode is slid across the surface of the skin is a distinct advantage over the use of laser treatment used to treat discrete areas of skin in a patchwork approach.
The continuous skin treatment methods (e.g. by sliding the electrode) afforded by embodiments of the present invention would be particularly advantageous/desirable to surgeons and other physicians who typically use their hands during medical procedures would rather have a instrument where they can have some control over movement of the instrument. Moreover the apparatus of the present invention presents the further advantage of allowing physicians to utilize their surgical skills and manual dexterity to achieve a finer and precise level of control over the delivery of the treatment and hence the quality of the clinical outcome versus laser devices that can only be used to treat skin in a noncontinuous patchwork fashion. The use of more continuous treatment with embodiments of the present invention could also significantly shorten procedure times. Also if the physician wanted to deliver more treatment in anyone spot he/she leaves the electrode/device there a little bit longer. This allows the physician to titrate the treatment effect in different areas of the target tissue.
Another advantage of various embodiments of energy delivery devices (e.g., dielectric-coated cryogen cooled electrodes) adapted to slide over the skin and deliver RF energy in a near continuous fashion is greater access to different areas of tissue where a laser could not get easily get access or would otherwise be obstructed. Such areas include parts of the body with pronounced curvature, acute angles or otherwise rough and uneven surfaces. In various embodiments of the invention, collagen-containing tissue is treated by controllably delivering thermal and/or mechanical energy through the epidermis to the collagen containing tissue so as to change a physical feature or property of the epidermis through the thermal modification of the collagen containing tissue. In various embodiments, the physical feature can be one or more of the following, a reduction in size of a wrinkle in the epidermis, a reduction in an elastosis of the epidermis, an improvement of an epidermis contour irregularity, a tightening of the epidermis, remodeling of the underlying collagen containing tissue site, remodeling of the epidermis, changes in three- dimensional contouring, and combinations thereof.
The collagen containing tissue can be in a dermal layer, a deep dermal layer, a subcutaneous layer underlying a dermal layer, in fat tissue, and the like. Intracellular modification of the epidermis and skin appendages can also be achieved. A reverse thermal gradient, wherein the temperature of the epidermis is less than a temperature of the collagen containing tissue, can be used to create the composition of matter. With the reverse thermal gradient, the surface temperature of the skin can be at, above or below body temperature. When the composition of matter is created there is controlled cell necrosis of the epidermis, the collagen As used in the application "in vivo" refers to the thermal, mechanical and/or magnetic modification of tissue within a living composition of matter.
An aesthetic composition of modified living matter is a composite three dimensional phenotype that is comprised of a remodeled preexisting cutaneous container of preexisting soft tissue contents. The aesthetic composition of matter can include combined remodeling of the soft tissue contents and its container. Matrix interactions of collagen with energy involve native or preexisting collagen and or the de novo production of nascent collagen by the induction of the wound healing sequence. These interactions are produced by the molecular and cellular remodeling of the collagen matrix. Molecular remodeling of the extracellular matrix occurs from the contraction and distraction of preexisting collagen fibrils. Cellular remodeling of the matrix is a delayed phenomenon and involves the activation of a wound healing sequence with fibroblast contraction and nascent collagen production as a static supporting structure of the remodeled matrix.
Electromagnetic and mechanical modalities are used to remodel the matrix and to alter intracellular metabolism. These modalities may be applied separately or in a coupled device geometry. Coupled mechanical force reduces the energy requirement to create a specific morphological result and is typically applied externally.
For many aesthetic applications, contact with the skin by the energy source is required. An alternating electrical cuπent may be used to remodel the extracellular collagen matrix of the dermis and subcutaneous tissue. However, weaker magnetic fields can also be employed to delicately modify the intracellular metabolism of these structures including the epidermis and skin appendages. More rapid phenotypic changes can occur from electrical remodeling of the extracellular matrix than magnetic modification of intracellular processes of the epidermis and skin appendages. Rather than producing observable changes, magnetic modification may also be used for maintenance or homeostasis of the aesthetic phenotype.
The visual perception of animate matter is due to a composite electromagnetic field of component atoms in various soft tissue structures. The human perception of animated matter is also determined and restricted by the limited span of the visual spectrum in comparison to the entire electromagnetic spectrum.
Methods of detecting the electromagnetic field (EMF) of animate matter by using a larger electromagnetic (EM) spectrum (than the visual spectrum) can provide a delineation of EMF patterns not typically seen by the human eye.
Changes in this broader EM spectrum may be detected before they become visually apparent. The pattern of change in the EMF may be used as a diagnostic modality before phenotypic changes of aging occur in tissue. These previously non- visualized changes in the EMF of individuals may provide an early warning signal before these changes become morphologically apparent.
Furthermore, manipulation of the EMF pattern to a more youthful EMF profile may provide the means to limit or reverse the morphological expression of this aging process.
Ablative methods include non invasive and minimally invasive removal of subcutaneous fat in addition to resurfacing of the skin. Non-ablative methodologies remodel skin and soft tissue with a minimum of cellular and extracellular necrosis. Both ablative and non-ablative methodologies are used to create an aesthetic composition of matter (ACM).
Depending upon the type of aesthetic composition of matter to be formed, a treatment modality matrix is created to determine the most effective combination of electromagnetic energy, mechanical force, method of application (ablative or non ablative) and tissue interaction (molecular vs. cellular remodeling). However, central to this matrix is the use of an energy source, including but not limited to electromagnetic energy, to alter the extracellular collagen matrix and intracellular metabolism of the epidermis and skin appendages with a minimum of collateral damage to tissues that do not require modification. Complimentary application of mechanical force can be used to lower electromagnetic energy requirements and potential side effects of treatment. The pattern of thermal energy delivery is no longer a random Brownian process. Instead, energy delivery becomes a directed process that produces a specific morphological effect without collateral tissue damage.
Ablation is avoided entirely or it is created selectively to limit thermal side effects in creation of the composition of matter. As a result, an aesthetic composition of modified living matter is reliably created that is either an entire phenotype or a constituent component of a whole. Vectors of external mechanical compression can be used to smooth surface wrinkling by conforming dermal defects within a preheated collagen matrix of the collagen containing tissue site. A partial phase transition of a matrix can be created at a lower temperature. As a result, the clinical effectiveness is enhanced while side effects of treatment are concomitantly reduced.
A more in-depth description of skin anatomy is required to understand the interaction of energy with its component parts. The epidermis is the cutaneous barrier to the outside world and is provided by the keratin bilipid layer of the stratum corneum which is produced by the continuing upward maturation of keratinocytes within the epidermis. Thermal and biological components of the skin barrier are created from this maturation process. The solar or ultraviolet component of the barrier is provided by melanocytes that reside in basilar layer of the epidermis. Melanin granules are produced in these cells which are then distributed to upwardly migrating keratinocytes by dendritic extensions of the cell membrane. An additional population of melanocytes and keratinocytes is also present in the skin appendages. These structures are the hair follicles, sebaceous and sweat glands which are present in the deeper dermal and subdermal levels. The dermis is the main structural support of the skin and is immediately subjacent to the epidermis. This supporting layer is mainly comprised of collagen fibrils that are subdivided into papillary and reticular component. The more superficial papillary dermis is immediately subjacent to the epidermis and is less dense than the deeper reticular dermis.
Burns are the morphological result of thermal energy interactions with skin and are classified into first, second and third degrees on the basis of dermal depth. A first-degree burn is a thermal injury that extends superficially into the epidermis and does not involve blistering or ablation of the skin. A temporary erythema of the skin occurs that resolves within twenty-four hours. A healing or reepithelialization process is not required. A second degree burn is a deeper thermal injury that extends into the dermis for a variable depth and is characterized by blistering and crusting. Ablation of the epidermis occurs with destruction of the dermis at either a superficial or deeper level. Superficial second-degree burns extend into the papillary dermis and are readily heal by reepithelialization because the skin appendages are not destroyed. For deeper second degree burns, a greater portion of the dermis is ablated which may complicate healing and reepithelialization. With a deep second degree burn, many of the skin appendages are destroyed in addition to the loss of normal dermal architecture. Thinning and disruption of normal dermal anatomy can permanently alter the texture and elasticity of the skin. For many of these bum patients, a plastic or translucent appearance of their face is apparent. Obviously, a thinner margin of safety is present in deep second degree burns. For this reason, deeper second-degree bums are more frequently converted to bum scar deformities than more superficial bums. A third degree burn is characterized by the full thickness destruction or ablation of all skin layers including the skin appendages. Healing by reepithelialization does not occur normally but is achieved by the lengthy healing process of secondary intention. Unless surgically closed the bum wound can form granulation tissue that slowly contracts to close the open rent in the biological barrier. Excessive scaπing and deformity is likely. A thin scar epithelium is typically formed over the bum scar. This fragile biological baπier is easily disrupted with minor trauma. Repeated ulceration of the bum scar may even require subsequent revisional surgery.
Aging of the skin can also be classified in a manner similar to thermal bums. Wrinkling is mainly caused by depletion of collagen matrix in the papillary dermis. This intradermal or second-degree deficit is a more superficial contour deformity than glabellar or nasolabial creases which are full thickness dermal defects that extend through the entire papillary and reticular dermis.
Resurfacing of the skin can also be classified in a manner similar to thermal bums. After ablation of the epidermis, skin appendages play a central role in the reepithelialization process. Skin appendages are present in different densities depending upon the specific area of the body. The highest density is present in the fascial skin where current laser modalities of resurfacing are practiced. Skin appendage density in other areas such as the neck, trunk and extremities is inadequate to provide a consistent pattern of reepithelialization. The skin appendages, consisting of hair follicles and sebaceous glands, contain keratinocytes and melanocyte that are the cmcial components of reepithelialization. Diminution in either cell population has significant ramifications in the reestablishment of a functional epidermal barrier. With deeper second degree resurfacing, there is also an increased risk that treated areas can be more easily converted to a third-degree bum if the reepithelialization process is protracted or if this process is complicated with infection.
Following reepithelialization, a four to eight month period of bum wound maturation ensues that is characterized by hyperemia and transparency in which the skin appears shinny and pink. Thinning of the remodeled dermis produces a porcelain texture of the skin that is similar to the faces of many bum patients. Although wrinkling is diminished, this alteration of normal skin texture remains a permanent feature of a patient's face. The use of a conformance-energy delivery device offers benefits of enhanced clinical outcomes and a reduction of treatment side effects. Enhanced clinical outcomes include a greater effectiveness to correct superficial and deep wrinkling of facial skin. Duration and pain during the healing period are significantly reduced as the level of resurfacing is more superficial. A conformance-energy delivery device can be safely applied to areas outside the face because the depth of dermal ablation has been minimized without loss of clinical effectiveness. Skin tightening of treatment areas is also provided while simultaneously correcting surface irregularities.
With an appropriately shaped energy delivery surface, the ability exists to shape the skin envelope into a desired three dimensional contour. These benefits are possible while minimizing surface ablation. Use of the conformance-energy delivery device reduces side effects by lowering the amount of thermal energy needed to resurface a treatment area. With this device, superficial resurfacing is capable of achieving deeper thermal effects. Healing from a superficial second degree resurfacing reduces the depigmentation and texture changes that are more common with deep second degree resurfacing. A prolonged period of erythema is avoided. Instead of an operating room, patients can be treated in an office setting without the occupational risks of a laser. With the composition of modified living matter of the present invention, a matrix of different operational modes can be used to create different tissue effects. A "pressing" or stationary mode of application with convection cooling can conform the skin surface with minimal ablation. In this instance, wrinkles and creases are treated by selectively heating and conforming the dermis. Skin tightening without ablation is also performed in this particular mode of application. A different mode of application is used to treat sun damaged skin or residual wrinkling that is not coπected by non-ablative applications. The device is applied in a mobile fashion similar to "ironing" a shirt. Mobile compression without convection cooling creates the present composition of matter resulting in a resurfacing of the skin and application of shearing vectors of force that additionally smooth the matrix.
A matrix of different modes of application can be created depending upon the clinical circumstances. For example, a cold iron (convection cooling with shearing and compression) may be ideal in conditions that require maximal smoothing of surface contour without ablation. This mode of application provides the greatest benefit in the hip and thigh areas where contour iπegularities of cellulite are severe but solar damage is minimal. Patients with severe wrinkling of the face without solar damage may also benefit from this particular permutation.
The creation of the composition of modified living matter of the present invention can employ the creation of a reverse thermal gradient and involve other strategies to avoid the blistering of skin. Hydration facilitates the passage of an electrical cuπent through the epidermis by reducing surface impedance. Another significant effect is the increase in thermal conductance of the stratum corneum. Tissue components such as the keratin/lipid bilayer of the stratum corneum are poor thermal conductors and function as thermal insulators to preserve the overall heat content of the patient. Hydrated stratum comeum is a better thermal conductor which promotes heat transfer to underlying collagen containing tissues. The collagen containing dermis that has not been hydrated can behave as a thermal insulator as well as an electrical resistor. As a result, the thermal content of the target collagen containing tissue is increased selectively. Energy delivered to the soft tissue system, defined by the collagen containing tissue site, remodels the collagen matrix by disrupting the intermolecular crosslinks within the fibril. Although temperature is a measure of heat content, an accurate measure of energy delivery to the tissue is required. Measure of dose rate and overall dose to the tissue is required to determine the most effective control parameters. Dose rate is important due to the time dependence of thermal conduction, thermal convection and relaxation processes. Total dose is also important as there are a known number of molecules to be contracted with a required amount of energy per molecule. Another factor that affects the heat content of tissue is the thermal dissipation that occurs through thermal conduction away from the target tissue and the thermal convection from vascular and surface structures.
In contrast to the application of energy, manipulation of energy losses to the collagen containing tissue underlying the epidermis provides another means to avoid surface ablation. Thermal conduction losses occur through the passive dissipation of heat through tissue and is limited by local tissue parameters. In contrast, convective heat transfer occurs through the physical movement of heated matter away from the target tissue and is a process that can be actively manipulated. Sequential flash cycles of surface cooling and tissue heating provides a reverse thermal gradient as the heat dissipated from surface convection occurs faster than subdermal tissues. Cycles of surface cooling and tissue heating are performed with a thermal energy source. A progressive increase in the subdermal heat content occurs while maintaining a constant surface temperature. This occurs because the removal of heat by surface convection is more rapid than thermal conduction within the dermis. Other approaches to reduce the thermal load to the skin surface can be employed. Multiple port focusing with ultrasound in a tandem fashion can have a similar effect of dispersing energy. A combination of these modalities may be employed to avoid thermal damage to the epidermis. Additionally, in creating the composition of the present invention, the stability of the collagen triple helix can be chemically altered prior to thermal denaturization. The collagen shrinkage temperature (Ts) is an indication of molecular stability and is determined by the amount of cross linkage. Reagents such as hyaluronidase (Wydase) that enzymatically decrease fiber stability can reduce the shrinkage temperature (Ts). Typically, a reduction of 10 C in the Ts is obtained by the injection of this reagent. As a result, power requirements to target collagen containing tissues are reduced. The solution can be combined with a dilute local anesthetic and injected into target tissues with the "tumescent" technique.
Thermal shrinkage, or tightening of the underlying collagen containing tissue can be provided without the destruction of the overlying epidermis. This process of molecular contraction has an immediate biophysical effect upon the matrix and is based upon the cleavage cascade of intramolecular and intermolecular bonds within the collagen fibril. Skin tightening with thermal contraction and remodeling of collagen can correct areas such as the thighs, knees, arms, back and hips without unsightly scaπing of standard techniques. Areas previously coπected by surgical procedures, such as face and neck lifts, could also be coπected without requiring surgery or the typical incisions around the ear. Elastosis, or stretching of the abdominal skin from pregnancy, can be coπected without the long scar commonly associated with an abdominoplasty. Thermal remodeling of underlying collagen containing tissues is effective, non- invasive alternative for the aesthetic treatment of these areas.
Treatment of "cellulite" of the thighs and hips is another example. Typically, the subcutaneous fat layers have loculations from fibrous septae that contain collagen. These fibrous septae can be remodeled to tighten the soft tissue in areas such as the hips and thighs. Additionally, dermal and subdermal telangiectasias (spider veins) are diminished by the contraction of the matrix adjacent to these vessels.
Another component of electromagnetic remodeling is cellular remodeling of collagen containing tissues with a thermal-conformance device. The use of low level thermal treatments over several days provides an additional way to contract skin without blistering. The cellular contraction process is initiated and involves the inflammatory/wound healing sequence that is perpetuated over several days with sequential and lengthy low level thermal treatments. This cellular contraction process is a biological threshold event that is initiated by the degranulation of the mast cell that releases histamine which initiates the inflammatory wound healing sequence. Histamine alters endothelial permeability and allows the creation of inflammatory edema. In this tissue system, contraction of skin is achieved through fibroblastic multiplication and contraction with the deposition of a static supporting matrix of nascent scar collagen. The nascent matrix is simultaneously remodeled with a conformance template that is incorporated in the thermal energy delivery device. For many aesthetic and functional applications, molecular and cellular effects occur in tandem with each other.
With the application of a conformance template, surface iπegularities with depressions and elevations have vectors directed to the lowest point of the deformity. Prominent "pores" or acne scaπing of the skin have a similar pattern to cellulite but on a smaller scale that can also be coπected. The application of pressure reduces the power required to remodel the matrix and should diminish surface ablation. Compression can also exert electrical impedance and thermal conductivity effects that can allow delineation within different components of collagen containing tissues.
Aesthetic conformers with a thermal energy source can also be used to remodel the subcutaneous fat of hips and thighs in addition to the tightening of the skin envelope. Digital capture of a preexisting aged contour is used to digitally form an aesthetic three dimensional contour that subsequently provides the means to fabricate a conformance template. Additional aesthetic applications include congenital prominence of the ear in which the convolutions (antehelical fold) are altered by remodeling the collagen within the cartilage.
The nasal tip can be conformed to a more aesthetically pleasing contour without surgery.
A conforming aesthetic template can be used with any process that remodels underlying collagen containing tissue. In addition to the thermal remodeling of collagen, chemical modalities that invoke the wound healing sequence can be combined with a conforming esthetic template. Glycolic acid can induce a low level inflammatory reaction of the skin. Scar collagen and fibroblastic (cellular contraction) are directed by converging and diverging vectors created from a conformer that smooths and tightens the skin envelope into a more desirable contour. Additionally, a softer and more compliant skin texture in achieved. Refeπing to Figure 21 , in an embodiment, skin treatment apparatus 10 can be coupled to an open or closed loop feedback system/resources 60. As shown in Figure 21, feedback system 60 couples sensor 346 to power source 392. For purposes of illustration, energy delivery device 314 is one or more RF electrodes 314 and power source 392 is an RF generator, however all other energy delivery devices and power sources discussed herein are equally applicable.
The temperature of the tissue, or of RF electrode 314 is monitored, and the output power of energy source 392 adjusted accordingly. The physician can, if desired, oveπide the closed or open loop system. A controller 394 or microprocessor 394 can be included and incorporated in the closed or open loop system 60 to switch power on and off, as well as modulate the power. The closed loop system utilizes microprocessor 394 to serve as a controller to monitor the temperature, adjust the RF power, analyze the result, refeed the result, and then modulate the power. More specifically, controller 394 governs the power levels, cycles, and duration that the radio frequency energy is distributed to the individual electrodes 314 to achieve and maintain power levels appropriate to achieve the desired treatment objectives and clinical endpoints. Controller 394 can also in tandem, govern the delivery of cooling fluid. Controller 394 can be integral to or otherwise coupled to power source 392 and can also be coupled to a fluid delivery apparatus. In one embodiment controller 394 is an Intel® Pentium® microprocessor, however it will be appreciated that any suitable microprocessor or general purpose digital or analog computer can be used to perform one or more of the functions of controller 394 stated herein. With the use of sensor 346 and feedback control system 60 skin or other tissue adjacent to RF electrode 314 can be maintained at a desired temperature for a selected period of time without causing a shut down of the power circuit to electrode 314 due to the development of excessive electrical impedance at electrode 314 or adjacent tissue. Each RF electrode 314 is connected to resources which generate an independent output. The output maintains a selected energy at RF electrode 314 for a selected length of time. Cuπent delivered through RF electrode 314 is measured by cuπent sensor 396. Voltage is measured by voltage sensor 398. Impedance and power are then calculated at power and impedance calculation device 400. These values can then be displayed at user interface and display 402. Signals representative of power and impedance values are received by a controller 404. A control signal is generated by controller 404 that is proportional to the difference between an actual measured value, and a desired value. The control signal is used by power circuits 406 to adjust the power output in an appropriate amount in order to maintain the desired power delivered at respective RF electrodes 314. In a similar manner, temperatures detected at sensor 346 provide feedback for maintaining a selected power. Temperature at sensor 346 is used as a safety means to interrupt the delivery of energy when maximum pre-set temperatures are exceeded. The actual temperatures are measured at temperature measurement device 408, and the temperatures are displayed at user interface and display 402. A control signal is generated by controller 404 that is proportional to the difference between an actual measured temperature and a desired temperature. The control signal is used by power circuits 406 to adjust the power output in an appropriate amount in order to maintain the desired temperature delivered at the sensor 346. A multiplexer can be included to measure cuπent, voltage and temperature at sensor 346. Energy can be delivered to RF electrode 314 in monopolar or bipolar fashion.
Controller 404 can be an analog or digital controller, or a computer with driven by control software. When controller 404 is a computer it can include a CPU coupled through a system bus. On the system can be a keyboard, disk drive, or other non- volatile memory systems, a display, and other peripherals, as are well known in the art. Also coupled to the bus are a program memory and a data memory. Also, controller 404 can be coupled to imaging systems including, but not limited to, ultrasound, thermal and impedance monitors. The output of cuπent sensor 396 and voltage sensor 398 are used by controller 404 to maintain a selected power level at RF electrode 314. The amount of RF energy delivered controls the amount of power. A profile of the power delivered to electrode 314 can be incorporated in controller 404 and a preset amount of energy to be delivered may also be profiled.
Circuitry, software and feedback to controller 404 result in process control, the maintenance of the selected power setting which is independent of changes in voltage or cuπent, and is used to change the following process variables: (i) the selected power setting, (ii) the duty cycle (e.g., on-off time), (iii) bipolar or monopolar energy delivery; and, (iv) fluid delivery, including flow rate and pressure. These process variables are controlled and varied, while maintaining the desired delivery of power independent of changes in voltage or cuπent, based on temperatures monitored at sensor 346.
Refeπing now to Figure 22, cuπent sensor 396 and voltage sensor 398 are connected to the input of an analog amplifier 410. Analog amplifier 410 can be a conventional differential amplifier circuit for use with sensor 346. The output of analog amplifier 410 is sequentially connected by an analog multiplexer 412 to the input of AID converter 414. The output of analog amplifier 410 is a voltage which represents the respective sensed temperatures. Digitized amplifier output voltages are supplied by A/D converter 414 to microprocessor 394. Microprocessor 394 sequentially receives and stores digital representations of impedance and temperature. Each digital value received by microprocessor 394 coπesponds to different temperatures and impedances. Calculated power and impedance values can be indicated on user interface and display 402. Alternatively, or in addition to the numerical indication of power or impedance, calculated impedance and power values can be compared by microprocessor 394 to power and impedance limits. When the values exceed predetermined power or impedance values, a warning can be given on user interface and display 402, and additionally, the delivery of RF energy can be reduced, modified or intermpted. A control signal from microprocessor 394 can modify the power level supplied by energy source 392.
Figure 23 illustrates a block diagram of a temperature and impedance feedback system that can be used to control the delivery of energy to tissue site
416 by energy source 392 and the delivery of cooling solution 48 to electrode 314 and or tissue site 416 by flow regulator 418. Energy is delivered to RF electrode 314 by energy source 392, and applied to tissue site 416. A monitor 420 ascertains tissue impedance, based on the energy delivered to tissue, and compares the measured impedance value to a set value. If the measured impedance exceeds the set value, a disabling signal 422 is transmitted to energy source 392, ceasing further delivery of energy to RF electrode 314. If the measured impedance is within acceptable limits, energy continues to be applied to the tissue. The control of the flow of cooling solution 48 to electrode 314 and or tissue site 416 is done in the following manner. During the application of energy, temperature measurement device 408 measures the temperature of tissue site 416 and/or RF electrode 314. A comparator 424 receives a signal representative of the measured temperature and compares this value to a pre-set signal representative of the desired temperature. If the tissue temperature is too high, comparator 424 sends a signal to a flow regulator 418 (which can be intergral to a pump 418) representing a need for an increased cooling solution flow rate. If the measured temperature has not exceeded the desired temperature, comparator 424 sends a signal to flow regulator 418 to maintain the cooling solution flow rate at its existing level.
The foregoing description of a prefeπed embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Obviously, many modifications and variations will be apparent to practitioners skilled in this art. It is intended that the scope of the invention be defined by the following claims and their equivalents. What is claimed is:

Claims

1. An apparatus for treating the skin comprising: a template having a tissue interface surface; and an energy delivery device coupled to the template, the energy delivery device having a variable resistance portion, the energy delivery device configured to be coupled to a power source; and a sensor coupled to one of the template, the energy delivery device, the tissue interface surface or a power source coupled to the energy delivery device.
2. The apparatus of claim 1, wherein the variable resistance portion is configured to reduce at least one of an edge effect, an electrode edge effect, an electrode temperature gradient, an electrode cuπent density gradient or a tissue interface surface temperature gradient.
3. The apparatus of claim 1 wherein the sensor is a thermal sensor, a thermocouple, an optical sensor, a cuπent sensor, voltage sensor, an impedance sensor or a flow sensor.
4. The apparatus of claim 1, further comprising: a source of fluid fludically coupled to at least one of the template, the template tissue interface surface, the energy delivery device, a flow control device, a control valve or a nozzle.
5. The apparatus of claim 4, wherein the fluid is one of a cooling fluid, a gas, a cryogenic gas, a liquid, an electrolytic solution, a cooled liquid or a cryogenic liquid.
6. The apparatus of claim 1, further comprising: a handpiece coupled to the template.
7. The apparatus of claim 6, wherein the handpiece includes at least one of a connector, an electrical connector, a fluid connector, a lumen, a fluid lumen, a cooling fluid lumen, a flow control device, a control valve or a nozzle.
8. The apparatus of claim 7, further comprising: a source of fluid fludically coupled to at least one of the handpiece, the connector or the lumen.
9. The apparatus of claim 1, wherein the variable resistance portion is positioned on a surface of the energy deliver device.
10. The apparatus of claim 9, wherein the energy delivery device surface is a tissue contacting surface.
11. The apparatus of claim 9, wherein the energy delivery device is substantially positioned at the tissue interface surface.
12. The apparatus of claim 1, wherein the tissue interface surface has a shape configured to receive an anatomical structure.
13. The apparatus of claim 12, wherein the tissue interface surface has a curved shape.
14. The apparatus of claim 1, wherein the tissue interface surface is conformable.
so -
15. The apparatus of claim 14, wherein the tissue interface surface is conformable to one of a skin surface, an anatomical stmcture, or a skin surface overlying an anatomical stmcture.
16. The apparatus of claim 1 , wherein the variable resistance portion has resistance that varies with a temperature.
17. The apparatus of claim 16, wherein the temperature is one of a tissue interface surface temperature, an energy delivery device temperature, a tissue temperature or a tissue interface temperature.
18. The apparatus of claim 1 , further comprising: a power source coupled to at least one of the energy delivery device or the sensor.
19. The apparatus of claim 18, further comprising:
feedback control resources coupled to at least one of the power source, the energy delivery device, the sensor, a flow control device, a control valve or a nozzle.
20. The apparatus of claim 19, wherein the feedback control resources include at least one of a microprocessor, a controller, a software program set forth in a tangible media, a power control circuit or a voltage and cuπent monitor,
21. The apparatus of claim 1 , wherein the energy delivery device is an RF electrode.
22. The apparatus of claim 21 , wherein the RF electrode is a monopolar electrode.
23. The apparatus of claim 22, further comprising: an RF power supply electronically coupled to the RF electrode; and a ground pad electrode positioned on the skin and electronically coupled to the RF power source and the RF electrode.
24. The apparatus of claim 21, wherein the RF electrode is a bipolar electrode and comprises one of a plurality of electrodes, a plurality of multiplexed electrodes, an array of electrodes or an array of multiplexed electrodes.
25. The apparatus of claim 24, further comprising: a switching device coupled to at least a portion of the plurality of RF electrodes, the switching device configured to be coupled to at least one of a power supply or feedback control resources.
26. The apparatus of claim 25, wherein the switching device includes one of a multiplexing device or a multiplexing device coupled to an RF power source.
27. An apparatus for treating the skin comprising: a template having a tissue interface surface; and an energy delivery device coupled to the template, the energy delivery device having a dielectric portion, the energy delivery device configured to be coupled to a power source; and a sensor coupled to one of the template, the energy delivery device, the tissue interface surface or a power source coupled to the energy delivery device.
28. The apparatus of claim 27, wherein the electrode is configured to be capacitively coupled to the skin.
29. The apparatus of claim 27, wherein the energy delivery device is an RF electrode.
30. The apparatus of claim 29, wherein the RF electrode is a monopolar electrode.
31. The apparatus of claim 30 further comprising: an RF power supply electronically coupled to the RF electrode; and ground pad electrode positioned on the skin and electronically coupled to the RF power source and the RF electrode.
32. The apparatus of claim 29, wherein the RF electrode is a bipolar electrode and comprises one of a plurality of electrodes, a plurality of multiplexed electrodes, an array of electrodes or an aπay of multiplexed electrodes.
33. The apparatus of claim 32, further comprising: a switching device coupled to at least a portion of the plurality of RF electrodes, the switching device configured to be coupled to at least one of a power supply or feedback control resources.
34. The apparatus of claim 33, wherein the switching device includes one of a multiplexing device or a multiplexing device coupled to an RF power source.
35. The apparatus of claim 27, wherein the dielectric portion comprises a plurality of dielectric portions including a first portion and second portion.
36. The apparatus of claim 35, wherein the first and second portions are substantially positioned on an energy delivery device surface.
37. The apparatus of claim 36, wherein the first portion is positioned within an interior area defined by the second portion.
38. The apparatus of claim 37, further comprising: a gap disposed between the first portion and the second portion.
39. The apparatus of claim 37, wherein the first and second portions have one of a substantially circular shape or an oval shape.
40. The apparatus of claim 39, wherein the first and second portions are substantially concentric.
41. The apparatus of claim 35 , further comprising : a switching device coupled to at least one of the plurality of dielectric portions.
42. The apparatus of claim 41 , wherein the switching device includes one of a multiplexing device or a multiplexing device coupled to an RF power source.
43. An apparatus for treating the skin comprising: a housing configured to hold an energy delivery device; and an energy delivery device coupled to the housing, the energy delivery device having a conductive portion and a dielectric portion, the energy delivery device configured to be coupled to a power source; and
a sensor coupled to one of the template, the energy delivery device, the tissue interface surface or a power source coupled to the energy delivery device.
44. The apparatus of claim 43 , wherein housing is configured to contain a gas.
45. The apparatus of claim 44, further comprising: a pressure relief valve coupled to the housing.
46. The apparatus of claim 43, wherein at least one of the energy delivery device, the dielectric portion or the conductive portion is configured to reduce at least one of an edge effect, an electrode edge effect, an electrode temperature gradient, an electrode cuπent density gradient or a tissue interface surface temperature gradient.
47. The apparatus of claim 43, wherein the conductive portion is a conductive layer and the dielectric portion is a dielectric layer.
48. The apparatus of claim 47, wherein the conducting layer has a surface area that is less than a dielectric layer surface area.
49. The apparatus of claim 47, wherein the energy delivery device is configured such that substantially all of an energy delivery device cuπent flows through the conducting layer.
50. The apparatus of claim 47, wherein the dielectric layer is a tissue contacting layer and the conductive layer is disposed on a non-tissue contacting side of the dielectric layer.
51. The apparatus of claim 47, wherein the dielectric layer is one of an oxide layer, a metal oxide layer, a polymer, a polyimide or a diamond.
52. The apparatus of claim 47, wherein the dielectric layer has a thickness of about 0.001 inches.
53. The apparatus of claim 47, wherein the conductive layer is one of a metal, a metal alloy, copper or a conductive polymer.
54. The apparatus of claim 43, wherein the one of the energy delivery device, the conductive portion or the dielectric portion is configured to be cooled by a cooling solution.
55. The apparatus of claim 54, wherein the cooling solution cools by at least of a conductive effect, an evaporative effect, a convective effect or an ebullient cooling effect.
56. The apparatus of claim 43, further comprising: a source of fluid fludically coupled to at least one of the housing, the
energy delivery device, the conductive portion, the dielectric portions, a flow control device, a control valve or a nozzle.
57. The apparatus of claim 56, wherein the fluid is one of a cooling fluid, a gas, a cryogenic gas, a liquid, an electrolytic solution, a cooled liquid or a cryogenic liquid.
58. The apparatus of claim 43, wherein at least a portion of the energy delivery device is flexible or elastic.
59. The apparatus of claim 58, wherein the energy delivery device is one of a membrane, a flexible membrane, a skin conforming membrane, a film, a flexible film or a skin conforming film.
60. The apparatus of claim 58, wherein the at least a portion of the energy delivery device is deformable in response to a pressure.
61. The apparatus of claim 60, wherein the pressure is a pressure in an interior of the housing and the housing is configured to contain a gas.
62. The apparatus of claim 61 , further comprising : a valve coupled to the housing, wherein the valve is one of a control valve, a pressure valve or a pressure relief valve.
63. The apparatus of claim 62, further comprising: feedback control resources coupled to at least one of the valve or the sensor.
64. The apparatus of claim 43, wherein the energy delivery device is an RF electrode.
65. The apparatus of claim 64, wherein the RF electrode is a monopolar electrode.
66. The apparatus of claim 65 further comprising: an RF power supply electronically coupled to the RF electrode; and a ground pad electrode positioned on the skin and electronically coupled to the RF power source and the RF electrode.
67. The apparatus of claim 64, wherein the RF electrode is a bipolar electrode and comprises one of a plurality of electrodes, a plurality of multiplexed electrodes, an aπay of electrodes or an aπay of multiplexed electrodes.
68. The apparatus of claim 67, further comprising: a switching device coupled to at least a portion of the plurality of RF electrodes, the switching device configured to be coupled to at least one of a power supply or feedback control resources.
69. The apparatus of claim 68, wherein the switching device includes one of a multiplexing device or a multiplexing device coupled to an RF power source.
PCT/US2000/006496 1999-03-09 2000-03-09 Apparatus and method for treatment of tissue WO2000053113A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE60021063T DE60021063T2 (en) 1999-03-09 2000-03-09 TREATMENT FOR TREATMENT OF TISSUE
AU37415/00A AU779100B2 (en) 1999-03-09 2000-03-09 Apparatus and method for treatment of tissue
AT00916288T ATE298536T1 (en) 1999-03-09 2000-03-09 DEVICE FOR TREATING TISSUE
CA2364098A CA2364098C (en) 1999-03-09 2000-03-09 Apparatus and method for treatment of tissue
EP00916288A EP1158919B1 (en) 1999-03-09 2000-03-09 Apparatus for treatment of tissue
JP2000603604A JP4102031B2 (en) 1999-03-09 2000-03-09 Apparatus and method for treating tissue

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12344099P 1999-03-09 1999-03-09
US60/123,440 1999-03-09

Publications (2)

Publication Number Publication Date
WO2000053113A1 true WO2000053113A1 (en) 2000-09-14
WO2000053113A9 WO2000053113A9 (en) 2002-07-18

Family

ID=22408703

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/006496 WO2000053113A1 (en) 1999-03-09 2000-03-09 Apparatus and method for treatment of tissue

Country Status (9)

Country Link
US (1) US6413255B1 (en)
EP (1) EP1158919B1 (en)
JP (1) JP4102031B2 (en)
AT (1) ATE298536T1 (en)
AU (1) AU779100B2 (en)
CA (1) CA2364098C (en)
DE (1) DE60021063T2 (en)
ES (1) ES2240078T3 (en)
WO (1) WO2000053113A1 (en)

Cited By (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003061497A1 (en) * 2002-01-22 2003-07-31 Syneron Medical Ltd. Rf device and method of selective thermolysis
WO2003065916A1 (en) * 2002-02-06 2003-08-14 Thermage, Inc. Handpiece for rf treatment of tissue
WO2003043696A3 (en) * 2001-11-20 2003-10-30 Syneron Medical Ltd Device and method for skin treatment using electrical current
WO2004047659A2 (en) * 2002-11-27 2004-06-10 Christopher Paul Hancock Tissue ablation apparatus and method of ablating tissue
WO2004052446A1 (en) * 2002-12-12 2004-06-24 Skop Gmbh Ltd. Electro stimulation treatment apparatus and method
WO2005065560A1 (en) 2003-12-30 2005-07-21 Smith & Nephew, Inc. Electrosurgical device
EP1707151A2 (en) 2005-03-31 2006-10-04 Sherwood Services AG Temperature regulating patient return electrode and return electrode monitoring system
WO2006120647A2 (en) * 2005-05-12 2006-11-16 Compex Medical S.A. Electrode for a neuromuscular stimulator
EP1759651A1 (en) * 2005-09-01 2007-03-07 Sherwood Services AG Return electrode pad with conductive element grid and method
EP1827279A2 (en) * 2004-12-15 2007-09-05 Cryovascular Systems, Inc. Efficient controlled cryogenic fluid delivery into a balloon catheter and other treatment devices
WO2007131248A1 (en) * 2006-05-16 2007-11-22 Medizinische Universität Wien Surface electrode
EP1885252A2 (en) * 2005-05-18 2008-02-13 Tyrell, Inc. Treatment device and method for treating skin lesions through application of heat
EP1905372A1 (en) * 2006-09-28 2008-04-02 Covidien AG Temperature sensing return electrode pad
EP1905374A1 (en) * 2006-09-28 2008-04-02 Covidien AG Smart return electrode pad
US7537605B2 (en) 1993-10-04 2009-05-26 Huan-Chen Li Medical device for treating skin itch and rash
AU2003294151B2 (en) * 2002-12-12 2009-07-23 Skop Gmbh Ltd Electro stimulation treatment apparatus and method
EP2134293A1 (en) * 2007-04-06 2009-12-23 Stephen Flock Inductive heating of tissues using alternating magnetic fields and uses thereof
WO2010007614A3 (en) * 2008-06-29 2010-05-06 Venus Technologies Ltd An esthetic apparatus useful for increasing skin rejuvenation and methods thereof
ITBO20080781A1 (en) * 2008-12-29 2010-06-30 Spark S R L METHOD FOR THE APPLICATION OF VARIABLE ELECTROMAGNETIC FIELDS ON BIOLOGICAL FABRICS AND DEVICE THAT ACTIVATE THIS METHOD
US7957815B2 (en) 2005-10-11 2011-06-07 Thermage, Inc. Electrode assembly and handpiece with adjustable system impedance, and methods of operating an energy-based medical system to treat tissue
ITVI20100030A1 (en) * 2010-02-12 2011-08-13 Patrizio Grando DEVICE AND METHOD FOR HEATING A LIVING BODY AND / OR TO KEEP A LIVING BODY WARM
US8121704B2 (en) 2008-06-19 2012-02-21 Thermage, Inc. Leakage-resistant tissue treatment apparatus and methods of using same
US8180458B2 (en) 2007-12-17 2012-05-15 Thermage, Inc. Method and apparatus for digital signal processing for radio frequency surgery measurements
US8187263B2 (en) 2008-02-04 2012-05-29 Tyco Healthcare Group Lp System and method for return electrode monitoring
US8216218B2 (en) 2007-07-10 2012-07-10 Thermage, Inc. Treatment apparatus and methods for delivering high frequency energy across large tissue areas
US8221410B2 (en) 1996-01-05 2012-07-17 Thermage, Inc. Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient
US8285392B2 (en) 2008-06-19 2012-10-09 Thermage, Inc. Leakage-resistant tissue treatment apparatus and methods of using such tissue treatment apparatus
US8287579B2 (en) 2007-09-17 2012-10-16 Thermage, Inc. Method of using cryogenic compositions for cooling heated skin
US8317779B2 (en) 2005-04-22 2012-11-27 Cynosure, Inc. Methods and systems for laser treatment using non-uniform output beam
US8515553B2 (en) 2008-04-28 2013-08-20 Thermage, Inc. Methods and apparatus for predictively controlling the temperature of a coolant delivered to a treatment device
US8523853B2 (en) 2008-02-05 2013-09-03 Covidien Lp Hybrid contact quality monitoring return electrode
EP2646103A1 (en) * 2010-12-03 2013-10-09 Syneron Medical Ltd. A method and apparatus for improving electrode-skin contact
US8672938B2 (en) 2009-07-23 2014-03-18 Covidien Lp Active cooling system and apparatus for controlling temperature of a fluid used during treatment of biological tissue
US8685017B2 (en) 1996-01-05 2014-04-01 Thermage, Inc. Method and kit for treatment of tissue
US8700176B2 (en) 2006-07-27 2014-04-15 Pollogen Ltd. Apparatus and method for non-invasive treatment of skin tissue
US8702691B2 (en) 2005-10-19 2014-04-22 Thermage, Inc. Treatment apparatus and methods for delivering energy at multiple selectable depths in tissue
US9028536B2 (en) 2006-08-02 2015-05-12 Cynosure, Inc. Picosecond laser apparatus and methods for its operation and use
US9039617B2 (en) 2009-11-24 2015-05-26 Guided Therapy Systems, Llc Methods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
US9039619B2 (en) 2004-10-06 2015-05-26 Guided Therapy Systems, L.L.C. Methods for treating skin laxity
US9364287B2 (en) 2007-06-05 2016-06-14 Reliant Technologies, Inc. Method for reducing pain of dermatological treatments
US9370399B2 (en) 2009-09-29 2016-06-21 Covidien Lp Flow rate monitor for fluid cooled microwave ablation probe
US9446258B1 (en) 2015-03-04 2016-09-20 Btl Holdings Limited Device and method for contactless skin treatment
US9468774B2 (en) 2011-11-16 2016-10-18 Btl Holdings Limited Methods and systems for skin treatment
US9539051B2 (en) 2007-08-01 2017-01-10 Covidien Lp System and method for return electrode monitoring
US9681916B2 (en) 2012-01-06 2017-06-20 Covidien Lp System and method for treating tissue using an expandable antenna
US9693823B2 (en) 2012-01-06 2017-07-04 Covidien Lp System and method for treating tissue using an expandable antenna
US9694212B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, Llc Method and system for ultrasound treatment of skin
US9700340B2 (en) 2004-10-06 2017-07-11 Guided Therapy Systems, Llc System and method for ultra-high frequency ultrasound treatment
US9707412B2 (en) 2004-10-06 2017-07-18 Guided Therapy Systems, Llc System and method for fat and cellulite reduction
US9713731B2 (en) 2004-10-06 2017-07-25 Guided Therapy Systems, Llc Energy based fat reduction
US9780518B2 (en) 2012-04-18 2017-10-03 Cynosure, Inc. Picosecond laser apparatus and methods for treating target tissues with same
US9802063B2 (en) 2012-09-21 2017-10-31 Guided Therapy Systems, Llc Reflective ultrasound technology for dermatological treatments
US9827449B2 (en) 2004-10-06 2017-11-28 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
US9867670B2 (en) 2009-04-01 2018-01-16 Covidien Lp Microwave ablation system and user-controlled ablation size and method of use
US9895560B2 (en) 2004-09-24 2018-02-20 Guided Therapy Systems, Llc Methods for rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US9907535B2 (en) 2000-12-28 2018-03-06 Ardent Sound, Inc. Visual imaging system for ultrasonic probe
US9949794B2 (en) 2008-03-27 2018-04-24 Covidien Lp Microwave ablation devices including expandable antennas and methods of use
US9974982B2 (en) 2004-10-06 2018-05-22 Guided Therapy Systems, Llc System and method for noninvasive skin tightening
US9981143B2 (en) 2008-06-29 2018-05-29 Venus Concept Ltd. Esthetic apparatus useful for increasing skin rejuvenation and methods thereof
US10039938B2 (en) 2004-09-16 2018-08-07 Guided Therapy Systems, Llc System and method for variable depth ultrasound treatment
US10046181B2 (en) 2004-10-06 2018-08-14 Guided Therapy Systems, Llc Energy based hyperhidrosis treatment
US10183182B2 (en) 2010-08-02 2019-01-22 Guided Therapy Systems, Llc Methods and systems for treating plantar fascia
US10245107B2 (en) 2013-03-15 2019-04-02 Cynosure, Inc. Picosecond optical radiation systems and methods of use
US10335230B2 (en) 2011-03-09 2019-07-02 Covidien Lp Systems for thermal-feedback-controlled rate of fluid flow to fluid-cooled antenna assembly and methods of directing energy to tissue using same
CN109965977A (en) * 2019-04-12 2019-07-05 深圳市是源医学科技有限公司 Improve the intelligent toxin-expelling Shaping System of human body basic metabolism
US10376693B2 (en) 2013-06-04 2019-08-13 Ya-Man Ltd. High-frequency cosmetic treatment apparatus
US10420960B2 (en) 2013-03-08 2019-09-24 Ulthera, Inc. Devices and methods for multi-focus ultrasound therapy
US10500413B2 (en) 2002-06-19 2019-12-10 Palomar Medical Technologies, Llc Method and apparatus for treatment of cutaneous and subcutaneous conditions
US10537304B2 (en) 2008-06-06 2020-01-21 Ulthera, Inc. Hand wand for ultrasonic cosmetic treatment and imaging
US10561862B2 (en) 2013-03-15 2020-02-18 Guided Therapy Systems, Llc Ultrasound treatment device and methods of use
US10588693B2 (en) 2011-05-31 2020-03-17 Covidien Lp Modified wet tip antenna design
US10603521B2 (en) 2014-04-18 2020-03-31 Ulthera, Inc. Band transducer ultrasound therapy
US10828100B2 (en) 2009-08-25 2020-11-10 Covidien Lp Microwave ablation with tissue temperature monitoring
US10864385B2 (en) 2004-09-24 2020-12-15 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US11207548B2 (en) 2004-10-07 2021-12-28 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US11224895B2 (en) 2016-01-18 2022-01-18 Ulthera, Inc. Compact ultrasound device having annular ultrasound array peripherally electrically connected to flexible printed circuit board and method of assembly thereof
US11235179B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc Energy based skin gland treatment
US11241218B2 (en) 2016-08-16 2022-02-08 Ulthera, Inc. Systems and methods for cosmetic ultrasound treatment of skin
US11338156B2 (en) 2004-10-06 2022-05-24 Guided Therapy Systems, Llc Noninvasive tissue tightening system
US11364076B2 (en) 2019-12-12 2022-06-21 Covidien Lp Monopolar return pad
US11418000B2 (en) 2018-02-26 2022-08-16 Cynosure, Llc Q-switched cavity dumped sub-nanosecond laser
US11547462B2 (en) 2014-12-03 2023-01-10 Koninklijke Philips N.V. Radio frequency skin treatment
US11717661B2 (en) 2007-05-07 2023-08-08 Guided Therapy Systems, Llc Methods and systems for ultrasound assisted delivery of a medicant to tissue
US11724133B2 (en) 2004-10-07 2023-08-15 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US11883688B2 (en) 2004-10-06 2024-01-30 Guided Therapy Systems, Llc Energy based fat reduction
US11944849B2 (en) 2018-02-20 2024-04-02 Ulthera, Inc. Systems and methods for combined cosmetic treatment of cellulite with ultrasound

Families Citing this family (583)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6302875B1 (en) 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US7115123B2 (en) * 1996-01-05 2006-10-03 Thermage, Inc. Handpiece with electrode and non-volatile memory
US7022121B2 (en) * 1999-03-09 2006-04-04 Thermage, Inc. Handpiece for treatment of tissue
US7452358B2 (en) * 1996-01-05 2008-11-18 Thermage, Inc. RF electrode assembly for handpiece
US7267675B2 (en) * 1996-01-05 2007-09-11 Thermage, Inc. RF device with thermo-electric cooler
US20040000316A1 (en) * 1996-01-05 2004-01-01 Knowlton Edward W. Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient
US6104959A (en) 1997-07-31 2000-08-15 Microwave Medical Corp. Method and apparatus for treating subcutaneous histological features
US6050943A (en) 1997-10-14 2000-04-18 Guided Therapy Systems, Inc. Imaging, therapy, and temperature monitoring ultrasonic system
US6974450B2 (en) * 1999-12-30 2005-12-13 Pearl Technology Holdings, Llc Face-lifting device
US7494488B2 (en) * 1998-05-28 2009-02-24 Pearl Technology Holdings, Llc Facial tissue strengthening and tightening device and methods
DE102004033595A1 (en) 2004-07-07 2006-02-16 Celon Ag Medical Instruments Bipolar coagulation electrode
FR2793681B1 (en) * 1999-05-18 2001-06-22 Oreal USE OF AT LEAST ONE INHIBITOR OF AT LEAST ONE CALCIUM CHANNEL IN THE TREATMENT OF WRINKLES
CN1617689A (en) * 1999-06-30 2005-05-18 塞梅格公司 Fluid delivery apparatus
US6692489B1 (en) * 1999-07-21 2004-02-17 Team Medical, Llc Electrosurgical mode conversion system
US6587730B2 (en) * 1999-07-27 2003-07-01 Mattioli Engineering Ltd. Method and apparatus for skin brown spot removal and collagen formation
US8447395B2 (en) * 2000-02-17 2013-05-21 Novocure Ltd Treating bacteria with electric fields
US8175698B2 (en) * 2000-02-17 2012-05-08 Novocure Ltd. Treating bacteria with electric fields
EP2335776A1 (en) 2000-02-17 2011-06-22 Yoram Palti Method and apparatus for destroying dividing cells
US7599746B2 (en) 2000-02-17 2009-10-06 Standen Ltd Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases
US7136699B2 (en) * 2002-10-02 2006-11-14 Standen, Ltd. Apparatus for destroying dividing cells
US7089054B2 (en) * 2002-10-02 2006-08-08 Standen Ltd. Apparatus and method for treating a tumor or the like
US6868289B2 (en) * 2002-10-02 2005-03-15 Standen Ltd. Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor
US7146210B2 (en) * 2000-02-17 2006-12-05 Standen Ltd. Apparatus and method for optimizing tumor treatment efficiency by electric fields
US7016725B2 (en) * 2001-11-06 2006-03-21 Standen Ltd. Method and apparatus for destroying dividing cells
US7890183B2 (en) * 2000-02-17 2011-02-15 Novocure Ltd. Treating parasites with electric fields
US20070027446A1 (en) * 2000-02-22 2007-02-01 Rhytec Limited Method of removing a tattoo
US20060116674A1 (en) * 2000-02-22 2006-06-01 Rhytec Limited Method of regenerating the recticular architecture of the dermis
US6558380B2 (en) * 2000-12-08 2003-05-06 Gfd Gesellschaft Fur Diamantprodukte Mbh Instrument for surgical purposes and method of cleaning same
ITPR20000067A1 (en) * 2000-12-19 2002-06-19 Irene Cantoni LIPOLYSIS EQUIPMENT FOR AESTHETIC TREATMENT.
US6761729B2 (en) * 2000-12-22 2004-07-13 Advanced Medicalapplications, Inc. Wound treatment method and device with combination of ultrasound and laser energy
US20080214967A1 (en) * 2004-02-17 2008-09-04 Ernest Aranyi Ultrasonic surgical instrument
ES2373782T3 (en) 2001-02-08 2012-02-08 Tyco Healthcare Group Lp ULTRASONIC SURGICAL INSTRUMENT.
US7422586B2 (en) * 2001-02-28 2008-09-09 Angiodynamics, Inc. Tissue surface treatment apparatus and method
WO2002099442A2 (en) 2001-06-01 2002-12-12 Sherwood Services Ag Return pad cable connector
US7044911B2 (en) * 2001-06-29 2006-05-16 Philometron, Inc. Gateway platform for biological monitoring and delivery of therapeutic compounds
US6582429B2 (en) * 2001-07-10 2003-06-24 Cardiac Pacemakers, Inc. Ablation catheter with covered electrodes allowing electrical conduction therethrough
US20030069569A1 (en) 2001-08-29 2003-04-10 Burdette Everette C. Ultrasound device for treatment of intervertebral disc tissue
US7517349B2 (en) * 2001-10-22 2009-04-14 Vnus Medical Technologies, Inc. Electrosurgical instrument and method
US7354440B2 (en) * 2001-10-22 2008-04-08 Surgrx, Inc. Electrosurgical instrument and method of use
US20060293656A1 (en) * 2001-10-22 2006-12-28 Shadduck John H Electrosurgical instrument and method of use
AU2002354042A1 (en) * 2001-11-06 2003-05-19 The Johns Hopkins University Device for thermal stimulation of small neural fibers
JP4472996B2 (en) 2002-03-15 2010-06-02 ザ・ジェネラル・ホスピタル・コーポレイション Method for controlling a medical device that selectively destroys adipose tissue
US8840608B2 (en) * 2002-03-15 2014-09-23 The General Hospital Corporation Methods and devices for selective disruption of fatty tissue by controlled cooling
US6882885B2 (en) * 2002-03-19 2005-04-19 Solarant Medical, Inc. Heating method for tissue contraction
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US20070129761A1 (en) 2002-04-08 2007-06-07 Ardian, Inc. Methods for treating heart arrhythmia
US8131371B2 (en) * 2002-04-08 2012-03-06 Ardian, Inc. Methods and apparatus for monopolar renal neuromodulation
US20080213331A1 (en) 2002-04-08 2008-09-04 Ardian, Inc. Methods and devices for renal nerve blocking
US20110207758A1 (en) 2003-04-08 2011-08-25 Medtronic Vascular, Inc. Methods for Therapeutic Renal Denervation
US20070135875A1 (en) 2002-04-08 2007-06-14 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US9308044B2 (en) 2002-04-08 2016-04-12 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US8774922B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods
US9636174B2 (en) 2002-04-08 2017-05-02 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US6978174B2 (en) 2002-04-08 2005-12-20 Ardian, Inc. Methods and devices for renal nerve blocking
US7853333B2 (en) 2002-04-08 2010-12-14 Ardian, Inc. Methods and apparatus for multi-vessel renal neuromodulation
US7162303B2 (en) 2002-04-08 2007-01-09 Ardian, Inc. Renal nerve stimulation method and apparatus for treatment of patients
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US8175711B2 (en) 2002-04-08 2012-05-08 Ardian, Inc. Methods for treating a condition or disease associated with cardio-renal function
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US20140018880A1 (en) 2002-04-08 2014-01-16 Medtronic Ardian Luxembourg S.A.R.L. Methods for monopolar renal neuromodulation
US8145317B2 (en) * 2002-04-08 2012-03-27 Ardian, Inc. Methods for renal neuromodulation
US7620451B2 (en) 2005-12-29 2009-11-17 Ardian, Inc. Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US9308043B2 (en) 2002-04-08 2016-04-12 Medtronic Ardian Luxembourg S.A.R.L. Methods for monopolar renal neuromodulation
US8145316B2 (en) 2002-04-08 2012-03-27 Ardian, Inc. Methods and apparatus for renal neuromodulation
US8774913B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for intravasculary-induced neuromodulation
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US20040082859A1 (en) 2002-07-01 2004-04-29 Alan Schaer Method and apparatus employing ultrasound energy to treat body sphincters
WO2004010883A1 (en) 2002-07-25 2004-02-05 Sherwood Services Ag Electrosurgical pencil with drag sensing capability
US6852110B2 (en) * 2002-08-01 2005-02-08 Solarant Medical, Inc. Needle deployment for temperature sensing from an electrode
US7125406B2 (en) * 2002-09-13 2006-10-24 Given Kenna S Electrocautery instrument
US6860881B2 (en) * 2002-09-25 2005-03-01 Sherwood Services Ag Multiple RF return pad contact detection system
US6905496B1 (en) * 2002-11-01 2005-06-14 Alan G. Ellman RF electrosurgery cryogenic system
US7244257B2 (en) * 2002-11-05 2007-07-17 Sherwood Services Ag Electrosurgical pencil having a single button variable control
US20060167448A1 (en) * 2002-11-15 2006-07-27 Kozel Peter D Electrophysiology catheter with ablation electrode
CA2511767A1 (en) * 2002-12-09 2004-06-24 The Trustees Of Dartmouth College Electrically-induced thermokeratoplasty systems and method
US8348936B2 (en) * 2002-12-09 2013-01-08 The Trustees Of Dartmouth College Thermal treatment systems with acoustic monitoring, and associated methods
US7377917B2 (en) * 2002-12-09 2008-05-27 The Trustees Of Dartmouth College Feedback control of thermokeratoplasty treatments
US7195627B2 (en) 2003-01-09 2007-03-27 Gyrus Medical Limited Electrosurgical generator
AU2003290301B2 (en) * 2003-01-09 2009-01-08 Gyrus Medical Limited An electrosurgical generator
US7049558B2 (en) * 2003-01-27 2006-05-23 Arcturas Bioscience, Inc. Apparatus and method for heating microfluidic volumes and moving fluids
ES2300746T3 (en) 2003-02-20 2008-06-16 Covidien Ag MOTION DETECTOR TO CONTROL THE ELECTROCHURGICAL OUTPUT.
WO2004075976A2 (en) * 2003-02-25 2004-09-10 Spectragenics, Inc. Method and apparatus for the treatment of benign pigmented lesions
EP2604215B1 (en) 2003-02-25 2017-10-11 Tria Beauty, Inc. Eye-safe dermatologic treatment apparatus and method
JP4361082B2 (en) 2003-02-25 2009-11-11 トリア ビューティ インコーポレイテッド Built-in diode laser dermatological treatment device
EP2589335A3 (en) 2003-04-10 2017-10-04 Adidas AG Systems and methods for respiratory event dedection
KR100466866B1 (en) * 2003-04-24 2005-01-24 전명기 Electrode for radiofrequency tissue ablation
JP4698935B2 (en) * 2003-05-07 2011-06-08 雪印乳業株式会社 Skin collagen production promoter
US7292893B2 (en) * 2003-05-16 2007-11-06 Waverx, Inc. Apparatus and method for the treatment of infectious disease in keratinized tissue
US7137979B2 (en) * 2003-05-31 2006-11-21 Tyrell, Inc. Methods and devices for the treatment of skin lesions
AU2004285412A1 (en) 2003-09-12 2005-05-12 Minnow Medical, Llc Selectable eccentric remodeling and/or ablation of atherosclerotic material
US7503917B2 (en) 2003-11-20 2009-03-17 Covidien Ag Electrosurgical pencil with improved controls
US7156842B2 (en) 2003-11-20 2007-01-02 Sherwood Services Ag Electrosurgical pencil with improved controls
US7879033B2 (en) 2003-11-20 2011-02-01 Covidien Ag Electrosurgical pencil with advanced ES controls
US20050148910A1 (en) * 2003-12-24 2005-07-07 Gregory Skover Apparatus having a skin-contactable element containing an agent
US7251531B2 (en) * 2004-01-30 2007-07-31 Ams Research Corporation Heating method for tissue contraction
US7476242B2 (en) * 2004-01-30 2009-01-13 Ams Research Corporation Electrically heated/phase change probe temperature control
US20060009749A1 (en) * 2004-02-19 2006-01-12 Weckwerth Mark V Efficient diffuse light source assembly and method
US8777935B2 (en) 2004-02-25 2014-07-15 Tria Beauty, Inc. Optical sensor and method for identifying the presence of skin
AU2005231443B2 (en) 2004-04-01 2012-02-23 The General Hospital Corporation Method and apparatus for dermatological treatment and tissue reshaping
EP1740268A2 (en) * 2004-04-23 2007-01-10 Standen Ltd. Treating a tumor or the like with electric fields at different frequencies
US7842007B2 (en) * 2004-04-30 2010-11-30 Clawson Burrell E Apparatus and methods for isolating human body areas for localized cooling
US20050251116A1 (en) * 2004-05-05 2005-11-10 Minnow Medical, Llc Imaging and eccentric atherosclerotic material laser remodeling and/or ablation catheter
AU2004319770A1 (en) * 2004-05-13 2005-11-24 Waverx, Inc. Apparatus and method for the treatment of infectious disease in keratinized tissue
US8805480B2 (en) * 2004-05-26 2014-08-12 Medical Device Innovations Limited Tissue detection and ablation apparatus and apparatus and method for actuating a tuner
US7896875B2 (en) * 2004-07-20 2011-03-01 Microline Surgical, Inc. Battery powered electrosurgical system
US20060036300A1 (en) * 2004-08-16 2006-02-16 Syneron Medical Ltd. Method for lypolisis
US20060047281A1 (en) 2004-09-01 2006-03-02 Syneron Medical Ltd. Method and system for invasive skin treatment
US20060058593A1 (en) * 2004-09-02 2006-03-16 Drinan Darrel D Monitoring platform for detection of hypovolemia, hemorrhage and blood loss
US20060052856A1 (en) 2004-09-08 2006-03-09 Kim Daniel H Stimulation components
US9205261B2 (en) 2004-09-08 2015-12-08 The Board Of Trustees Of The Leland Stanford Junior University Neurostimulation methods and systems
US20120277839A1 (en) 2004-09-08 2012-11-01 Kramer Jeffery M Selective stimulation to modulate the sympathetic nervous system
US20060095096A1 (en) * 2004-09-09 2006-05-04 Debenedictis Leonard C Interchangeable tips for medical laser treatments and methods for using same
US20080154251A1 (en) * 2004-09-09 2008-06-26 Reliant Technologies, Inc. Interchangeable Tips for Medical Laser Treatments and Methods for Using Same
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
US9713730B2 (en) 2004-09-10 2017-07-25 Boston Scientific Scimed, Inc. Apparatus and method for treatment of in-stent restenosis
US7393325B2 (en) 2004-09-16 2008-07-01 Guided Therapy Systems, L.L.C. Method and system for ultrasound treatment with a multi-directional transducer
US9011336B2 (en) 2004-09-16 2015-04-21 Guided Therapy Systems, Llc Method and system for combined energy therapy profile
WO2006041648A2 (en) * 2004-10-04 2006-04-20 Peerlead Medical, Inc. A capacitive medical electrode
EP2279697A3 (en) 2004-10-06 2014-02-19 Guided Therapy Systems, L.L.C. Method and system for non-invasive cosmetic enhancement of blood vessel disorders
US20090240249A1 (en) * 2004-11-08 2009-09-24 Cardima, Inc. System and Method for Performing Ablation and Other Medical Procedures Using An Electrode Array with Flexible Circuit
US20060100618A1 (en) * 2004-11-08 2006-05-11 Cardima, Inc. System and method for performing ablation and other medical procedures using an electrode array with flex circuit
ES2663782T3 (en) * 2004-12-07 2018-04-17 Novocure Limited   Electrodes to apply an electric field in vivo for a period of time
US7407503B2 (en) * 2004-12-21 2008-08-05 Ethicon Endo-Surgey, Inc. Medical-treatment electrode assembly having treatment-monitoring application
WO2006085150A2 (en) * 2004-12-27 2006-08-17 Standen Ltd. Treating a tumor or the like with electric fields at different orientations
ATE556745T1 (en) * 2005-01-18 2012-05-15 Alma Lasers Ltd IMPROVED SYSTEM FOR HEATING BIOLOGICAL TISSUE USING RF ENERGY
US8244369B2 (en) * 2005-01-28 2012-08-14 Syneron Medical Ltd. Device and method for treating skin with temperature control
US7643883B2 (en) * 2005-01-28 2010-01-05 Syneron Medical Ltd. Device and method for treating skin
US20060276859A1 (en) * 2005-06-02 2006-12-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Photopatterning of skin
US8679101B2 (en) * 2005-03-04 2014-03-25 The Invention Science Fund I, Llc Method and system for temporary hair removal
US8157807B2 (en) * 2005-06-02 2012-04-17 The Invention Science Fund I, Llc Skin treatment including patterned light
US20060200114A1 (en) * 2005-03-04 2006-09-07 Searete Llc, A Limited Liability Corporation Of State Of Delaware Hair removal system with light source array
US8529560B2 (en) 2005-03-04 2013-09-10 The Invention Science Fund I, Llc Hair treatment system
US8540701B2 (en) * 2005-03-04 2013-09-24 The Invention Science Fund I, Llc Hair treatment system
US20060281763A1 (en) * 2005-03-25 2006-12-14 Axon Jonathan R Carboxamide inhibitors of TGFbeta
ES2565342T3 (en) * 2005-03-28 2016-04-04 Vessix Vascular, Inc. Intraluminal electrical characterization of tissue and regulated RF energy for selective treatment of atheroma and other target tissues
US20060265034A1 (en) * 2005-04-05 2006-11-23 Ams Medical Sa Microwave devices for treating biological samples and tissue and methods for using same
EP1875327A2 (en) 2005-04-25 2008-01-09 Guided Therapy Systems, L.L.C. Method and system for enhancing computer peripheral saftey
US7217265B2 (en) * 2005-05-18 2007-05-15 Cooltouch Incorporated Treatment of cellulite with mid-infrared radiation
US20070032846A1 (en) * 2005-08-05 2007-02-08 Bran Ferren Holographic tattoo
CN100420420C (en) * 2005-06-13 2008-09-24 田明清 Method for obtaining and eliminating pain index and pain detection therapeutic apparatus
US7500974B2 (en) 2005-06-28 2009-03-10 Covidien Ag Electrode with rotatably deployable sheath
US9055958B2 (en) * 2005-06-29 2015-06-16 The Invention Science Fund I, Llc Hair modification using converging light
US8562603B2 (en) * 2005-06-30 2013-10-22 Microline Surgical, Inc. Method for conducting electrosurgery with increased crest factor
US7867226B2 (en) * 2005-06-30 2011-01-11 Microline Surgical, Inc. Electrosurgical needle electrode
US20070005056A1 (en) * 2005-06-30 2007-01-04 Surginetics, Llc Electrosurgical Instrument With Blade Profile For Reduced Tissue Damage
US20070005057A1 (en) * 2005-06-30 2007-01-04 Surginetics, Llc Electrosurgical Blade With Profile For Minimizing Tissue Damage
US7935112B2 (en) * 2005-06-30 2011-05-03 Microline Surgical, Inc. Electrosurgical instrument
US7935113B2 (en) * 2005-06-30 2011-05-03 Microline Surgical, Inc. Electrosurgical blade
US20070038270A1 (en) * 2005-07-05 2007-02-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Multi step photopatterning of skin
US20070021803A1 (en) 2005-07-22 2007-01-25 The Foundry Inc. Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction
US7828794B2 (en) 2005-08-25 2010-11-09 Covidien Ag Handheld electrosurgical apparatus for controlling operating room equipment
US20070048340A1 (en) * 2005-08-31 2007-03-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Multi step patterning of a skin surface
FR2890307A1 (en) * 2005-09-05 2007-03-09 Michel Trezon Manual depilation device for destroying hairs by electrical contact, notably for legs, bikini lines and armpits
US10548659B2 (en) 2006-01-17 2020-02-04 Ulthera, Inc. High pressure pre-burst for improved fluid delivery
US9011473B2 (en) 2005-09-07 2015-04-21 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US9358033B2 (en) 2005-09-07 2016-06-07 Ulthera, Inc. Fluid-jet dissection system and method for reducing the appearance of cellulite
AU2006287633A1 (en) * 2005-09-07 2007-03-15 The Foundry, Inc. Apparatus and method for disrupting subcutaneous structures
US8518069B2 (en) 2005-09-07 2013-08-27 Cabochon Aesthetics, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US7967763B2 (en) 2005-09-07 2011-06-28 Cabochon Aesthetics, Inc. Method for treating subcutaneous tissues
US9486274B2 (en) 2005-09-07 2016-11-08 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
CN101321555B (en) * 2005-10-03 2020-12-08 诺沃库勒有限责任公司 Optimizing electric field characteristics to increase the effect of an electric field on proliferating cells
US20070078502A1 (en) * 2005-10-05 2007-04-05 Thermage, Inc. Method and apparatus for estimating a local impedance factor
US7885793B2 (en) 2007-05-22 2011-02-08 International Business Machines Corporation Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution
US9248317B2 (en) 2005-12-02 2016-02-02 Ulthera, Inc. Devices and methods for selectively lysing cells
FR2894162B1 (en) * 2005-12-07 2008-02-22 Oreal PRODUCT DISPENSER, IN PARTICULAR A COSMETIC PRODUCT AND METHOD FOR APPLYING SUCH A PRODUCT
US20070135876A1 (en) * 2005-12-08 2007-06-14 Weber Paul J Acne and skin defect treatment via non-radiofrequency electrical current controlled power delivery device and methods
US7799018B2 (en) 2006-01-06 2010-09-21 Olga Goulko Cryogenic applicator for rejuvenating human skin and related method
US7736359B2 (en) 2006-01-12 2010-06-15 Covidien Ag RF return pad current detection system
US8206381B2 (en) 2006-01-17 2012-06-26 Endymed Medical Ltd. Electrosurgical methods and devices employing phase-controlled radiofrequency energy
US9844682B2 (en) * 2006-01-17 2017-12-19 Endymed Medical Ltd. Skin treatment devices and methods
US9827437B2 (en) * 2006-01-17 2017-11-28 Endymed Medical Ltd Skin treatment devices and methods
US20070167942A1 (en) * 2006-01-18 2007-07-19 Sherwood Services Ag RF return pad current distribution system
US7887534B2 (en) * 2006-01-18 2011-02-15 Stryker Corporation Electrosurgical system
EP1993971A2 (en) 2006-01-25 2008-11-26 Team Medical, L.L.C. Coating suitable for surgical instruments
WO2007092610A2 (en) * 2006-02-07 2007-08-16 Tivamed, Inc. Vaginal remodeling device and methods
US7854754B2 (en) 2006-02-22 2010-12-21 Zeltiq Aesthetics, Inc. Cooling device for removing heat from subcutaneous lipid-rich cells
US7769468B2 (en) * 2006-03-03 2010-08-03 Bsd Medical Corporation Transparent electromagnetic applicator and hyperthermia treatment method
US20080031833A1 (en) * 2006-03-13 2008-02-07 Oblong John E Combined energy and topical composition application for regulating the condition of mammalian skin
US8019414B2 (en) 2006-04-05 2011-09-13 Novocure Ltd. Treating cancer using electromagnetic fields in combination with other treatment regimens
US8019435B2 (en) 2006-05-02 2011-09-13 Boston Scientific Scimed, Inc. Control of arterial smooth muscle tone
US20070260240A1 (en) 2006-05-05 2007-11-08 Sherwood Services Ag Soft tissue RF transection and resection device
US7846158B2 (en) 2006-05-05 2010-12-07 Covidien Ag Apparatus and method for electrode thermosurgery
US7789882B2 (en) 2006-05-09 2010-09-07 Kirwan Surgical Products, Inc. Electrosurgical forceps with composite material tips
US20070282318A1 (en) * 2006-05-16 2007-12-06 Spooner Gregory J Subcutaneous thermolipolysis using radiofrequency energy
US8246611B2 (en) 2006-06-14 2012-08-21 Candela Corporation Treatment of skin by spatial modulation of thermal heating
US9630003B2 (en) * 2006-06-15 2017-04-25 Htk Enterprises, Inc. Non-invasive neuro stimulation system
US20070293917A1 (en) * 2006-06-15 2007-12-20 Thompson Thomas C Non-invasive neuro stimulation system
ATE494040T1 (en) 2006-06-28 2011-01-15 Ardian Inc SYSTEMS FOR HEAT-INDUCED RENAL NEUROMODULATION
US7909819B2 (en) * 2006-09-01 2011-03-22 Applied Medical Resources Corporation Monopolar electrosurgical return electrode
US20080065059A1 (en) * 2006-09-08 2008-03-13 Marc Lukowiak Microwave devices for transcutaneous treatments
US9566454B2 (en) 2006-09-18 2017-02-14 Guided Therapy Systems, Llc Method and sysem for non-ablative acne treatment and prevention
US7637907B2 (en) * 2006-09-19 2009-12-29 Covidien Ag System and method for return electrode monitoring
US9132031B2 (en) 2006-09-26 2015-09-15 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US8192474B2 (en) 2006-09-26 2012-06-05 Zeltiq Aesthetics, Inc. Tissue treatment methods
US8620422B2 (en) 2006-09-28 2013-12-31 Cvrx, Inc. Electrode array structures and methods of use for cardiovascular reflex control
US8708210B2 (en) * 2006-10-05 2014-04-29 Covidien Lp Method and force-limiting handle mechanism for a surgical instrument
US8273080B2 (en) 2006-10-16 2012-09-25 Syneron Medical Ltd. Methods and devices for treating tissue
US8133216B2 (en) * 2006-10-16 2012-03-13 Syneron Medical Ltd. Methods and devices for treating tissue
US8007493B2 (en) * 2006-10-16 2011-08-30 Syneron Medical Ltd. Methods and devices for treating tissue
US8142426B2 (en) 2006-10-16 2012-03-27 Syneron Medical Ltd. Methods and devices for treating tissue
CA2666661C (en) 2006-10-18 2015-01-20 Minnow Medical, Inc. Tuned rf energy and electrical tissue characterization for selective treatment of target tissues
EP2992850A1 (en) 2006-10-18 2016-03-09 Vessix Vascular, Inc. Inducing desirable temperature effects on body tissue
EP3257462B1 (en) 2006-10-18 2022-12-21 Vessix Vascular, Inc. System for inducing desirable temperature effects on body tissue
US8444683B2 (en) * 2006-11-27 2013-05-21 Vanderbilt University Apparatus and methods for optical stimulation of neural tissues
US9314618B2 (en) * 2006-12-06 2016-04-19 Spinal Modulation, Inc. Implantable flexible circuit leads and methods of use
WO2008070808A2 (en) 2006-12-06 2008-06-12 Spinal Modulation, Inc. Expandable stimulation leads and methods of use
WO2008070807A2 (en) 2006-12-06 2008-06-12 Spinal Modulation, Inc. Delivery devices, systems and methods for stimulating nerve tissue on multiple spinal levels
GB0624584D0 (en) * 2006-12-08 2007-01-17 Medical Device Innovations Ltd Skin treatment apparatus and method
US9375246B2 (en) * 2007-01-19 2016-06-28 Covidien Lp System and method of using thermal and electrical conductivity of tissue
WO2008091983A2 (en) * 2007-01-25 2008-07-31 Thermage, Inc. Treatment apparatus and methods for inducing microburn patterns in tissue
CN101678203A (en) 2007-01-29 2010-03-24 脊髓调制公司 Sutureless lead retention features
US20080200969A1 (en) * 2007-02-16 2008-08-21 Thermage, Inc. Temperature sensing apparatus and methods for treatment devices used to deliver high frequency energy to tissue
EP3231480A1 (en) 2007-03-06 2017-10-18 Novocure Ltd. Treating cancer using electromagnetic fields in combination with photodynamic therapy
WO2008116232A1 (en) * 2007-03-22 2008-09-25 Alan David Widgerow Apparatus for use in methods of cosmetic surgery and to such methods
US8021360B2 (en) 2007-04-03 2011-09-20 Tyco Healthcare Group Lp System and method for providing even heat distribution and cooling return pads
US10183183B2 (en) * 2007-04-13 2019-01-22 Acoustic Medsystems, Inc. Acoustic applicators for controlled thermal modification of tissue
WO2009075879A1 (en) 2007-12-12 2009-06-18 Miramar Labs, Inc. Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
EP2767308B1 (en) 2007-04-19 2016-04-13 Miramar Labs, Inc. Devices, and systems for non-invasive delivery of microwave therapy
US20100211059A1 (en) 2007-04-19 2010-08-19 Deem Mark E Systems and methods for creating an effect using microwave energy to specified tissue
BRPI0810066A2 (en) 2007-04-19 2015-05-05 The Foundry Inc Systems and methods for creating an effect using microwave energy for specific tissue
WO2008131302A2 (en) 2007-04-19 2008-10-30 The Foundry, Inc. Methods and apparatus for reducing sweat production
US8496653B2 (en) 2007-04-23 2013-07-30 Boston Scientific Scimed, Inc. Thrombus removal
US20080269735A1 (en) * 2007-04-26 2008-10-30 Agustina Vila Echague Optical array for treating biological tissue
US8080007B2 (en) 2007-05-07 2011-12-20 Tyco Healthcare Group Lp Capacitive electrosurgical return pad with contact quality monitoring
ES2699477T3 (en) 2007-05-07 2019-02-11 Guided Therapy Systems Llc Methods and systems for coupling and focusing acoustic energy using a coupling member
WO2008137942A1 (en) 2007-05-07 2008-11-13 Guided Therapy Systems, Llc. Methods and systems for modulating medicants using acoustic energy
US8388612B2 (en) 2007-05-11 2013-03-05 Covidien Lp Temperature monitoring return electrode
US8231614B2 (en) 2007-05-11 2012-07-31 Tyco Healthcare Group Lp Temperature monitoring return electrode
US20080287839A1 (en) 2007-05-18 2008-11-20 Juniper Medical, Inc. Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator
US8798756B2 (en) * 2007-11-07 2014-08-05 Second Sight Medical Products, Inc. Video processing unit for a visual prosthetic apparatus
US20120143178A9 (en) * 2007-06-15 2012-06-07 Primaeva Medical, Inc. Devices and methods for percutaneous energy delivery
US8845630B2 (en) * 2007-06-15 2014-09-30 Syneron Medical Ltd Devices and methods for percutaneous energy delivery
US20080312651A1 (en) * 2007-06-15 2008-12-18 Karl Pope Apparatus and methods for selective heating of tissue
US20090012515A1 (en) * 2007-07-06 2009-01-08 Hoenig Peter A Devices, systems and methods for treating tissues
US8523927B2 (en) 2007-07-13 2013-09-03 Zeltiq Aesthetics, Inc. System for treating lipid-rich regions
US8202272B2 (en) * 2007-07-19 2012-06-19 Avedro, Inc. Eye therapy system
US8992516B2 (en) * 2007-07-19 2015-03-31 Avedro, Inc. Eye therapy system
US8100898B2 (en) * 2007-08-01 2012-01-24 Tyco Healthcare Group Lp System and method for return electrode monitoring
JP5474791B2 (en) 2007-08-21 2014-04-16 ゼルティック エステティックス インコーポレイテッド Monitoring of cooling of subcutaneous lipid-rich cells such as cooling of adipose tissue
US8506565B2 (en) 2007-08-23 2013-08-13 Covidien Lp Electrosurgical device with LED adapter
US8439940B2 (en) 2010-12-22 2013-05-14 Cabochon Aesthetics, Inc. Dissection handpiece with aspiration means for reducing the appearance of cellulite
US20090112205A1 (en) * 2007-10-31 2009-04-30 Primaeva Medical, Inc. Cartridge electrode device
US8235987B2 (en) 2007-12-05 2012-08-07 Tyco Healthcare Group Lp Thermal penetration and arc length controllable electrosurgical pencil
EP2227197A4 (en) * 2007-12-05 2011-06-22 Avedro Inc Eye therapy system
US20090149930A1 (en) * 2007-12-07 2009-06-11 Thermage, Inc. Apparatus and methods for cooling a treatment apparatus configured to non-invasively deliver electromagnetic energy to a patient's tissue
US20090156958A1 (en) * 2007-12-12 2009-06-18 Mehta Bankim H Devices and methods for percutaneous energy delivery
JP5545668B2 (en) 2007-12-12 2014-07-09 ミラマー ラブズ, インコーポレイテッド System, apparatus method, and procedure for non-invasive tissue treatment using microwave energy
ES2395454T3 (en) 2008-01-17 2013-02-12 Syneron Medical Ltd. A device for hair removal for personal use and the method of use thereof
US8348935B2 (en) * 2008-01-23 2013-01-08 Avedro, Inc. System and method for reshaping an eye feature
US8409189B2 (en) * 2008-01-23 2013-04-02 Avedro, Inc. System and method for reshaping an eye feature
US8469952B2 (en) 2008-01-23 2013-06-25 Avedro, Inc. System and method for positioning an eye therapy device
US20090187173A1 (en) * 2008-01-23 2009-07-23 David Muller System and method for reshaping an eye feature
WO2010029529A1 (en) * 2008-09-11 2010-03-18 Syneron Medical Ltd. A device, apparatus, and method of adipose tissue treatment
CN101951851B (en) 2008-01-24 2013-02-06 赛诺龙医疗公司 A device and apparatus of adipose tissue treatment
US20120022512A1 (en) * 2008-01-24 2012-01-26 Boris Vaynberg Device, apparatus, and method of adipose tissue treatment
US9198723B2 (en) * 2008-03-31 2015-12-01 Covidien Lp Re-hydration antenna for ablation
US8636733B2 (en) 2008-03-31 2014-01-28 Covidien Lp Electrosurgical pencil including improved controls
US8663219B2 (en) 2008-03-31 2014-03-04 Covidien Lp Electrosurgical pencil including improved controls
US8597292B2 (en) 2008-03-31 2013-12-03 Covidien Lp Electrosurgical pencil including improved controls
US8632528B2 (en) 2008-04-11 2014-01-21 Jorge Fausto Ottini Methods for nonablative photorejuvenation
EP2271276A4 (en) 2008-04-17 2013-01-23 Miramar Labs Inc Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
KR20100139144A (en) * 2008-04-21 2010-12-31 카를 프레데릭 에드만 Metabolic energy monitoring system
WO2009132355A1 (en) 2008-04-25 2009-10-29 Tria Beauty, Inc. Optical sensor and method for identifying the presence of skin and the pigmentation of skin
US20090275936A1 (en) * 2008-05-01 2009-11-05 David Muller System and method for applying therapy to an eye using energy conduction
WO2009137609A2 (en) 2008-05-06 2009-11-12 Cellutions, Inc. Apparatus and systems for treating a human tissue condition
US8172835B2 (en) 2008-06-05 2012-05-08 Cutera, Inc. Subcutaneous electric field distribution system and methods
US20090306647A1 (en) * 2008-06-05 2009-12-10 Greg Leyh Dynamically controllable multi-electrode apparatus & methods
US8162937B2 (en) 2008-06-27 2012-04-24 Tyco Healthcare Group Lp High volume fluid seal for electrosurgical handpiece
US20100016782A1 (en) * 2008-07-16 2010-01-21 John Erich Oblong Method of Regulating Hair Growth
US20100017750A1 (en) 2008-07-16 2010-01-21 Avner Rosenberg User interface
US9314293B2 (en) * 2008-07-16 2016-04-19 Syneron Medical Ltd RF electrode for aesthetic and body shaping devices and method of using same
US20100022999A1 (en) * 2008-07-24 2010-01-28 Gollnick David A Symmetrical rf electrosurgical system and methods
US8303582B2 (en) 2008-09-15 2012-11-06 Tyco Healthcare Group Lp Electrosurgical instrument having a coated electrode utilizing an atomic layer deposition technique
US8398628B2 (en) * 2008-09-19 2013-03-19 Avedro, Inc. Eye therapy system
US8778003B2 (en) 2008-09-21 2014-07-15 Syneron Medical Ltd Method and apparatus for personal skin treatment
US8275442B2 (en) 2008-09-25 2012-09-25 Zeltiq Aesthetics, Inc. Treatment planning systems and methods for body contouring applications
US8366689B2 (en) * 2008-09-30 2013-02-05 Avedro, Inc. Method for making structural changes in corneal fibrils
WO2010039979A1 (en) * 2008-10-01 2010-04-08 Avedro, Inc. Eye therapy system
EP3202457B1 (en) 2008-10-27 2020-05-27 Spinal Modulation Inc. Selective stimulation systems and signal parameters for medical conditions
EP2355739A4 (en) 2008-11-11 2014-03-12 Avedro Inc Eye therapy system
CN102271603A (en) 2008-11-17 2011-12-07 明诺医学股份有限公司 Selective accumulation of energy with or without knowledge of tissue topography
US8357150B2 (en) 2009-07-20 2013-01-22 Syneron Medical Ltd. Method and apparatus for fractional skin treatment
US8603073B2 (en) 2008-12-17 2013-12-10 Zeltiq Aesthetics, Inc. Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
US8652129B2 (en) 2008-12-31 2014-02-18 Medtronic Ardian Luxembourg S.A.R.L. Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation
US8808345B2 (en) 2008-12-31 2014-08-19 Medtronic Ardian Luxembourg S.A.R.L. Handle assemblies for intravascular treatment devices and associated systems and methods
US8974445B2 (en) 2009-01-09 2015-03-10 Recor Medical, Inc. Methods and apparatus for treatment of cardiac valve insufficiency
US8882758B2 (en) 2009-01-09 2014-11-11 Solta Medical, Inc. Tissue treatment apparatus and systems with pain mitigation and methods for mitigating pain during tissue treatments
US8506506B2 (en) * 2009-01-12 2013-08-13 Solta Medical, Inc. Tissue treatment apparatus with functional mechanical stimulation and methods for reducing pain during tissue treatments
US8231620B2 (en) 2009-02-10 2012-07-31 Tyco Healthcare Group Lp Extension cutting blade
US8211097B2 (en) 2009-02-13 2012-07-03 Cutera, Inc. Optimizing RF power spatial distribution using frequency control
US20100211060A1 (en) * 2009-02-13 2010-08-19 Cutera, Inc. Radio frequency treatment of subcutaneous fat
US20100211055A1 (en) * 2009-02-18 2010-08-19 Shimon Eckhouse Method for body toning and an integrated data management system for the same
CA2747767A1 (en) 2009-02-25 2010-09-02 Transpharma Medical Ltd. Electrical skin rejuvenation
US20100217254A1 (en) * 2009-02-25 2010-08-26 Primaeva Medical, Inc. Methods for applying energy to tissue using isolated energy sources
CN102438698B (en) 2009-03-24 2014-09-10 脊髓调制公司 Pain management with stimulation subthreshold to parasthesia
US8712536B2 (en) * 2009-04-02 2014-04-29 Avedro, Inc. Eye therapy system
US20100280509A1 (en) * 2009-04-02 2010-11-04 Avedro, Inc. Eye Therapy System
BRPI1014623B1 (en) 2009-04-30 2020-01-07 Zeltiq Aesthetics, Inc. SYSTEM FOR TREATING SUBCUTANEOUS CELLS RICH IN LIPIDS IN A TARGET AREA
US8551096B2 (en) 2009-05-13 2013-10-08 Boston Scientific Scimed, Inc. Directional delivery of energy and bioactives
AU2010248802B2 (en) 2009-05-15 2017-02-02 Spinal Modulation, Inc. Methods, systems and devices for neuromodulating spinal anatomy
US8433401B2 (en) * 2009-07-09 2013-04-30 Incube Labs, Llc Ring electrode assembly and applications thereof
US8788060B2 (en) 2009-07-16 2014-07-22 Solta Medical, Inc. Tissue treatment systems with high powered functional electrical stimulation and methods for reducing pain during tissue treatments
US11096708B2 (en) 2009-08-07 2021-08-24 Ulthera, Inc. Devices and methods for performing subcutaneous surgery
US9358064B2 (en) 2009-08-07 2016-06-07 Ulthera, Inc. Handpiece and methods for performing subcutaneous surgery
US8398625B2 (en) * 2009-09-02 2013-03-19 Covidien Lp Electrosurgical electrode with insulative coating
US9113925B2 (en) 2009-09-09 2015-08-25 Covidien Lp System and method for performing an ablation procedure
US8355803B2 (en) 2009-09-16 2013-01-15 Vivant Medical, Inc. Perfused core dielectrically loaded dipole microwave antenna probe
EP2477695B1 (en) * 2009-09-18 2015-10-21 Viveve Inc. Vaginal remodeling device
WO2011050164A1 (en) 2009-10-21 2011-04-28 Avedro, Inc. Eye therapy
WO2011053768A2 (en) * 2009-10-30 2011-05-05 Avedro, Inc. System and method for stabilizing corneal tissue after treatment
US20110112400A1 (en) * 2009-11-06 2011-05-12 Ardian, Inc. High intensity focused ultrasound catheter apparatuses, systems, and methods for renal neuromodulation
US8882759B2 (en) 2009-12-18 2014-11-11 Covidien Lp Microwave ablation system with dielectric temperature probe
US20110200171A1 (en) * 2010-01-19 2011-08-18 Ardian, Inc. Methods and apparatus for renal neuromodulation via stereotactic radiotherapy
AU2011207506A1 (en) 2010-01-25 2012-08-09 Zeltiq Aesthetics, Inc. Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associated devices, systems and methods
US20110196438A1 (en) * 2010-02-10 2011-08-11 Lukas Mnozil Therapy device and method for treating underlying tissue using electrical and acoustic energies
US20110202048A1 (en) * 2010-02-12 2011-08-18 Solta Medical, Inc. Methods for pain reduction with functional thermal stimulation and tissue treatment systems
US8568404B2 (en) 2010-02-19 2013-10-29 Covidien Lp Bipolar electrode probe for ablation monitoring
US20110208173A1 (en) * 2010-02-24 2011-08-25 Medtronic Vascular, Inc. Methods for Treating sleep apnea via renal Denervation
US8556891B2 (en) 2010-03-03 2013-10-15 Medtronic Ablation Frontiers Llc Variable-output radiofrequency ablation power supply
US9075910B2 (en) * 2010-03-11 2015-07-07 Philometron, Inc. Physiological monitor system for determining medication delivery and outcome
JP6377906B2 (en) 2010-03-19 2018-08-22 アヴェドロ・インコーポレーテッドAvedro,Inc. System for applying and monitoring eye treatment
CA2795229A1 (en) 2010-04-09 2011-10-13 Vessix Vascular, Inc. Power generating and control apparatus for the treatment of tissue
US9192790B2 (en) 2010-04-14 2015-11-24 Boston Scientific Scimed, Inc. Focused ultrasonic renal denervation
CN102869789B (en) 2010-04-19 2015-09-30 赛诺龙医疗公司 Use to skin the gene label and gene chip and associated method and process that are associated with the radio-frequency current of conductivity
KR101490573B1 (en) 2010-04-19 2015-02-05 시네론 메디컬 리미티드 Combined energy and topical composition application for regulating the condition of mammalian skin
US8870863B2 (en) 2010-04-26 2014-10-28 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses, systems, and methods for renal neuromodulation
US9173700B2 (en) 2010-04-26 2015-11-03 9234438 Canada Inc. Electrosurgical device and methods
US20110276056A1 (en) 2010-05-10 2011-11-10 Grigsby Eric J Methods, systems and devices for reducing migration
ITFI20100102A1 (en) * 2010-05-12 2011-11-13 Easytech S R L ELECTRODE COOLED FOR APPLIANCES WITH CAPACITIVE / RESISTIVE ELECTROMAGNETIC HEATING.
EP2394693A1 (en) * 2010-06-10 2011-12-14 Golsen Limited Electrical impulse stimulation device for the healing of wounds
US8473067B2 (en) 2010-06-11 2013-06-25 Boston Scientific Scimed, Inc. Renal denervation and stimulation employing wireless vascular energy transfer arrangement
US8676338B2 (en) 2010-07-20 2014-03-18 Zeltiq Aesthetics, Inc. Combined modality treatment systems, methods and apparatus for body contouring applications
US9155589B2 (en) 2010-07-30 2015-10-13 Boston Scientific Scimed, Inc. Sequential activation RF electrode set for renal nerve ablation
US9463062B2 (en) 2010-07-30 2016-10-11 Boston Scientific Scimed, Inc. Cooled conductive balloon RF catheter for renal nerve ablation
US9084609B2 (en) 2010-07-30 2015-07-21 Boston Scientific Scime, Inc. Spiral balloon catheter for renal nerve ablation
US9408661B2 (en) 2010-07-30 2016-08-09 Patrick A. Haverkost RF electrodes on multiple flexible wires for renal nerve ablation
US9358365B2 (en) 2010-07-30 2016-06-07 Boston Scientific Scimed, Inc. Precision electrode movement control for renal nerve ablation
US9504446B2 (en) 2010-08-02 2016-11-29 Guided Therapy Systems, Llc Systems and methods for coupling an ultrasound source to tissue
CA2807277C (en) 2010-08-05 2020-05-12 Medtronic Ardian Luxembourg S.A.R.L. Cryoablation apparatuses, systems, and methods for renal neuromodulation
JP5934211B2 (en) * 2010-08-19 2016-06-15 シネロン メディカル リミテッド Electromagnetic energy applicator for personal cosmetic skin treatment
DE102010041649A1 (en) * 2010-09-29 2012-03-29 Zimmer Medizinsysteme Gmbh Electromedical device for non-invasively reducing or removing subcutaneous adipose tissue
KR101734612B1 (en) * 2010-10-17 2017-05-11 시네론 메디컬 리미티드 A disposable patch for personal aesthetic skin treatment
TWI556849B (en) 2010-10-21 2016-11-11 美敦力阿福盧森堡公司 Catheter apparatus for renal neuromodulation
CN106377312B (en) 2010-10-25 2019-12-10 美敦力Af卢森堡有限责任公司 Microwave catheter apparatus, systems, and methods for renal neuromodulation
WO2012061153A1 (en) 2010-10-25 2012-05-10 Medtronic Ardian Luxembourg S.A.R.L. Devices, systems and methods for evaluation and feedback of neuromodulation treatment
US8974451B2 (en) 2010-10-25 2015-03-10 Boston Scientific Scimed, Inc. Renal nerve ablation using conductive fluid jet and RF energy
RU2013118108A (en) 2010-10-25 2014-12-10 Медтроник Ардиан Люксембург С.А.Р.Л. CATHETER DEVICES CONTAINING MULTIPLE ELECTRODE GROUPS FOR RENAL NEUROMODULATION AND RELATED SYSTEMS AND METHODS
US9060754B2 (en) 2010-10-26 2015-06-23 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
US20120136344A1 (en) 2010-10-26 2012-05-31 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
US9220558B2 (en) 2010-10-27 2015-12-29 Boston Scientific Scimed, Inc. RF renal denervation catheter with multiple independent electrodes
US8857438B2 (en) 2010-11-08 2014-10-14 Ulthera, Inc. Devices and methods for acoustic shielding
US9028485B2 (en) 2010-11-15 2015-05-12 Boston Scientific Scimed, Inc. Self-expanding cooling electrode for renal nerve ablation
US9668811B2 (en) 2010-11-16 2017-06-06 Boston Scientific Scimed, Inc. Minimally invasive access for renal nerve ablation
US9089350B2 (en) 2010-11-16 2015-07-28 Boston Scientific Scimed, Inc. Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
WO2012068268A2 (en) 2010-11-17 2012-05-24 Medtronic Ardian Luxembourg S.A.R.L. Therapeutic renal neuromodulation for treating dyspnea and associated systems and methods
US9326751B2 (en) 2010-11-17 2016-05-03 Boston Scientific Scimed, Inc. Catheter guidance of external energy for renal denervation
US9060761B2 (en) 2010-11-18 2015-06-23 Boston Scientific Scime, Inc. Catheter-focused magnetic field induced renal nerve ablation
US9023034B2 (en) 2010-11-22 2015-05-05 Boston Scientific Scimed, Inc. Renal ablation electrode with force-activatable conduction apparatus
US9192435B2 (en) 2010-11-22 2015-11-24 Boston Scientific Scimed, Inc. Renal denervation catheter with cooled RF electrode
US20120157993A1 (en) 2010-12-15 2012-06-21 Jenson Mark L Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
US10292763B2 (en) 2016-01-25 2019-05-21 Biosense Webster (Israel) Ltd. Temperature controlled short duration ablation
US10405920B2 (en) * 2016-01-25 2019-09-10 Biosense Webster (Israel) Ltd. Temperature controlled short duration ablation
WO2012100095A1 (en) 2011-01-19 2012-07-26 Boston Scientific Scimed, Inc. Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
WO2012103242A1 (en) 2011-01-25 2012-08-02 Zeltiq Aesthetics, Inc. Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells
CA2825763A1 (en) 2011-02-02 2012-08-09 Spinal Modulation, Inc. Devices, systems and methods for the targeted treatment of movement disorders
US9198724B2 (en) 2011-04-08 2015-12-01 Covidien Lp Microwave tissue dissection and coagulation
CN103930061B (en) 2011-04-25 2016-09-14 美敦力阿迪安卢森堡有限责任公司 Relevant low temperature sacculus for restricted conduit wall cryogenic ablation limits the device and method disposed
WO2012162529A1 (en) 2011-05-24 2012-11-29 Avedro, Inc. Systems and methods for reshaping an eye feature
WO2012167260A2 (en) 2011-06-02 2012-12-06 Avedro, Inc. Systems and methods for monitoring time based photo active agent delivery or photo active marker presence
US20130012816A1 (en) 2011-07-10 2013-01-10 Guided Therapy Systems, Llc Methods and systems for controlling acoustic energy deposition into a medium
EP2731675B1 (en) 2011-07-11 2023-05-03 Guided Therapy Systems, L.L.C. Systems and methods for coupling an ultrasound source to tissue
CN103813745B (en) 2011-07-20 2016-06-29 波士顿科学西美德公司 In order to visualize, be directed at and to melt transcutaneous device and the method for nerve
US9186209B2 (en) 2011-07-22 2015-11-17 Boston Scientific Scimed, Inc. Nerve modulation system having helical guide
US9314301B2 (en) 2011-08-01 2016-04-19 Miramar Labs, Inc. Applicator and tissue interface module for dermatological device
DE102011053731A1 (en) * 2011-09-16 2013-03-21 Wassili Garbartschuk Electromechanical structure for transcutaneous electrical nerve stimulation device utilized for treatment of e.g. human body, has electrode and outer electrodes respectively connected with waveguide shim by conductive spring elements
WO2013055826A1 (en) 2011-10-10 2013-04-18 Boston Scientific Scimed, Inc. Medical devices including ablation electrodes
US9420955B2 (en) 2011-10-11 2016-08-23 Boston Scientific Scimed, Inc. Intravascular temperature monitoring system and method
EP2765940B1 (en) * 2011-10-11 2015-08-26 Boston Scientific Scimed, Inc. Off-wall electrode device for nerve modulation
US9364284B2 (en) 2011-10-12 2016-06-14 Boston Scientific Scimed, Inc. Method of making an off-wall spacer cage
EP2768568B1 (en) 2011-10-18 2020-05-06 Boston Scientific Scimed, Inc. Integrated crossing balloon catheter
US9162046B2 (en) 2011-10-18 2015-10-20 Boston Scientific Scimed, Inc. Deflectable medical devices
PL221643B1 (en) * 2011-10-21 2016-05-31 Univ Warszawski Chamber for measuring the electrical properties of the powder or liquid samples and the method for measurement of electrical properties of the reactive powder or liquid samples
EP3287067B1 (en) 2011-11-07 2019-10-30 Medtronic Ardian Luxembourg S.à.r.l. Endovascular nerve monitoring devices and associated systems
CN104023662B (en) 2011-11-08 2018-02-09 波士顿科学西美德公司 Hole portion renal nerve melts
EP2779929A1 (en) 2011-11-15 2014-09-24 Boston Scientific Scimed, Inc. Device and methods for renal nerve modulation monitoring
US20130123765A1 (en) * 2011-11-16 2013-05-16 Btl Holdings Limited Methods and systems for subcutaneous treatments
US8548599B2 (en) * 2011-11-16 2013-10-01 Btl Holdings Limited Methods and systems for subcutaneous treatments
CN104136074B (en) * 2011-11-16 2017-08-08 Btl控股有限公司 Method and system for subcutaneous treatment
US9119632B2 (en) 2011-11-21 2015-09-01 Boston Scientific Scimed, Inc. Deflectable renal nerve ablation catheter
KR101273617B1 (en) * 2011-11-24 2013-06-10 주식회사 루트로닉 A treatment apparatus using radio frequency energy
US9192766B2 (en) 2011-12-02 2015-11-24 Medtronic Ardian Luxembourg S.A.R.L. Renal neuromodulation methods and devices for treatment of polycystic kidney disease
EP2790775B1 (en) 2011-12-12 2018-02-07 Pulse Biosciences, Inc. Electric pulse generators
US9265969B2 (en) 2011-12-21 2016-02-23 Cardiac Pacemakers, Inc. Methods for modulating cell function
WO2013096920A1 (en) 2011-12-23 2013-06-27 Vessix Vascular, Inc. Methods and apparatuses for remodeling tissue of or adjacent to a body passage
CN104135958B (en) 2011-12-28 2017-05-03 波士顿科学西美德公司 By the apparatus and method that have the new ablation catheter modulation nerve of polymer ablation
US9050106B2 (en) 2011-12-29 2015-06-09 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
CN104093447A (en) * 2012-01-16 2014-10-08 泰索医疗公司 A device for treatment of a wound
US10076383B2 (en) 2012-01-25 2018-09-18 Covidien Lp Electrosurgical device having a multiplexer
US9889297B2 (en) 2012-02-22 2018-02-13 Candela Corporation Reduction of RF electrode edge effect
US9277958B2 (en) * 2012-02-22 2016-03-08 Candela Corporation Reduction of RF electrode edge effect
US9144449B2 (en) 2012-03-02 2015-09-29 Csa Medical, Inc. Cryosurgery system
US10342592B2 (en) 2012-03-07 2019-07-09 Medtronic Ardian Luxembourg S.A.R.L. Selective modulation of renal nerves
US9883909B2 (en) 2012-03-08 2018-02-06 Medtronic Ardian Luxembourg S.A.R.L. Renal neuromodulation methods and systems for treatment of hyperaldosteronism
WO2013134548A2 (en) 2012-03-08 2013-09-12 Medtronic Ardian Luxembourg S.A.R.L. Ovarian neuromodulation and associated systems and methods
AU2013230906A1 (en) 2012-03-08 2014-09-18 Medtronic Af Luxembourg S.A.R.L. Neuromodulation and associated systems and methods for the treatment of sexual dysfunction
AU2013229776B2 (en) 2012-03-08 2016-12-15 Medtronic Af Luxembourg S.A.R.L. Biomarker sampling in the context of neuromodulation devices and associated systems
WO2013134479A1 (en) 2012-03-08 2013-09-12 Medtronic Ardian Luxembourg Sarl Neuromodulation and associated systems and methods for the management of pain
WO2013134541A2 (en) 2012-03-08 2013-09-12 Medtronic Ardian Luxembourg Sarl Gastrointestinal neuromodulation and associated systems and methods
US20130245727A1 (en) * 2012-03-16 2013-09-19 Cutera, Inc. Systems and methods for thermolipolysis using rf energy
CN103301567B (en) 2012-03-16 2016-04-06 女康乐公司 A kind of therapeutic apparatus repairing vagina tissue
US9263663B2 (en) 2012-04-13 2016-02-16 Ardent Sound, Inc. Method of making thick film transducer arrays
EP2838460A1 (en) * 2012-04-16 2015-02-25 Koninklijke Philips N.V. Method and system for skin treatment
US9848950B2 (en) 2012-04-27 2017-12-26 Medtronic Ardian Luxembourg S.A.R.L. Methods and devices for localized disease treatment by ablation
US10258791B2 (en) 2012-04-27 2019-04-16 Medtronic Ardian Luxembourg S.A.R.L. Catheter assemblies for neuromodulation proximate a bifurcation of a renal artery and associated systems and methods
US20150088113A1 (en) 2012-04-27 2015-03-26 Medtronic Ardian Luxembourg S.A.R.L. Cryotherapeutic devices for renal neuromodulation and associated systems and methods
US9241752B2 (en) 2012-04-27 2016-01-26 Medtronic Ardian Luxembourg S.A.R.L. Shafts with pressure relief in cryotherapeutic catheters and associated devices, systems, and methods
WO2013162721A1 (en) 2012-04-27 2013-10-31 Medtronic Ardian Luxembourg Sarl Methods and devices for localized inhibition of inflammation by ablation
WO2013169927A1 (en) 2012-05-08 2013-11-14 Boston Scientific Scimed, Inc. Renal nerve modulation devices
DE102012207750A1 (en) * 2012-05-09 2013-11-28 Leibniz-Institut für Plasmaforschung und Technologie e.V. APPARATUS FOR THE PLASMA TREATMENT OF HUMAN, ANIMAL OR VEGETABLE SURFACES, IN PARTICULAR OF SKIN OR TINIAL TIPS
RU2601906C2 (en) 2012-05-11 2016-11-10 Медтроник АФ Люксембург С.а.р.л. Catheter device containing blocks of several electrodes for renal neuromodulation and appropriate systems and methods
US8951296B2 (en) 2012-06-29 2015-02-10 Medtronic Ardian Luxembourg S.A.R.L. Devices and methods for photodynamically modulating neural function in a human
DE102012013534B3 (en) 2012-07-05 2013-09-19 Tobias Sokolowski Apparatus for repetitive nerve stimulation for the degradation of adipose tissue by means of inductive magnetic fields
EP2872081B1 (en) 2012-07-16 2022-06-08 Avedro, Inc. Systems for corneal cross-linking with pulsed light
DE102012015482A1 (en) 2012-08-07 2014-02-13 Cinogy Gmbh Electrode arrangement for a disabled plasma
US20150209551A1 (en) 2012-08-15 2015-07-30 Everette C. Burdette Mri compatible ablation catheter system incorporating directional high-intensity ultrasound for treatment
US9757190B2 (en) * 2012-08-17 2017-09-12 Medtronic Ablation Frontiers Llc Methods of manufacturing monophasic action potential mapping catheters
CN104540465A (en) 2012-08-24 2015-04-22 波士顿科学西美德公司 Intravascular catheter with a balloon comprising separate microporous regions
US8612022B1 (en) 2012-09-13 2013-12-17 Invatec S.P.A. Neuromodulation catheters and associated systems and methods
WO2014043687A2 (en) 2012-09-17 2014-03-20 Boston Scientific Scimed, Inc. Self-positioning electrode system and method for renal nerve modulation
US10549127B2 (en) 2012-09-21 2020-02-04 Boston Scientific Scimed, Inc. Self-cooling ultrasound ablation catheter
WO2014047411A1 (en) 2012-09-21 2014-03-27 Boston Scientific Scimed, Inc. System for nerve modulation and innocuous thermal gradient nerve block
WO2014059165A2 (en) 2012-10-10 2014-04-17 Boston Scientific Scimed, Inc. Renal nerve modulation devices and methods
US20140110296A1 (en) 2012-10-19 2014-04-24 Medtronic Ardian Luxembourg S.A.R.L. Packaging for Catheter Treatment Devices and Associated Devices, Systems, and Methods
US9044575B2 (en) 2012-10-22 2015-06-02 Medtronic Adrian Luxembourg S.a.r.l. Catheters with enhanced flexibility and associated devices, systems, and methods
US9399115B2 (en) 2012-10-22 2016-07-26 Medtronic Ardian Luxembourg S.A.R.L. Catheters with enhanced flexibility and associated devices, systems, and methods
US9095321B2 (en) 2012-11-21 2015-08-04 Medtronic Ardian Luxembourg S.A.R.L. Cryotherapeutic devices having integral multi-helical balloons and methods of making the same
US9017317B2 (en) 2012-12-06 2015-04-28 Medtronic Ardian Luxembourg S.A.R.L. Refrigerant supply system for cryotherapy including refrigerant recompression and associated devices, systems, and methods
US9877707B2 (en) * 2013-03-07 2018-01-30 Kyphon SÀRL Systems and methods for track coagulation
WO2014163987A1 (en) 2013-03-11 2014-10-09 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
WO2014143571A1 (en) 2013-03-11 2014-09-18 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9808311B2 (en) 2013-03-13 2017-11-07 Boston Scientific Scimed, Inc. Deflectable medical devices
US9844460B2 (en) 2013-03-14 2017-12-19 Zeltiq Aesthetics, Inc. Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
US9545523B2 (en) 2013-03-14 2017-01-17 Zeltiq Aesthetics, Inc. Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue
US9301723B2 (en) 2013-03-15 2016-04-05 Covidien Lp Microwave energy-delivery device and system
WO2014145148A2 (en) 2013-03-15 2014-09-18 Ellman International, Inc. Surgical instruments and systems with multimodes of treatments and electrosurgical operation
EP2967734B1 (en) 2013-03-15 2019-05-15 Boston Scientific Scimed, Inc. Methods and apparatuses for remodeling tissue of or adjacent to a body passage
US9066726B2 (en) 2013-03-15 2015-06-30 Medtronic Ardian Luxembourg S.A.R.L. Multi-electrode apposition judgment using pressure elements
EP2968919B1 (en) 2013-03-15 2021-08-25 Medtronic Ardian Luxembourg S.à.r.l. Controlled neuromodulation systems
US10265122B2 (en) 2013-03-15 2019-04-23 Boston Scientific Scimed, Inc. Nerve ablation devices and related methods of use
US9119650B2 (en) 2013-03-15 2015-09-01 Covidien Lp Microwave energy-delivery device and system
US9179974B2 (en) 2013-03-15 2015-11-10 Medtronic Ardian Luxembourg S.A.R.L. Helical push wire electrode
CN105228546B (en) 2013-03-15 2017-11-14 波士顿科学国际有限公司 Utilize the impedance-compensated medicine equipment and method that are used to treat hypertension
KR101297791B1 (en) * 2013-03-22 2013-08-19 이기세 Tip structure for a skin care apparatus
US20140303608A1 (en) * 2013-04-08 2014-10-09 Scientific Image Center Management, Inc. System and method for providing treatment feedback for a thermal treatment device
EP2996754B1 (en) 2013-05-18 2023-04-26 Medtronic Ardian Luxembourg S.à.r.l. Neuromodulation catheters with shafts for enhanced flexibility and control and associated devices and systems
US9498122B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
CN105473092B (en) 2013-06-21 2019-05-17 波士顿科学国际有限公司 The medical instrument for renal nerve ablation with rotatable shaft
EP3010437A1 (en) 2013-06-21 2016-04-27 Boston Scientific Scimed, Inc. Renal denervation balloon catheter with ride along electrode support
US9707036B2 (en) 2013-06-25 2017-07-18 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation using localized indifferent electrodes
CN105358084B (en) 2013-07-01 2018-11-09 波士顿科学国际有限公司 Medical instrument for renal nerve ablation
CN105377169B (en) 2013-07-11 2019-04-19 波士顿科学国际有限公司 Device and method for neuromodulation
CN105377170A (en) 2013-07-11 2016-03-02 波士顿科学国际有限公司 Medical device with stretchable electrode assemblies
WO2015010074A1 (en) 2013-07-19 2015-01-22 Boston Scientific Scimed, Inc. Spiral bipolar electrode renal denervation balloon
CN105555220B (en) 2013-07-22 2019-05-17 波士顿科学国际有限公司 Medical instrument for renal nerve ablation
EP3024405A1 (en) 2013-07-22 2016-06-01 Boston Scientific Scimed, Inc. Renal nerve ablation catheter having twist balloon
WO2015013502A2 (en) 2013-07-24 2015-01-29 Miramar Labs, Inc. Apparatus and methods for the treatment of tissue using microwave energy
WO2015027096A1 (en) 2013-08-22 2015-02-26 Boston Scientific Scimed, Inc. Flexible circuit having improved adhesion to a renal nerve modulation balloon
US9326816B2 (en) 2013-08-30 2016-05-03 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation systems having nerve monitoring assemblies and associated devices, systems, and methods
US9339332B2 (en) 2013-08-30 2016-05-17 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation catheters with nerve monitoring features for transmitting digital neural signals and associated systems and methods
US9895194B2 (en) 2013-09-04 2018-02-20 Boston Scientific Scimed, Inc. Radio frequency (RF) balloon catheter having flushing and cooling capability
US20150073515A1 (en) 2013-09-09 2015-03-12 Medtronic Ardian Luxembourg S.a.r.I. Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods
US9138578B2 (en) 2013-09-10 2015-09-22 Medtronic Ardian Luxembourg S.A.R.L. Endovascular catheters with tuned control members and associated systems and methods
CN105530885B (en) 2013-09-13 2020-09-22 波士顿科学国际有限公司 Ablation balloon with vapor deposited covering
US11246654B2 (en) 2013-10-14 2022-02-15 Boston Scientific Scimed, Inc. Flexible renal nerve ablation devices and related methods of use and manufacture
EP3057488B1 (en) 2013-10-14 2018-05-16 Boston Scientific Scimed, Inc. High resolution cardiac mapping electrode array catheter
US9770606B2 (en) 2013-10-15 2017-09-26 Boston Scientific Scimed, Inc. Ultrasound ablation catheter with cooling infusion and centering basket
AU2014334574B2 (en) 2013-10-15 2017-07-06 Boston Scientific Scimed, Inc. Medical device balloon
CN105636538B (en) 2013-10-18 2019-01-15 波士顿科学国际有限公司 Foley's tube with flexible wire and its correlation technique for using and manufacturing
US10433902B2 (en) 2013-10-23 2019-10-08 Medtronic Ardian Luxembourg S.A.R.L. Current control methods and systems
WO2015061457A1 (en) 2013-10-25 2015-04-30 Boston Scientific Scimed, Inc. Embedded thermocouple in denervation flex circuit
KR101622143B1 (en) 2013-10-30 2016-05-18 주식회사 화니메디칼 High Frequency Stimulating Apparatus for Treatment of Skin Texture or Removal of Subcutaneous Fat
JP6382989B2 (en) 2014-01-06 2018-08-29 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical device with tear resistant flexible circuit assembly
EP4253024A3 (en) 2014-01-27 2023-12-27 Medtronic Ireland Manufacturing Unlimited Company Neuromodulation catheters having jacketed neuromodulation elements and related devices
EP3099259A1 (en) 2014-01-31 2016-12-07 Zeltiq Aesthetics, Inc. Treatment systems and methods for affecting glands and other targeted structures
US11000679B2 (en) 2014-02-04 2021-05-11 Boston Scientific Scimed, Inc. Balloon protection and rewrapping devices and related methods of use
JP6325121B2 (en) 2014-02-04 2018-05-16 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Alternative placement of temperature sensors on bipolar electrodes
US10492842B2 (en) 2014-03-07 2019-12-03 Medtronic Ardian Luxembourg S.A.R.L. Monitoring and controlling internally administered cryotherapy
US10463424B2 (en) 2014-03-11 2019-11-05 Medtronic Ardian Luxembourg S.A.R.L. Catheters with independent radial-expansion members and associated devices, systems, and methods
US9579149B2 (en) 2014-03-13 2017-02-28 Medtronic Ardian Luxembourg S.A.R.L. Low profile catheter assemblies and associated systems and methods
US10675176B1 (en) 2014-03-19 2020-06-09 Zeltiq Aesthetics, Inc. Treatment systems, devices, and methods for cooling targeted tissue
USD777338S1 (en) 2014-03-20 2017-01-24 Zeltiq Aesthetics, Inc. Cryotherapy applicator for cooling tissue
US10194979B1 (en) 2014-03-28 2019-02-05 Medtronic Ardian Luxembourg S.A.R.L. Methods for catheter-based renal neuromodulation
US10194980B1 (en) 2014-03-28 2019-02-05 Medtronic Ardian Luxembourg S.A.R.L. Methods for catheter-based renal neuromodulation
US9980766B1 (en) 2014-03-28 2018-05-29 Medtronic Ardian Luxembourg S.A.R.L. Methods and systems for renal neuromodulation
EP3125837A4 (en) * 2014-04-04 2017-11-08 Aesthetics Biomedical, Inc. System and method for providing treatment feedback for a thermal treatment device
CN106232043B (en) 2014-04-24 2019-07-23 美敦力阿迪安卢森堡有限公司 Nerve modulation conduit and relevant system and method with braiding axle
US10610292B2 (en) 2014-04-25 2020-04-07 Medtronic Ardian Luxembourg S.A.R.L. Devices, systems, and methods for monitoring and/or controlling deployment of a neuromodulation element within a body lumen and related technology
US10709490B2 (en) 2014-05-07 2020-07-14 Medtronic Ardian Luxembourg S.A.R.L. Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods
US10952891B1 (en) 2014-05-13 2021-03-23 Zeltiq Aesthetics, Inc. Treatment systems with adjustable gap applicators and methods for cooling tissue
WO2015188013A1 (en) * 2014-06-04 2015-12-10 Csa Medical, Inc. Method and system for consistent, repeatable, and safe cryospray treatment of airway tissue
US11819679B2 (en) * 2014-06-04 2023-11-21 Koninklijke Philips N.V. Centrosymmetric radio frequency electrode configuration for skin treatment
EP3154463B1 (en) * 2014-06-12 2019-03-27 Farapulse, Inc. Apparatus for rapid and selective transurethral tissue ablation
CN106659532B (en) * 2014-07-24 2019-08-23 皇家飞利浦有限公司 It is used to heat the first interior zone of skin and the processing equipment of the second interior zone using radio-frequency current
US20160045755A1 (en) * 2014-08-18 2016-02-18 Donghoon CHUN Apparatus, system and method for treating fat tissue
US10935174B2 (en) 2014-08-19 2021-03-02 Zeltiq Aesthetics, Inc. Stress relief couplings for cryotherapy apparatuses
US10568759B2 (en) 2014-08-19 2020-02-25 Zeltiq Aesthetics, Inc. Treatment systems, small volume applicators, and methods for treating submental tissue
US11154712B2 (en) 2014-08-28 2021-10-26 Medtronic Ardian Luxembourg S.A.R.L. Methods for assessing efficacy of renal neuromodulation and associated systems and devices
US10149969B2 (en) * 2014-09-25 2018-12-11 L'oréal Skin treatment appliance with changeable workpiece
EP3791817A1 (en) 2014-10-01 2021-03-17 Medtronic Ardian Luxembourg S.à.r.l. Systems for evaluating neuromodulation therapy via hemodynamic responses
CN107205845B (en) 2014-10-27 2020-03-31 艾维德洛公司 Systems and methods for cross-linking treatment of the eye
WO2016077747A1 (en) 2014-11-13 2016-05-19 Avedro, Inc. Multipass virtually imaged phased array etalon
CN104306141B (en) * 2014-11-14 2016-08-31 李云祥 Stone needle scraping back masseur
EP3217904B1 (en) 2014-11-14 2021-09-08 Medtronic Ardian Luxembourg S.à.r.l. Catheter apparatuses for modulation of nerves in communication with the pulmonary system and associated systems
WO2016100720A1 (en) 2014-12-17 2016-06-23 Medtronic Ardian Luxembourg S.A.R.L. Systems and methods for assessing sympathetic nervous system tone for renal neuromodulation therapy
JP2018509264A (en) * 2015-04-08 2018-04-05 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Non-invasive skin treatment device using RF current with treatment setting determiner
US10758741B2 (en) 2015-04-14 2020-09-01 Vasily Dronov System and method for selective treatment of skin and subcutaneous fat using a single frequency dual mode radio frequency antenna device
WO2016172695A1 (en) 2015-04-24 2016-10-27 Avedro, Inc. Systems and methods for photoactivating a photosensitizer applied to an eye
US11491342B2 (en) 2015-07-01 2022-11-08 Btl Medical Solutions A.S. Magnetic stimulation methods and devices for therapeutic treatments
WO2016191342A1 (en) 2015-05-22 2016-12-01 Avedro, Inc. Systems and methods for monitoring cross-linking activity for corneal treatments
US11266850B2 (en) 2015-07-01 2022-03-08 Btl Healthcare Technologies A.S. High power time varying magnetic field therapy
US10695575B1 (en) 2016-05-10 2020-06-30 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US20180001107A1 (en) 2016-07-01 2018-01-04 Btl Holdings Limited Aesthetic method of biological structure treatment by magnetic field
US9937358B2 (en) 2015-07-01 2018-04-10 Btl Holdings Limited Aesthetic methods of biological structure treatment by magnetic field
EP3324973B1 (en) 2015-07-21 2020-06-03 Avedro, Inc. Treament of an eye with a photosensitizer
US20170079833A1 (en) * 2015-09-21 2017-03-23 Zeltiq Aesthestics, Inc. Transcutaneous treatment systems, cooling devices, and methods for cooling nerves
EP3364900B1 (en) 2015-10-19 2021-08-18 Zeltiq Aesthetics, Inc. Vascular treatment methods for cooling vascular structures
US11253717B2 (en) 2015-10-29 2022-02-22 Btl Healthcare Technologies A.S. Aesthetic method of biological structure treatment by magnetic field
US10441339B2 (en) 2015-11-17 2019-10-15 Medtronic Holding Company Sárl Spinal tissue ablation apparatus, system, and method
WO2017120538A1 (en) 2016-01-07 2017-07-13 Zeltiq Aesthetics, Inc. Temperature-dependent adhesion between applicator and skin during cooling of tissue
US10765552B2 (en) 2016-02-18 2020-09-08 Zeltiq Aesthetics, Inc. Cooling cup applicators with contoured heads and liner assemblies
US10813692B2 (en) 2016-02-29 2020-10-27 Covidien Lp 90-degree interlocking geometry for introducer for facilitating deployment of microwave radiating catheter
US10736692B2 (en) 2016-04-28 2020-08-11 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation and associated systems and methods for the treatment of cancer
US11247039B2 (en) 2016-05-03 2022-02-15 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11464993B2 (en) 2016-05-03 2022-10-11 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US10682297B2 (en) 2016-05-10 2020-06-16 Zeltiq Aesthetics, Inc. Liposomes, emulsions, and methods for cryotherapy
US11534619B2 (en) 2016-05-10 2022-12-27 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US10555831B2 (en) 2016-05-10 2020-02-11 Zeltiq Aesthetics, Inc. Hydrogel substances and methods of cryotherapy
US11382790B2 (en) 2016-05-10 2022-07-12 Zeltiq Aesthetics, Inc. Skin freezing systems for treating acne and skin conditions
US10583287B2 (en) 2016-05-23 2020-03-10 Btl Medical Technologies S.R.O. Systems and methods for tissue treatment
US10556122B1 (en) 2016-07-01 2020-02-11 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
KR20180010672A (en) * 2016-07-22 2018-01-31 엘지전자 주식회사 Electronic device
US10231784B2 (en) 2016-10-28 2019-03-19 Medtronic Ardian Luxembourg S.A.R.L. Methods and systems for optimizing perivascular neuromodulation therapy using computational fluid dynamics
US10646713B2 (en) 2017-02-22 2020-05-12 Medtronic Ardian Luxembourg S.A.R.L. Systems, devices, and associated methods for treating patients via renal neuromodulation to reduce a risk of developing cognitive impairment
KR20180111202A (en) * 2017-03-31 2018-10-11 주식회사 루트로닉 The apparatus of rf treatment and the method of controlling taht and the method of skin treatment using rf-energy
KR20180111203A (en) * 2017-03-31 2018-10-11 주식회사 루트로닉 The apparatus of rf treatment and the method of controlling taht and the method of skin treatment using rf-energy
US11896823B2 (en) 2017-04-04 2024-02-13 Btl Healthcare Technologies A.S. Method and device for pelvic floor tissue treatment
KR101813558B1 (en) * 2017-04-12 2018-01-03 주식회사 서린메디케어 Skin treatment apparatus using fractional plasma
US11076879B2 (en) 2017-04-26 2021-08-03 Zeltiq Aesthetics, Inc. Shallow surface cryotherapy applicators and related technology
DE102017111902B4 (en) 2017-05-31 2020-12-31 Cinogy Gmbh Flat support arrangement
JP7012228B2 (en) * 2017-06-13 2022-01-28 パナソニックIpマネジメント株式会社 Beauty equipment
CN107158566A (en) * 2017-06-30 2017-09-15 深圳半岛医疗有限公司 Radio frequency body-shaping treatment head and radio frequency body-shaping device
US20190059978A1 (en) * 2017-08-29 2019-02-28 Sea-Quan Su Non-invasive radio-frequency ablation system
WO2019071269A2 (en) 2017-10-06 2019-04-11 Powell Charles Lee System and method to treat obstructive sleep apnea
SG11202007028XA (en) * 2018-02-07 2020-08-28 Cynosure Inc Methods and apparatus for controlled rf treatments and rf generator system
CN108144186A (en) * 2018-02-13 2018-06-12 武汉中科科理光电技术有限公司 Skin nursing magnetoelectricity mutual benefit therapeutic equipment
KR102048383B1 (en) * 2018-05-23 2019-11-25 (주)클래시스 Rf electrode assembly for beauty treatment of skin and handpiece for beauty treatment of skin using the same
KR102048384B1 (en) * 2018-05-23 2020-01-08 (주)클래시스 Fluid rf electrode assembly for beauty treatment of skin and handpiece for beauty treatment of skin using the same
CA3101726A1 (en) * 2018-06-11 2019-12-19 Aigain Beauty Ltd. Artificial intelligence for improved skin tightening
AU2019204574A1 (en) 2018-06-27 2020-01-23 Viveve, Inc. Methods for treating urinary stress incontinence
WO2020028472A1 (en) 2018-07-31 2020-02-06 Zeltiq Aesthetics, Inc. Methods, devices, and systems for improving skin characteristics
CN108742834A (en) * 2018-08-21 2018-11-06 重庆半岛医疗科技有限公司 A kind of radiofrequency treatment device
US11395692B2 (en) * 2018-08-31 2022-07-26 Bausch Health Ireland Limited Methods and apparatus for pumping coolant to an energy delivery device
CN113423457A (en) 2019-01-16 2021-09-21 帕尔姆公司 Devices, systems, and methods for delivering electrical current to a body
CN109771816A (en) * 2019-02-19 2019-05-21 华中科技大学 A kind of electrical transcranial stimulation electrode reducing electrode edge current density
SG11202110891TA (en) 2019-04-11 2021-10-28 Btl Healthcare Tech A S Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy
CN112057744B (en) * 2019-06-11 2022-04-26 承奕科技股份有限公司 Scald preventing casing that skin equipment was used is gone into in illumination and utensil this scald preventing casing's equipment
USD1005484S1 (en) 2019-07-19 2023-11-21 Cynosure, Llc Handheld medical instrument and docking base
CN110559559B (en) * 2019-08-28 2021-04-06 徐晓婷 Device for removing eye swelling fat
KR102156034B1 (en) * 2019-09-17 2020-09-15 (주)제이시스메디칼 Apparatus for treating skin using radio frequency
KR102083392B1 (en) * 2019-10-21 2020-03-02 (주)클래시스 Ionic massage device for skin care
KR102367865B1 (en) * 2019-11-11 2022-02-25 주식회사 루트로닉 Skin patch for apparatus of generating rf-energy, apparatus of generating rf-energy and control method for that
US20220313988A1 (en) * 2019-11-11 2022-10-06 Lutronic Corporation Skin patch for rf energy-based treatment device, a rf energy-based treatment device using same, a method of controlling the same, and a rf energy-based skin treatment method
US11564732B2 (en) 2019-12-05 2023-01-31 Covidien Lp Tensioning mechanism for bipolar pencil
USD971415S1 (en) 2019-12-30 2022-11-29 Cynosure, Llc Flexible applicator
US11878167B2 (en) 2020-05-04 2024-01-23 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
CA3173876A1 (en) 2020-05-04 2021-11-11 Tomas SCHWARZ Device and method for unattended treatment of a patient
WO2021226534A1 (en) * 2020-05-07 2021-11-11 Accure Acne Inc. Photo-thermal targeted treatment system and associated methods
KR102409465B1 (en) * 2020-07-28 2022-06-16 원텍 주식회사 Apparatus for delivering high frequency energy
KR20220136112A (en) * 2021-03-31 2022-10-07 주식회사 루트로닉 Body contouring device using rf energy, control method thereof and body contouring method using the same
US20230079700A1 (en) * 2021-09-13 2023-03-16 Intelis Instruments Ltd. Double Monopolar RF Body Contouring
US11896816B2 (en) 2021-11-03 2024-02-13 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996034568A1 (en) * 1995-05-05 1996-11-07 Knowlton Edward W Apparatus for skin resurfacing
WO1999008614A1 (en) * 1997-08-13 1999-02-25 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4976709A (en) * 1988-12-15 1990-12-11 Sand Bruce J Method for collagen treatment
US6277116B1 (en) * 1994-05-06 2001-08-21 Vidaderm Systems and methods for shrinking collagen in the dermis
US5755753A (en) * 1995-05-05 1998-05-26 Thermage, Inc. Method for controlled contraction of collagen tissue
US6228078B1 (en) * 1995-11-22 2001-05-08 Arthrocare Corporation Methods for electrosurgical dermatological treatment
US6169926B1 (en) * 1998-02-27 2001-01-02 James A. Baker RF electrode array for low-rate collagen shrinkage in capsular shift procedures and methods of use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996034568A1 (en) * 1995-05-05 1996-11-07 Knowlton Edward W Apparatus for skin resurfacing
WO1999008614A1 (en) * 1997-08-13 1999-02-25 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues

Cited By (168)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7537605B2 (en) 1993-10-04 2009-05-26 Huan-Chen Li Medical device for treating skin itch and rash
US8221410B2 (en) 1996-01-05 2012-07-17 Thermage, Inc. Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient
US8685017B2 (en) 1996-01-05 2014-04-01 Thermage, Inc. Method and kit for treatment of tissue
US9907535B2 (en) 2000-12-28 2018-03-06 Ardent Sound, Inc. Visual imaging system for ultrasonic probe
WO2003043696A3 (en) * 2001-11-20 2003-10-30 Syneron Medical Ltd Device and method for skin treatment using electrical current
WO2003061497A1 (en) * 2002-01-22 2003-07-31 Syneron Medical Ltd. Rf device and method of selective thermolysis
US7238183B2 (en) 2002-01-22 2007-07-03 Syneron Medical Ltd. System and method for treating skin
KR100706155B1 (en) * 2002-02-06 2007-04-11 써메이쥐, 인크. Handpiece for rf treatment of tissue
WO2003065916A1 (en) * 2002-02-06 2003-08-14 Thermage, Inc. Handpiece for rf treatment of tissue
US10556123B2 (en) 2002-06-19 2020-02-11 Palomar Medical Technologies, Llc Method and apparatus for treatment of cutaneous and subcutaneous conditions
US10500413B2 (en) 2002-06-19 2019-12-10 Palomar Medical Technologies, Llc Method and apparatus for treatment of cutaneous and subcutaneous conditions
WO2004047659A3 (en) * 2002-11-27 2004-07-29 Christopher Paul Hancock Tissue ablation apparatus and method of ablating tissue
EP1723921A1 (en) * 2002-11-27 2006-11-22 Christopher Paul Hancock Tissue ablating apparatus
WO2004047659A2 (en) * 2002-11-27 2004-06-10 Christopher Paul Hancock Tissue ablation apparatus and method of ablating tissue
SG166000A1 (en) * 2002-12-12 2010-11-29 Skop Gmbh Ltd Electro stimulation treatment apparatus and mehtod
AU2003294151B2 (en) * 2002-12-12 2009-07-23 Skop Gmbh Ltd Electro stimulation treatment apparatus and method
JP2006509542A (en) * 2002-12-12 2006-03-23 スコップ ゲーエムベーハー リミテッド Electric acupuncture treatment apparatus and method
WO2004052446A1 (en) * 2002-12-12 2004-06-24 Skop Gmbh Ltd. Electro stimulation treatment apparatus and method
US9572978B2 (en) 2002-12-12 2017-02-21 Skop Gmbh Ltd Electro stimulation treatment apparatus and method
US7182762B2 (en) 2003-12-30 2007-02-27 Smith & Nephew, Inc. Electrosurgical device
WO2005065560A1 (en) 2003-12-30 2005-07-21 Smith & Nephew, Inc. Electrosurgical device
US10039938B2 (en) 2004-09-16 2018-08-07 Guided Therapy Systems, Llc System and method for variable depth ultrasound treatment
US9895560B2 (en) 2004-09-24 2018-02-20 Guided Therapy Systems, Llc Methods for rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US10864385B2 (en) 2004-09-24 2020-12-15 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US10328289B2 (en) 2004-09-24 2019-06-25 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US10888716B2 (en) 2004-10-06 2021-01-12 Guided Therapy Systems, Llc Energy based fat reduction
US10010721B2 (en) 2004-10-06 2018-07-03 Guided Therapy Systems, L.L.C. Energy based fat reduction
US11883688B2 (en) 2004-10-06 2024-01-30 Guided Therapy Systems, Llc Energy based fat reduction
US10525288B2 (en) 2004-10-06 2020-01-07 Guided Therapy Systems, Llc System and method for noninvasive skin tightening
US10532230B2 (en) 2004-10-06 2020-01-14 Guided Therapy Systems, Llc Methods for face and neck lifts
US10265550B2 (en) 2004-10-06 2019-04-23 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US10252086B2 (en) 2004-10-06 2019-04-09 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US10603523B2 (en) 2004-10-06 2020-03-31 Guided Therapy Systems, Llc Ultrasound probe for tissue treatment
US10245450B2 (en) 2004-10-06 2019-04-02 Guided Therapy Systems, Llc Ultrasound probe for fat and cellulite reduction
US10238894B2 (en) 2004-10-06 2019-03-26 Guided Therapy Systems, L.L.C. Energy based fat reduction
US10603519B2 (en) 2004-10-06 2020-03-31 Guided Therapy Systems, Llc Energy based fat reduction
US10610705B2 (en) 2004-10-06 2020-04-07 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US10610706B2 (en) 2004-10-06 2020-04-07 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US10046182B2 (en) 2004-10-06 2018-08-14 Guided Therapy Systems, Llc Methods for face and neck lifts
US10046181B2 (en) 2004-10-06 2018-08-14 Guided Therapy Systems, Llc Energy based hyperhidrosis treatment
US10010724B2 (en) 2004-10-06 2018-07-03 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US10010725B2 (en) 2004-10-06 2018-07-03 Guided Therapy Systems, Llc Ultrasound probe for fat and cellulite reduction
US10010726B2 (en) 2004-10-06 2018-07-03 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US9974982B2 (en) 2004-10-06 2018-05-22 Guided Therapy Systems, Llc System and method for noninvasive skin tightening
US10888718B2 (en) 2004-10-06 2021-01-12 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US11717707B2 (en) 2004-10-06 2023-08-08 Guided Therapy Systems, Llc System and method for noninvasive skin tightening
US10888717B2 (en) 2004-10-06 2021-01-12 Guided Therapy Systems, Llc Probe for ultrasound tissue treatment
US9833639B2 (en) 2004-10-06 2017-12-05 Guided Therapy Systems, L.L.C. Energy based fat reduction
US9833640B2 (en) 2004-10-06 2017-12-05 Guided Therapy Systems, L.L.C. Method and system for ultrasound treatment of skin
US9827449B2 (en) 2004-10-06 2017-11-28 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
US9827450B2 (en) 2004-10-06 2017-11-28 Guided Therapy Systems, L.L.C. System and method for fat and cellulite reduction
US11697033B2 (en) 2004-10-06 2023-07-11 Guided Therapy Systems, Llc Methods for lifting skin tissue
US10960236B2 (en) 2004-10-06 2021-03-30 Guided Therapy Systems, Llc System and method for noninvasive skin tightening
US11400319B2 (en) 2004-10-06 2022-08-02 Guided Therapy Systems, Llc Methods for lifting skin tissue
US9039619B2 (en) 2004-10-06 2015-05-26 Guided Therapy Systems, L.L.C. Methods for treating skin laxity
US9713731B2 (en) 2004-10-06 2017-07-25 Guided Therapy Systems, Llc Energy based fat reduction
US11338156B2 (en) 2004-10-06 2022-05-24 Guided Therapy Systems, Llc Noninvasive tissue tightening system
US11235179B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc Energy based skin gland treatment
US11235180B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc System and method for noninvasive skin tightening
US9707412B2 (en) 2004-10-06 2017-07-18 Guided Therapy Systems, Llc System and method for fat and cellulite reduction
US9700340B2 (en) 2004-10-06 2017-07-11 Guided Therapy Systems, Llc System and method for ultra-high frequency ultrasound treatment
US9694212B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, Llc Method and system for ultrasound treatment of skin
US11207547B2 (en) 2004-10-06 2021-12-28 Guided Therapy Systems, Llc Probe for ultrasound tissue treatment
US11179580B2 (en) 2004-10-06 2021-11-23 Guided Therapy Systems, Llc Energy based fat reduction
US9694211B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
US11167155B2 (en) 2004-10-06 2021-11-09 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US11724133B2 (en) 2004-10-07 2023-08-15 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US11207548B2 (en) 2004-10-07 2021-12-28 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
EP1827279A2 (en) * 2004-12-15 2007-09-05 Cryovascular Systems, Inc. Efficient controlled cryogenic fluid delivery into a balloon catheter and other treatment devices
EP1827279A4 (en) * 2004-12-15 2009-02-04 Cryovascular Systems Inc Efficient controlled cryogenic fluid delivery into a balloon catheter and other treatment devices
EP1707151A2 (en) 2005-03-31 2006-10-04 Sherwood Services AG Temperature regulating patient return electrode and return electrode monitoring system
EP1707151A3 (en) * 2005-03-31 2007-11-21 Covidien AG Temperature regulating patient return electrode and return electrode monitoring system
US8322348B2 (en) 2005-04-22 2012-12-04 Cynosure, Inc. Methods and systems for laser treatment using non-uniform output beam
US10434324B2 (en) 2005-04-22 2019-10-08 Cynosure, Llc Methods and systems for laser treatment using non-uniform output beam
US8317779B2 (en) 2005-04-22 2012-11-27 Cynosure, Inc. Methods and systems for laser treatment using non-uniform output beam
WO2006120647A3 (en) * 2005-05-12 2007-04-05 Compex Medical Sa Electrode for a neuromuscular stimulator
WO2006120647A2 (en) * 2005-05-12 2006-11-16 Compex Medical S.A. Electrode for a neuromuscular stimulator
EP1885252A2 (en) * 2005-05-18 2008-02-13 Tyrell, Inc. Treatment device and method for treating skin lesions through application of heat
EP1885252A4 (en) * 2005-05-18 2009-10-21 Zeno Corp Treatment device and method for treating skin lesions through application of heat
EP1759651A1 (en) * 2005-09-01 2007-03-07 Sherwood Services AG Return electrode pad with conductive element grid and method
US7957815B2 (en) 2005-10-11 2011-06-07 Thermage, Inc. Electrode assembly and handpiece with adjustable system impedance, and methods of operating an energy-based medical system to treat tissue
US8702691B2 (en) 2005-10-19 2014-04-22 Thermage, Inc. Treatment apparatus and methods for delivering energy at multiple selectable depths in tissue
WO2007131248A1 (en) * 2006-05-16 2007-11-22 Medizinische Universität Wien Surface electrode
US8700176B2 (en) 2006-07-27 2014-04-15 Pollogen Ltd. Apparatus and method for non-invasive treatment of skin tissue
US11712299B2 (en) 2006-08-02 2023-08-01 Cynosure, LLC. Picosecond laser apparatus and methods for its operation and use
US9028536B2 (en) 2006-08-02 2015-05-12 Cynosure, Inc. Picosecond laser apparatus and methods for its operation and use
US10966785B2 (en) 2006-08-02 2021-04-06 Cynosure, Llc Picosecond laser apparatus and methods for its operation and use
US10849687B2 (en) 2006-08-02 2020-12-01 Cynosure, Llc Picosecond laser apparatus and methods for its operation and use
EP1905374A1 (en) * 2006-09-28 2008-04-02 Covidien AG Smart return electrode pad
EP1905372A1 (en) * 2006-09-28 2008-04-02 Covidien AG Temperature sensing return electrode pad
EP2134293A1 (en) * 2007-04-06 2009-12-23 Stephen Flock Inductive heating of tissues using alternating magnetic fields and uses thereof
EP2134293A4 (en) * 2007-04-06 2012-12-12 Stephen Flock Inductive heating of tissues using alternating magnetic fields and uses thereof
US11717661B2 (en) 2007-05-07 2023-08-08 Guided Therapy Systems, Llc Methods and systems for ultrasound assisted delivery of a medicant to tissue
US9364287B2 (en) 2007-06-05 2016-06-14 Reliant Technologies, Inc. Method for reducing pain of dermatological treatments
US8216218B2 (en) 2007-07-10 2012-07-10 Thermage, Inc. Treatment apparatus and methods for delivering high frequency energy across large tissue areas
US9539051B2 (en) 2007-08-01 2017-01-10 Covidien Lp System and method for return electrode monitoring
US8287579B2 (en) 2007-09-17 2012-10-16 Thermage, Inc. Method of using cryogenic compositions for cooling heated skin
US8180458B2 (en) 2007-12-17 2012-05-15 Thermage, Inc. Method and apparatus for digital signal processing for radio frequency surgery measurements
US8187263B2 (en) 2008-02-04 2012-05-29 Tyco Healthcare Group Lp System and method for return electrode monitoring
US8790337B2 (en) 2008-02-04 2014-07-29 Covidien Lp System and method for return electrode monitoring
US8523853B2 (en) 2008-02-05 2013-09-03 Covidien Lp Hybrid contact quality monitoring return electrode
US9949794B2 (en) 2008-03-27 2018-04-24 Covidien Lp Microwave ablation devices including expandable antennas and methods of use
US8515553B2 (en) 2008-04-28 2013-08-20 Thermage, Inc. Methods and apparatus for predictively controlling the temperature of a coolant delivered to a treatment device
US10537304B2 (en) 2008-06-06 2020-01-21 Ulthera, Inc. Hand wand for ultrasonic cosmetic treatment and imaging
US11723622B2 (en) 2008-06-06 2023-08-15 Ulthera, Inc. Systems for ultrasound treatment
US11123039B2 (en) 2008-06-06 2021-09-21 Ulthera, Inc. System and method for ultrasound treatment
US8285392B2 (en) 2008-06-19 2012-10-09 Thermage, Inc. Leakage-resistant tissue treatment apparatus and methods of using such tissue treatment apparatus
US8121704B2 (en) 2008-06-19 2012-02-21 Thermage, Inc. Leakage-resistant tissue treatment apparatus and methods of using same
US9981143B2 (en) 2008-06-29 2018-05-29 Venus Concept Ltd. Esthetic apparatus useful for increasing skin rejuvenation and methods thereof
US8979727B2 (en) 2008-06-29 2015-03-17 Venus Concept Ltd. Esthetic apparatus useful for increasing skin rejuvenation and methods thereof
US11890486B2 (en) 2008-06-29 2024-02-06 Venus Concept Ltd. Esthetic apparatus useful for increasing skin rejuvenation and methods thereof
WO2010007614A3 (en) * 2008-06-29 2010-05-06 Venus Technologies Ltd An esthetic apparatus useful for increasing skin rejuvenation and methods thereof
US11547866B2 (en) 2008-06-29 2023-01-10 Venus Concept Ltd. Esthetic apparatus useful for increasing skin rejuvenation and methods thereof
US11684794B2 (en) 2008-06-29 2023-06-27 Venus Concept Ltd. Esthetic apparatus useful for increasing skin rejuvenation and methods thereof
US9694194B2 (en) 2008-06-29 2017-07-04 Venus Concept Ltd Esthetic apparatus useful for increasing skin rejuvenation and methods thereof
US9814897B2 (en) 2008-06-29 2017-11-14 Venus Concept Ltd. Esthetic apparatus useful for increasing skin rejuvenation and methods thereof
US10661093B2 (en) 2008-06-29 2020-05-26 Venus Concept Ltd Esthetic apparatus useful for increasing skin rejuvenation and methods thereof
US9901743B2 (en) 2008-06-29 2018-02-27 Venus Concept Ltd. Esthetic apparatus useful for increasing skin rejuvenation and methods thereof
ITBO20080781A1 (en) * 2008-12-29 2010-06-30 Spark S R L METHOD FOR THE APPLICATION OF VARIABLE ELECTROMAGNETIC FIELDS ON BIOLOGICAL FABRICS AND DEVICE THAT ACTIVATE THIS METHOD
US10111718B2 (en) 2009-04-01 2018-10-30 Covidien Lp Microwave ablation system with user-controlled ablation size and method of use
US9867670B2 (en) 2009-04-01 2018-01-16 Covidien Lp Microwave ablation system and user-controlled ablation size and method of use
US10499998B2 (en) 2009-04-01 2019-12-10 Covidien Lp Microwave ablation system with user-controlled ablation size and method of use
US8672938B2 (en) 2009-07-23 2014-03-18 Covidien Lp Active cooling system and apparatus for controlling temperature of a fluid used during treatment of biological tissue
US10194934B2 (en) 2009-07-23 2019-02-05 Covidien Lp Active cooling system and apparatus for controlling temperature of a fluid used during treatment of biological tissue
US10828100B2 (en) 2009-08-25 2020-11-10 Covidien Lp Microwave ablation with tissue temperature monitoring
US10182866B2 (en) 2009-09-29 2019-01-22 Covidien Lp Flow rate monitor for fluid cooled microwave ablation probe
US10390882B2 (en) 2009-09-29 2019-08-27 Covidien Lp Flow rate monitor for fluid cooled microwave ablation probe
US9370399B2 (en) 2009-09-29 2016-06-21 Covidien Lp Flow rate monitor for fluid cooled microwave ablation probe
US9572625B2 (en) 2009-09-29 2017-02-21 Covidien Lp Flow rate monitor for fluid cooled microwave ablation probe
US9039617B2 (en) 2009-11-24 2015-05-26 Guided Therapy Systems, Llc Methods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
ITVI20100030A1 (en) * 2010-02-12 2011-08-13 Patrizio Grando DEVICE AND METHOD FOR HEATING A LIVING BODY AND / OR TO KEEP A LIVING BODY WARM
US10183182B2 (en) 2010-08-02 2019-01-22 Guided Therapy Systems, Llc Methods and systems for treating plantar fascia
EP2646103A1 (en) * 2010-12-03 2013-10-09 Syneron Medical Ltd. A method and apparatus for improving electrode-skin contact
EP2646103A4 (en) * 2010-12-03 2014-09-10 Syneron Medical Ltd A method and apparatus for improving electrode-skin contact
US11147622B2 (en) 2011-03-09 2021-10-19 Covidien Lp Systems for thermal-feedback-controlled rate of fluid flow to fluid-cooled antenna assembly and methods of directing energy to tissue using same
US10335230B2 (en) 2011-03-09 2019-07-02 Covidien Lp Systems for thermal-feedback-controlled rate of fluid flow to fluid-cooled antenna assembly and methods of directing energy to tissue using same
US10588693B2 (en) 2011-05-31 2020-03-17 Covidien Lp Modified wet tip antenna design
US9867996B2 (en) 2011-11-16 2018-01-16 Btl Holdings Limited Methods and systems for skin treatment
US9468774B2 (en) 2011-11-16 2016-10-18 Btl Holdings Limited Methods and systems for skin treatment
US10271902B2 (en) 2012-01-06 2019-04-30 Covidien Lp System and method for treating tissue using an expandable antenna
US9693823B2 (en) 2012-01-06 2017-07-04 Covidien Lp System and method for treating tissue using an expandable antenna
US9681916B2 (en) 2012-01-06 2017-06-20 Covidien Lp System and method for treating tissue using an expandable antenna
US11095087B2 (en) 2012-04-18 2021-08-17 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US9780518B2 (en) 2012-04-18 2017-10-03 Cynosure, Inc. Picosecond laser apparatus and methods for treating target tissues with same
US10305244B2 (en) 2012-04-18 2019-05-28 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US10581217B2 (en) 2012-04-18 2020-03-03 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US11664637B2 (en) 2012-04-18 2023-05-30 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US9802063B2 (en) 2012-09-21 2017-10-31 Guided Therapy Systems, Llc Reflective ultrasound technology for dermatological treatments
US11517772B2 (en) 2013-03-08 2022-12-06 Ulthera, Inc. Devices and methods for multi-focus ultrasound therapy
US10420960B2 (en) 2013-03-08 2019-09-24 Ulthera, Inc. Devices and methods for multi-focus ultrasound therapy
US10285757B2 (en) 2013-03-15 2019-05-14 Cynosure, Llc Picosecond optical radiation systems and methods of use
US10245107B2 (en) 2013-03-15 2019-04-02 Cynosure, Inc. Picosecond optical radiation systems and methods of use
US11446086B2 (en) 2013-03-15 2022-09-20 Cynosure, Llc Picosecond optical radiation systems and methods of use
US10561862B2 (en) 2013-03-15 2020-02-18 Guided Therapy Systems, Llc Ultrasound treatment device and methods of use
US10765478B2 (en) 2013-03-15 2020-09-08 Cynosurce, Llc Picosecond optical radiation systems and methods of use
US10376693B2 (en) 2013-06-04 2019-08-13 Ya-Man Ltd. High-frequency cosmetic treatment apparatus
US11351401B2 (en) 2014-04-18 2022-06-07 Ulthera, Inc. Band transducer ultrasound therapy
US10603521B2 (en) 2014-04-18 2020-03-31 Ulthera, Inc. Band transducer ultrasound therapy
US11547462B2 (en) 2014-12-03 2023-01-10 Koninklijke Philips N.V. Radio frequency skin treatment
US9962553B2 (en) 2015-03-04 2018-05-08 Btl Holdings Limited Device and method for contactless skin treatment
US9446258B1 (en) 2015-03-04 2016-09-20 Btl Holdings Limited Device and method for contactless skin treatment
US11224895B2 (en) 2016-01-18 2022-01-18 Ulthera, Inc. Compact ultrasound device having annular ultrasound array peripherally electrically connected to flexible printed circuit board and method of assembly thereof
US11241218B2 (en) 2016-08-16 2022-02-08 Ulthera, Inc. Systems and methods for cosmetic ultrasound treatment of skin
US11944849B2 (en) 2018-02-20 2024-04-02 Ulthera, Inc. Systems and methods for combined cosmetic treatment of cellulite with ultrasound
US11418000B2 (en) 2018-02-26 2022-08-16 Cynosure, Llc Q-switched cavity dumped sub-nanosecond laser
US11791603B2 (en) 2018-02-26 2023-10-17 Cynosure, LLC. Q-switched cavity dumped sub-nanosecond laser
CN109965977A (en) * 2019-04-12 2019-07-05 深圳市是源医学科技有限公司 Improve the intelligent toxin-expelling Shaping System of human body basic metabolism
US11364076B2 (en) 2019-12-12 2022-06-21 Covidien Lp Monopolar return pad

Also Published As

Publication number Publication date
ATE298536T1 (en) 2005-07-15
CA2364098C (en) 2010-11-16
AU779100B2 (en) 2005-01-06
US6413255B1 (en) 2002-07-02
AU3741500A (en) 2000-09-28
DE60021063T2 (en) 2006-05-11
CA2364098A1 (en) 2000-09-14
ES2240078T3 (en) 2005-10-16
JP2002537939A (en) 2002-11-12
EP1158919A1 (en) 2001-12-05
JP4102031B2 (en) 2008-06-18
WO2000053113A9 (en) 2002-07-18
EP1158919B1 (en) 2005-06-29
DE60021063D1 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
CA2364098C (en) Apparatus and method for treatment of tissue
US20190247104A1 (en) Method and kit for treatment of tissue
US20190090947A1 (en) Apparatus for transcutaneously treating tissue
AU2003302939B8 (en) Apparatus for Cooling a Skin Surface and for Treating Tissue Beneath the Skin
AU2004226484B2 (en) RF electrode assembly for handpiece
US7189230B2 (en) Method for treating skin and underlying tissue
US7267675B2 (en) RF device with thermo-electric cooler
AU2003210833B2 (en) Handpiece for RF treatment of tissue
US20040000316A1 (en) Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient
US20040002705A1 (en) Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2364098

Country of ref document: CA

Ref country code: CA

Ref document number: 2364098

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 603604

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 37415/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000916288

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000916288

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/22-22/22, DRAWINGS, REPLACED BY NEW PAGES 1/22-22/22; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

WWG Wipo information: grant in national office

Ref document number: 2000916288

Country of ref document: EP